{
 "cells": [
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## Import Packages"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 1,
   "metadata": {},
   "outputs": [],
   "source": [
    "import numpy as np\n",
    "import pandas as pd\n",
    "import nltk\n",
    "import multiprocessing "
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## Upload data"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 3,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>PostId</th>\n",
       "      <th>TopicTitle</th>\n",
       "      <th>PostType</th>\n",
       "      <th>Sequence</th>\n",
       "      <th>ForumName</th>\n",
       "      <th>RawText</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>F162 T829657 original</td>\n",
       "      <td>Immunotherapy drugs for breast cancer</td>\n",
       "      <td>original</td>\n",
       "      <td>0</td>\n",
       "      <td>Immunotherapy - Before, During and After</td>\n",
       "      <td>Immuno-Oncology (IO) and Immunotherapy drugs ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>F162 T829657 post_4337424</td>\n",
       "      <td>Immunotherapy drugs for breast cancer</td>\n",
       "      <td>reply</td>\n",
       "      <td>1</td>\n",
       "      <td>Immunotherapy - Before, During and After</td>\n",
       "      <td>I'm no expert.I found this and maybe it wi...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>F162 T829657 post_4337443</td>\n",
       "      <td>Immunotherapy drugs for breast cancer</td>\n",
       "      <td>reply</td>\n",
       "      <td>2</td>\n",
       "      <td>Immunotherapy - Before, During and After</td>\n",
       "      <td>The Her2+ recurrence prevention trial I di...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>F162 T829657 post_4353477</td>\n",
       "      <td>Immunotherapy drugs for breast cancer</td>\n",
       "      <td>reply</td>\n",
       "      <td>3</td>\n",
       "      <td>Immunotherapy - Before, During and After</td>\n",
       "      <td>SpecialK what immune drug was part of your...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>F162 T829657 post_4353488</td>\n",
       "      <td>Immunotherapy drugs for breast cancer</td>\n",
       "      <td>reply</td>\n",
       "      <td>4</td>\n",
       "      <td>Immunotherapy - Before, During and After</td>\n",
       "      <td>chrissie - it was the GP2 peptide vaccine ...</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                      PostId                             TopicTitle  PostType  \\\n",
       "0      F162 T829657 original  Immunotherapy drugs for breast cancer  original   \n",
       "1  F162 T829657 post_4337424  Immunotherapy drugs for breast cancer     reply   \n",
       "2  F162 T829657 post_4337443  Immunotherapy drugs for breast cancer     reply   \n",
       "3  F162 T829657 post_4353477  Immunotherapy drugs for breast cancer     reply   \n",
       "4  F162 T829657 post_4353488  Immunotherapy drugs for breast cancer     reply   \n",
       "\n",
       "   Sequence                                 ForumName  \\\n",
       "0         0  Immunotherapy - Before, During and After   \n",
       "1         1  Immunotherapy - Before, During and After   \n",
       "2         2  Immunotherapy - Before, During and After   \n",
       "3         3  Immunotherapy - Before, During and After   \n",
       "4         4  Immunotherapy - Before, During and After   \n",
       "\n",
       "                                             RawText  \n",
       "0   Immuno-Oncology (IO) and Immunotherapy drugs ...  \n",
       "1      I'm no expert.I found this and maybe it wi...  \n",
       "2      The Her2+ recurrence prevention trial I di...  \n",
       "3      SpecialK what immune drug was part of your...  \n",
       "4      chrissie - it was the GP2 peptide vaccine ...  "
      ]
     },
     "execution_count": 3,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df = pd.read_csv('/Users/maitreyimokashi/Documents/Thesis/Data/brca_new.csv')\n",
    "df.head()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 4,
   "metadata": {},
   "outputs": [],
   "source": [
    "df[['ID', 'Post_ID', 'Post_No']] = pd.DataFrame([ x.split() for x in df['PostId'].tolist() ])"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 5,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>PostId</th>\n",
       "      <th>TopicTitle</th>\n",
       "      <th>PostType</th>\n",
       "      <th>Sequence</th>\n",
       "      <th>ForumName</th>\n",
       "      <th>RawText</th>\n",
       "      <th>ID</th>\n",
       "      <th>Post_ID</th>\n",
       "      <th>Post_No</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>F162 T829657 original</td>\n",
       "      <td>Immunotherapy drugs for breast cancer</td>\n",
       "      <td>original</td>\n",
       "      <td>0</td>\n",
       "      <td>Immunotherapy - Before, During and After</td>\n",
       "      <td>Immuno-Oncology (IO) and Immunotherapy drugs ...</td>\n",
       "      <td>F162</td>\n",
       "      <td>T829657</td>\n",
       "      <td>original</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>F162 T829657 post_4337424</td>\n",
       "      <td>Immunotherapy drugs for breast cancer</td>\n",
       "      <td>reply</td>\n",
       "      <td>1</td>\n",
       "      <td>Immunotherapy - Before, During and After</td>\n",
       "      <td>I'm no expert.I found this and maybe it wi...</td>\n",
       "      <td>F162</td>\n",
       "      <td>T829657</td>\n",
       "      <td>post_4337424</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>F162 T829657 post_4337443</td>\n",
       "      <td>Immunotherapy drugs for breast cancer</td>\n",
       "      <td>reply</td>\n",
       "      <td>2</td>\n",
       "      <td>Immunotherapy - Before, During and After</td>\n",
       "      <td>The Her2+ recurrence prevention trial I di...</td>\n",
       "      <td>F162</td>\n",
       "      <td>T829657</td>\n",
       "      <td>post_4337443</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>F162 T829657 post_4353477</td>\n",
       "      <td>Immunotherapy drugs for breast cancer</td>\n",
       "      <td>reply</td>\n",
       "      <td>3</td>\n",
       "      <td>Immunotherapy - Before, During and After</td>\n",
       "      <td>SpecialK what immune drug was part of your...</td>\n",
       "      <td>F162</td>\n",
       "      <td>T829657</td>\n",
       "      <td>post_4353477</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>F162 T829657 post_4353488</td>\n",
       "      <td>Immunotherapy drugs for breast cancer</td>\n",
       "      <td>reply</td>\n",
       "      <td>4</td>\n",
       "      <td>Immunotherapy - Before, During and After</td>\n",
       "      <td>chrissie - it was the GP2 peptide vaccine ...</td>\n",
       "      <td>F162</td>\n",
       "      <td>T829657</td>\n",
       "      <td>post_4353488</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                      PostId                             TopicTitle  PostType  \\\n",
       "0      F162 T829657 original  Immunotherapy drugs for breast cancer  original   \n",
       "1  F162 T829657 post_4337424  Immunotherapy drugs for breast cancer     reply   \n",
       "2  F162 T829657 post_4337443  Immunotherapy drugs for breast cancer     reply   \n",
       "3  F162 T829657 post_4353477  Immunotherapy drugs for breast cancer     reply   \n",
       "4  F162 T829657 post_4353488  Immunotherapy drugs for breast cancer     reply   \n",
       "\n",
       "   Sequence                                 ForumName  \\\n",
       "0         0  Immunotherapy - Before, During and After   \n",
       "1         1  Immunotherapy - Before, During and After   \n",
       "2         2  Immunotherapy - Before, During and After   \n",
       "3         3  Immunotherapy - Before, During and After   \n",
       "4         4  Immunotherapy - Before, During and After   \n",
       "\n",
       "                                             RawText    ID  Post_ID  \\\n",
       "0   Immuno-Oncology (IO) and Immunotherapy drugs ...  F162  T829657   \n",
       "1      I'm no expert.I found this and maybe it wi...  F162  T829657   \n",
       "2      The Her2+ recurrence prevention trial I di...  F162  T829657   \n",
       "3      SpecialK what immune drug was part of your...  F162  T829657   \n",
       "4      chrissie - it was the GP2 peptide vaccine ...  F162  T829657   \n",
       "\n",
       "        Post_No  \n",
       "0      original  \n",
       "1  post_4337424  \n",
       "2  post_4337443  \n",
       "3  post_4353477  \n",
       "4  post_4353488  "
      ]
     },
     "execution_count": 5,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df.head()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 79,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Frequency of Immuno-Oncology is : 2\n",
      "Frequency of (IO) is : 1\n",
      "Frequency of and is : 96\n",
      "Frequency of Immunotherapy is : 16\n",
      "Frequency of drugs is : 3\n",
      "Frequency of are is : 32\n",
      "Frequency of humanitys is : 1\n",
      "Frequency of best is : 1\n",
      "Frequency of shot is : 1\n",
      "Frequency of at is : 20\n",
      "Frequency of beating is : 1\n",
      "Frequency of cancer. is : 10\n",
      "Frequency of During is : 1\n",
      "Frequency of the is : 143\n",
      "Frequency of last is : 6\n",
      "Frequency of few is : 2\n",
      "Frequency of years, is : 2\n",
      "Frequency of IO is : 3\n",
      "Frequency of has is : 11\n",
      "Frequency of revealed is : 1\n",
      "Frequency of impressive, is : 1\n",
      "Frequency of durable is : 1\n",
      "Frequency of responses is : 1\n",
      "Frequency of in is : 79\n",
      "Frequency of a is : 90\n",
      "Frequency of variety is : 2\n",
      "Frequency of of is : 107\n",
      "Frequency of tumor is : 12\n",
      "Frequency of types is : 4\n",
      "Frequency of for is : 74\n",
      "Frequency of which is : 15\n",
      "Frequency of conventional is : 2\n",
      "Frequency of therapies is : 4\n",
      "Frequency of historically is : 2\n",
      "Frequency of have is : 22\n",
      "Frequency of had is : 13\n",
      "Frequency of limited is : 1\n",
      "Frequency of success is : 1\n",
      "Frequency of (melanoma, is : 1\n",
      "Frequency of leukemia, is : 1\n",
      "Frequency of lymphoma, is : 1\n",
      "Frequency of lung, is : 1\n",
      "Frequency of liver, is : 1\n",
      "Frequency of bladder, is : 1\n",
      "Frequency of etc). is : 1\n",
      "Frequency of The is : 27\n",
      "Frequency of power is : 2\n",
      "Frequency of this is : 27\n",
      "Frequency of approach is : 2\n",
      "Frequency of is is : 58\n",
      "Frequency of highlighted is : 1\n",
      "Frequency of countless is : 1\n",
      "Frequency of articles is : 1\n",
      "Frequency of (like is : 3\n",
      "Frequency of here is : 2\n",
      "Frequency of here) is : 2\n",
      "Frequency of as is : 20\n",
      "Frequency of well is : 4\n",
      "Frequency of TV is : 4\n",
      "Frequency of broadcasts, is : 1\n",
      "Frequency of including: is : 2\n",
      "Frequency of 1) is : 2\n",
      "Frequency of HBOs is : 1\n",
      "Frequency of Vice is : 1\n",
      "Frequency of special: is : 3\n",
      "Frequency of Killing is : 2\n",
      "Frequency of Cancer, is : 3\n",
      "Frequency of explored is : 2\n",
      "Frequency of subset is : 1\n",
      "Frequency of called is : 9\n",
      "Frequency of Virotherapy is : 1\n",
      "Frequency of how is : 5\n",
      "Frequency of following is : 8\n",
      "Frequency of three is : 3\n",
      "Frequency of common is : 2\n",
      "Frequency of viruses is : 1\n",
      "Frequency of genetically is : 2\n",
      "Frequency of modified is : 2\n",
      "Frequency of to is : 118\n",
      "Frequency of find is : 9\n",
      "Frequency of kill is : 3\n",
      "Frequency of cancer:- is : 1\n",
      "Frequency of A is : 11\n",
      "Frequency of re-engineered is : 4\n",
      "Frequency of Measles is : 1\n",
      "Frequency of virus is : 2\n",
      "Frequency of was is : 26\n",
      "Frequency of used is : 4\n",
      "Frequency of treat is : 4\n",
      "Frequency of patients is : 16\n",
      "Frequency of with is : 31\n",
      "Frequency of Multiple is : 2\n",
      "Frequency of Myeloma. is : 1\n",
      "Frequency of Adenovirus is : 1\n",
      "Frequency of cold) is : 1\n",
      "Frequency of Glioblastoma is : 2\n",
      "Frequency of (GBM) is : 1\n",
      "Frequency of brain is : 1\n",
      "Frequency of tumors. is : 1\n",
      "Frequency of HIV is : 1\n",
      "Frequency of blood is : 2\n",
      "Frequency of cancer is : 67\n",
      "Frequency of Leukemia. is : 1\n",
      "Frequency of 2) is : 3\n",
      "Frequency of 60 is : 1\n",
      "Frequency of Minutes is : 1\n",
      "Frequency of Cancer is : 20\n",
      "Frequency of focused is : 1\n",
      "Frequency of on is : 23\n",
      "Frequency of curing is : 1\n",
      "Frequency of GBM is : 1\n",
      "Frequency of by is : 15\n",
      "Frequency of using is : 3\n",
      "Frequency of Polio is : 1\n",
      "Frequency of virus. is : 1\n",
      "Frequency of 3) is : 4\n",
      "Frequency of PBS is : 1\n",
      "Frequency of Cancer: is : 3\n",
      "Frequency of Emperor is : 1\n",
      "Frequency of All is : 3\n",
      "Frequency of Maladies is : 1\n",
      "Frequency of tells is : 1\n",
      "Frequency of complete is : 4\n",
      "Frequency of story is : 4\n",
      "Frequency of cancer, is : 6\n",
      "Frequency of from is : 15\n",
      "Frequency of its is : 5\n",
      "Frequency of history is : 1\n",
      "Frequency of current is : 1\n",
      "Frequency of breakthroughs. is : 1\n",
      "Frequency of Its is : 5\n",
      "Frequency of six is : 2\n",
      "Frequency of hours is : 1\n",
      "Frequency of long, is : 1\n",
      "Frequency of broken is : 1\n",
      "Frequency of into is : 6\n",
      "Frequency of videos, is : 1\n",
      "Frequency of part is : 3\n",
      "Frequency of covering is : 1\n",
      "Frequency of IO. is : 2\n",
      "Frequency of Weve is : 1\n",
      "Frequency of reached is : 2\n",
      "Frequency of an is : 16\n",
      "Frequency of inflection is : 1\n",
      "Frequency of point is : 2\n",
      "Frequency of change is : 1\n",
      "Frequency of trajectory is : 1\n",
      "Frequency of breast is : 57\n",
      "Frequency of treatment. is : 2\n",
      "Frequency of In is : 5\n",
      "Frequency of late is : 2\n",
      "Frequency of 2015, is : 2\n",
      "Frequency of unprecedented is : 1\n",
      "Frequency of coalition is : 1\n",
      "Frequency of formed is : 1\n",
      "Frequency of accelerate is : 1\n",
      "Frequency of progress is : 4\n",
      "Frequency of Called is : 1\n",
      "Frequency of Moon is : 1\n",
      "Frequency of Shot is : 1\n",
      "Frequency of 2020 is : 2\n",
      "Frequency of (#CancerMoonShot), is : 1\n",
      "Frequency of endeavor is : 1\n",
      "Frequency of will is : 14\n",
      "Frequency of bring is : 1\n",
      "Frequency of closer is : 1\n",
      "Frequency of Immunotherapies is : 2\n",
      "Frequency of precision is : 1\n",
      "Frequency of medicine, is : 1\n",
      "Frequency of not is : 12\n",
      "Frequency of only is : 6\n",
      "Frequency of exploiting is : 1\n",
      "Frequency of genetics is : 1\n",
      "Frequency of (DNA), is : 1\n",
      "Frequency of but is : 11\n",
      "Frequency of also is : 8\n",
      "Frequency of epigenetics is : 1\n",
      "Frequency of (gene is : 1\n",
      "Frequency of expression), is : 2\n",
      "Frequency of proteomics is : 1\n",
      "Frequency of (protein is : 1\n",
      "Frequency of metabolomics is : 1\n",
      "Frequency of (cancer is : 1\n",
      "Frequency of metabolism). is : 1\n",
      "Frequency of Heres is : 3\n",
      "Frequency of couple is : 1\n",
      "Frequency of videos is : 1\n",
      "Frequency of discussing is : 2\n",
      "Frequency of effort:4) is : 1\n",
      "Frequency of MoonShot is : 2\n",
      "Frequency of 2020, is : 1\n",
      "Frequency of explained is : 1\n",
      "Frequency of very is : 11\n",
      "Frequency of simple is : 1\n",
      "Frequency of terms, is : 1\n",
      "Frequency of here. is : 5\n",
      "Frequency of 5) is : 3\n",
      "Frequency of Press is : 1\n",
      "Frequency of Conference is : 1\n",
      "Frequency of (Jan is : 1\n",
      "Frequency of 2016), is : 1\n",
      "Frequency of Listen is : 3\n",
      "Frequency of experts. is : 1\n",
      "Frequency of If is : 2\n",
      "Frequency of youre is : 3\n",
      "Frequency of smart, is : 1\n",
      "Frequency of you is : 31\n",
      "Frequency of asked is : 2\n",
      "Frequency of question: is : 1\n",
      "Frequency of can is : 10\n",
      "Frequency of immunotherapy is : 18\n",
      "Frequency of be is : 31\n",
      "Frequency of harnessed is : 1\n",
      "Frequency of Breast is : 14\n",
      "Frequency of Cancer? is : 1\n",
      "Frequency of To is : 1\n",
      "Frequency of answer is : 2\n",
      "Frequency of this, is : 1\n",
      "Frequency of I is : 97\n",
      "Frequency of researched is : 7\n",
      "Frequency of usual is : 1\n",
      "Frequency of resources is : 2\n",
      "Frequency of surprised is : 1\n",
      "Frequency of paucity is : 1\n",
      "Frequency of info. is : 3\n",
      "Frequency of Breastcancer_orgs is : 1\n",
      "Frequency of page, is : 1\n",
      "Frequency of Using is : 2\n",
      "Frequency of Immune is : 4\n",
      "Frequency of Response is : 1\n",
      "Frequency of Treat is : 1\n",
      "Frequency of BC is : 1\n",
      "Frequency of outdated is : 1\n",
      "Frequency of extremely is : 1\n",
      "Frequency of incomplete. is : 1\n",
      "Frequency of It is : 8\n",
      "Frequency of discusses is : 1\n",
      "Frequency of these is : 5\n",
      "Frequency of Monoclonal is : 4\n",
      "Frequency of Antibodies is : 1\n",
      "Frequency of (mAbs) is : 2\n",
      "Frequency of HER2+ is : 7\n",
      "Frequency of patients: is : 1\n",
      "Frequency of Herceptin is : 3\n",
      "Frequency of (trastuzumab), is : 1\n",
      "Frequency of Tykerb is : 1\n",
      "Frequency of (lapatinib), is : 1\n",
      "Frequency of Perjeta is : 1\n",
      "Frequency of (pertuzumab), is : 1\n",
      "Frequency of Kadcyla is : 2\n",
      "Frequency of (Trastuzumab is : 1\n",
      "Frequency of or is : 26\n",
      "Frequency of T-DM1). is : 1\n",
      "Frequency of Research is : 3\n",
      "Frequency of Institutes is : 1\n",
      "Frequency of webpage, is : 1\n",
      "Frequency of most is : 3\n",
      "Frequency of comprehensive is : 1\n",
      "Frequency of resource is : 2\n",
      "Frequency of US is : 1\n",
      "Frequency of based is : 2\n",
      "Frequency of research, is : 1\n",
      "Frequency of although is : 1\n",
      "Frequency of it is : 33\n",
      "Frequency of updated is : 3\n",
      "Frequency of Sept is : 1\n",
      "Frequency of 2014. is : 1\n",
      "Frequency of [Dr is : 1\n",
      "Frequency of Leisha is : 1\n",
      "Frequency of Emens is : 1\n",
      "Frequency of John is : 1\n",
      "Frequency of Hopkins is : 1\n",
      "Frequency of reviewed is : 1\n",
      "Frequency of webpage is : 1\n",
      "Frequency of March is : 2\n",
      "Frequency of 2016]. is : 1\n",
      "Frequency of written is : 1\n",
      "Frequency of that is : 50\n",
      "Frequency of been is : 7\n",
      "Frequency of considered is : 3\n",
      "Frequency of immunologically is : 1\n",
      "Frequency of silent. is : 1\n",
      "Frequency of This is : 14\n",
      "Frequency of statement is : 1\n",
      "Frequency of may is : 7\n",
      "Frequency of contribute is : 1\n",
      "Frequency of why is : 3\n",
      "Frequency of lags is : 1\n",
      "Frequency of behind is : 1\n",
      "Frequency of when is : 2\n",
      "Frequency of compared is : 1\n",
      "Frequency of other is : 12\n",
      "Frequency of cancers. is : 1\n",
      "Frequency of notion is : 1\n",
      "Frequency of particular is : 2\n",
      "Frequency of ER+ is : 5\n",
      "Frequency of disease, is : 2\n",
      "Frequency of immunogenic is : 1\n",
      "Frequency of antiquated is : 1\n",
      "Frequency of view is : 2\n",
      "Frequency of needs is : 2\n",
      "Frequency of end. is : 1\n",
      "Frequency of understand is : 1\n",
      "Frequency of early is : 1\n",
      "Frequency of days, is : 1\n",
      "Frequency of industry is : 1\n",
      "Frequency of serious is : 1\n",
      "Frequency of paradigm is : 1\n",
      "Frequency of shift. is : 1\n",
      "Frequency of comment is : 1\n",
      "Frequency of 2016 is : 4\n",
      "Frequency of CancerMoonShot is : 1\n",
      "Frequency of press is : 1\n",
      "Frequency of conference is : 1\n",
      "Frequency of here). is : 1\n",
      "Frequency of Priorities is : 1\n",
      "Frequency of should is : 3\n",
      "Frequency of realigned is : 1\n",
      "Frequency of towards is : 1\n",
      "Frequency of basic is : 1\n",
      "Frequency of science is : 1\n",
      "Frequency of then is : 2\n",
      "Frequency of translated is : 1\n",
      "Frequency of cures is : 1\n",
      "Frequency of exceed is : 1\n",
      "Frequency of 7% is : 1\n",
      "Frequency of standard is : 5\n",
      "Frequency of offer is : 1\n",
      "Frequency of metastatic is : 27\n",
      "Frequency of over is : 2\n",
      "Frequency of 10 is : 1\n",
      "Frequency of years is : 1\n",
      "Frequency of (Source: is : 1\n",
      "Frequency of Weissman, is : 1\n",
      "Frequency of June is : 1\n",
      "Frequency of 10:00 is : 1\n",
      "Frequency of minute is : 1\n",
      "Frequency of mark). is : 1\n",
      "Frequency of As is : 4\n",
      "Frequency of / is : 3\n",
      "Frequency of caretakers, is : 1\n",
      "Frequency of we is : 7\n",
      "Frequency of our is : 3\n",
      "Frequency of doctors, is : 1\n",
      "Frequency of encouraging is : 1\n",
      "Frequency of researchers is : 3\n",
      "Frequency of explore is : 1\n",
      "Frequency of supporting is : 1\n",
      "Frequency of funding is : 1\n",
      "Frequency of efforts is : 1\n",
      "Frequency of aimed is : 1\n",
      "Frequency of moving is : 1\n",
      "Frequency of field is : 1\n",
      "Frequency of forward. is : 1\n",
      "Frequency of So, is : 2\n",
      "Frequency of effort is : 1\n",
      "Frequency of advocate is : 1\n",
      "Frequency of community, is : 1\n",
      "Frequency of wanted is : 1\n",
      "Frequency of start is : 5\n",
      "Frequency of topic is : 1\n",
      "Frequency of get is : 10\n",
      "Frequency of others is : 1\n",
      "Frequency of ask is : 1\n",
      "Frequency of questions:- is : 1\n",
      "Frequency of What is : 4\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Frequency of being is : 13\n",
      "Frequency of made is : 2\n",
      "Frequency of Immunotherapy?- is : 2\n",
      "Frequency of Who is : 1\n",
      "Frequency of thought is : 4\n",
      "Frequency of leaders is : 1\n",
      "Frequency of Most is : 1\n",
      "Frequency of importantly, is : 1\n",
      "Frequency of where is : 5\n",
      "Frequency of Cancer. is : 2\n",
      "Frequency of Im is : 4\n",
      "Frequency of no is : 9\n",
      "Frequency of expert. is : 1\n",
      "Frequency of found is : 4\n",
      "Frequency of maybe is : 18\n",
      "Frequency of some is : 9\n",
      "Frequency of help. is : 1\n",
      "Frequency of Her2+ is : 2\n",
      "Frequency of recurrence is : 5\n",
      "Frequency of prevention is : 1\n",
      "Frequency of trial is : 22\n",
      "Frequency of did is : 5\n",
      "Frequency of encouragement is : 1\n",
      "Frequency of immune is : 14\n",
      "Frequency of system is : 9\n",
      "Frequency of fight is : 1\n",
      "Frequency of through is : 7\n",
      "Frequency of vaccines. is : 1\n",
      "Frequency of chrissie is : 1\n",
      "Frequency of - is : 22\n",
      "Frequency of GP2 is : 2\n",
      "Frequency of peptide is : 3\n",
      "Frequency of vaccine is : 3\n",
      "Frequency of given is : 4\n",
      "Frequency of GM-CSF. is : 1\n",
      "Frequency of two is : 2\n",
      "Frequency of armed is : 1\n",
      "Frequency of trial, is : 4\n",
      "Frequency of half is : 2\n",
      "Frequency of were is : 5\n",
      "Frequency of AE37, is : 1\n",
      "Frequency of placebo is : 2\n",
      "Frequency of vaccine. is : 1\n",
      "Frequency of GM-CSF, is : 1\n",
      "Frequency of so is : 19\n",
      "Frequency of everybody is : 1\n",
      "Frequency of got is : 1\n",
      "Frequency of something, is : 1\n",
      "Frequency of GM-CSF is : 1\n",
      "Frequency of similar is : 2\n",
      "Frequency of Neulasta/Neupogen is : 1\n",
      "Frequency of potentially is : 1\n",
      "Frequency of boosting is : 1\n",
      "Frequency of itself. is : 1\n",
      "Frequency of We is : 1\n",
      "Frequency of sorted is : 1\n",
      "Frequency of arms is : 1\n",
      "Frequency of histological is : 1\n",
      "Frequency of tissue is : 2\n",
      "Frequency of type is : 1\n",
      "Frequency of like is : 11\n",
      "Frequency of organ is : 1\n",
      "Frequency of transplant. is : 1\n",
      "Frequency of phase is : 3\n",
      "Frequency of II, is : 2\n",
      "Frequency of now is : 5\n",
      "Frequency of closed is : 2\n",
      "Frequency of enrollment. is : 1\n",
      "Frequency of There is : 7\n",
      "Frequency of word is : 1\n",
      "Frequency of yet is : 4\n",
      "Frequency of regarding is : 1\n",
      "Frequency of III. is : 2\n",
      "Frequency of Thanks is : 3\n",
      "Frequency of Phase is : 11\n",
      "Frequency of 2 is : 2\n",
      "Frequency of Neuvax is : 2\n",
      "Frequency of might is : 5\n",
      "Frequency of too is : 1\n",
      "Frequency of inquiring is : 1\n",
      "Frequency of because is : 1\n",
      "Frequency of treatment is : 10\n",
      "Frequency of supposed is : 1\n",
      "Frequency of after is : 5\n",
      "Frequency of 3rd is : 1\n",
      "Frequency of adjuva. is : 1\n",
      "Frequency of Which is : 1\n",
      "Frequency of looking is : 4\n",
      "Frequency of at? is : 1\n",
      "Frequency of neuvax is : 1\n",
      "Frequency of low is : 2\n",
      "Frequency of Her2? is : 1\n",
      "Frequency of saw is : 2\n",
      "Frequency of one is : 11\n",
      "Frequency of one- is : 1\n",
      "Frequency of II is : 4\n",
      "Frequency of Trial is : 18\n",
      "Frequency of Combination is : 8\n",
      "Frequency of Immuno. is : 1\n",
      "Frequency of SpecialK is : 1\n",
      "Frequency of am is : 20\n",
      "Frequency of reading is : 2\n",
      "Frequency of wrong is : 1\n",
      "Frequency of active is : 3\n",
      "Frequency of study. is : 1\n",
      "Frequency of link is : 2\n",
      "Frequency of appears is : 1\n",
      "Frequency of up is : 3\n",
      "Frequency of date is : 3\n",
      "Frequency of summary is : 1\n",
      "Frequency of mostly is : 1\n",
      "Frequency of lot is : 1\n",
      "Frequency of big is : 3\n",
      "Frequency of words is : 2\n",
      "Frequency of probably is : 2\n",
      "Frequency of wont is : 2\n",
      "Frequency of make is : 1\n",
      "Frequency of much is : 6\n",
      "Frequency of sense is : 2\n",
      "Frequency of unless is : 3\n",
      "Frequency of doing is : 1\n",
      "Frequency of daily is : 1\n",
      "Frequency of research. is : 2\n",
      "Frequency of Someday, is : 1\n",
      "Frequency of Ill is : 2\n",
      "Frequency of edit is : 1\n",
      "Frequency of post is : 4\n",
      "Frequency of attempt is : 1\n",
      "Frequency of match is : 1\n",
      "Frequency of appropriate is : 3\n",
      "Frequency of clinical is : 24\n",
      "Frequency of trials. is : 6\n",
      "Frequency of Will is : 2\n",
      "Frequency of help is : 3\n",
      "Frequency of us is : 6\n",
      "Frequency of cure is : 1\n",
      "Frequency of cancer?1. is : 1\n",
      "Frequency of antibodies is : 4\n",
      "Frequency of currently is : 8\n",
      "Frequency of trials is : 18\n",
      "Frequency of include: is : 18\n",
      "Frequency of Avastin is : 1\n",
      "Frequency of (bevacizumab), is : 1\n",
      "Frequency of targets is : 5\n",
      "Frequency of growth is : 7\n",
      "Frequency of factor is : 4\n",
      "Frequency of VEGF-A is : 1\n",
      "Frequency of Cyramza is : 1\n",
      "Frequency of (ramucirumab), is : 1\n",
      "Frequency of VEGFR-2 is : 2\n",
      "Frequency of MGAH22 is : 1\n",
      "Frequency of (margetuximab), is : 1\n",
      "Frequency of blocks is : 3\n",
      "Frequency of action is : 1\n",
      "Frequency of HER2 is : 6\n",
      "Frequency of OMP-18R5 is : 1\n",
      "Frequency of (vantictumab), is : 1\n",
      "Frequency of pathway is : 2\n",
      "Frequency of known is : 1\n",
      "Frequency of Wnt is : 1\n",
      "Frequency of beta-catenin is : 1\n",
      "Frequency of signaling is : 1\n",
      "Frequency of LJM716, is : 1\n",
      "Frequency of protein is : 5\n",
      "Frequency of HER3 is : 1\n",
      "Frequency of enables is : 1\n",
      "Frequency of tumors is : 12\n",
      "Frequency of become is : 3\n",
      "Frequency of resistant is : 2\n",
      "Frequency of LY2875358, is : 1\n",
      "Frequency of anti-MET is : 1\n",
      "Frequency of antibody is : 4\n",
      "Frequency of CDX-011 is : 1\n",
      "Frequency of (glembatumumab is : 1\n",
      "Frequency of vedotin) is : 1\n",
      "Frequency of IMMU-132, is : 1\n",
      "Frequency of target is : 3\n",
      "Frequency of cellular is : 1\n",
      "Frequency of proteins is : 1\n",
      "Frequency of enable is : 1\n",
      "Frequency of metastasize2. is : 1\n",
      "Frequency of Therapeutic is : 1\n",
      "Frequency of vaccines is : 2\n",
      "Frequency of NeuVax is : 4\n",
      "Frequency of (nelipepimut-S) is : 1\n",
      "Frequency of UPDATE is : 1\n",
      "Frequency of JUNE is : 1\n",
      "Frequency of 2016: is : 1\n",
      "Frequency of 3 is : 2\n",
      "Frequency of (PRESENT) is : 1\n",
      "Frequency of stopped is : 1\n",
      "Frequency of (cancelled), is : 1\n",
      "Frequency of due is : 5\n",
      "Frequency of futility. is : 1\n",
      "Frequency of unable is : 1\n",
      "Frequency of prevent is : 2\n",
      "Frequency of trial; is : 1\n",
      "Frequency of HER2-pulsed is : 1\n",
      "Frequency of dendritic is : 1\n",
      "Frequency of cell is : 9\n",
      "Frequency of vaccine; is : 1\n",
      "Frequency of E39 is : 1\n",
      "Frequency of J65, is : 1\n",
      "Frequency of tested is : 1\n",
      "Frequency of AV901, is : 1\n",
      "Frequency of helps is : 1\n",
      "Frequency of destroy is : 1\n",
      "Frequency of cells is : 13\n",
      "Frequency of express is : 1\n",
      "Frequency of INO-1400 is : 1\n",
      "Frequency of (by is : 1\n",
      "Frequency of Inovio is : 1\n",
      "Frequency of Pharmaceuticals), is : 1\n",
      "Frequency of synthetic is : 1\n",
      "Frequency of DNA is : 1\n",
      "Frequency of targeting is : 1\n",
      "Frequency of hTERT is : 2\n",
      "Frequency of antigen. is : 1\n",
      "Frequency of = is : 1\n",
      "Frequency of human is : 1\n",
      "Frequency of telomerase is : 1\n",
      "Frequency of reverse is : 1\n",
      "Frequency of transcriptase is : 1\n",
      "Frequency of [This is : 1\n",
      "Frequency of Triple is : 1\n",
      "Frequency of Negative is : 1\n",
      "Frequency of BC]. is : 1\n",
      "Frequency of Checkpoint is : 3\n",
      "Frequency of inhibitors/immune is : 1\n",
      "Frequency of modulators is : 1\n",
      "Frequency of anti-CTLA-4 is : 1\n",
      "Frequency of Yervoy is : 1\n",
      "Frequency of (ipilimumab) is : 1\n",
      "Frequency of anti-PD-1 is : 1\n",
      "Frequency of Keytruda is : 9\n",
      "Frequency of (pembrolizumab, is : 1\n",
      "Frequency of MK-3475) is : 1\n",
      "Frequency of Opdivo is : 7\n",
      "Frequency of (nivolumab) is : 1\n",
      "Frequency of anti-PD-L1 is : 1\n",
      "Frequency of MPDL3280A is : 1\n",
      "Frequency of MEDI4736 is : 1\n",
      "Frequency of MEDI6469 is : 1\n",
      "Frequency of MEDI63834. is : 1\n",
      "Frequency of adoptive is : 1\n",
      "Frequency of T is : 10\n",
      "Frequency of transfer is : 1\n",
      "Frequency of cancer: is : 1\n",
      "Frequency of Tumor is : 4\n",
      "Frequency of infiltrating is : 1\n",
      "Frequency of lymphocytes is : 2\n",
      "Frequency of (TILs) is : 2\n",
      "Frequency of removed is : 1\n",
      "Frequency of tumor, is : 1\n",
      "Frequency of boosted is : 1\n",
      "Frequency of lab, is : 1\n",
      "Frequency of back is : 2\n",
      "Frequency of patient. is : 1\n",
      "Frequency of essentially is : 1\n",
      "Frequency of CAR-T is : 1\n",
      "Frequency of Immunotherapy, is : 2\n",
      "Frequency of cured is : 1\n",
      "Frequency of number is : 1\n",
      "Frequency of people is : 3\n",
      "Frequency of hematological is : 1\n",
      "Frequency of malignancies is : 1\n",
      "Frequency of Leukemia is : 1\n",
      "Frequency of & is : 10\n",
      "Frequency of Lymphoma. is : 1\n",
      "Frequency of engineered is : 1\n",
      "Frequency of several is : 1\n",
      "Frequency of cancer-associated is : 1\n",
      "Frequency of antigens, is : 1\n",
      "Frequency of * is : 5\n",
      "Frequency of cMet is : 1\n",
      "Frequency of CEA is : 1\n",
      "Frequency of MAGE-A35. is : 1\n",
      "Frequency of Cytokines is : 1\n",
      "Frequency of include is : 1\n",
      "Frequency of interleukins:- is : 1\n",
      "Frequency of Interleukin-2, is : 1\n",
      "Frequency of important is : 2\n",
      "Frequency of white is : 1\n",
      "Frequency of Interleukin-7, is : 1\n",
      "Frequency of B is : 1\n",
      "Frequency of cells. is : 6\n",
      "Frequency of 6) is : 2\n",
      "Frequency of Adjuvant is : 1\n",
      "Frequency of immunotherapies is : 2\n",
      "Frequency of include:- is : 1\n",
      "Frequency of Indoximod, is : 1\n",
      "Frequency of IDO is : 2\n",
      "Frequency of inhibitor, is : 4\n",
      "Frequency of immunosuppressive is : 1\n",
      "Frequency of molecule is : 1\n",
      "Frequency of produced is : 1\n",
      "Frequency of cells- is : 1\n",
      "Frequency of Poly-ICLC, is : 1\n",
      "Frequency of Toll-like is : 1\n",
      "Frequency of receptor is : 1\n",
      "Frequency of (T is : 1\n",
      "Frequency of update is : 2\n",
      "Frequency of Immunotherpy is : 1\n",
      "Frequency of drug is : 5\n",
      "Frequency of (AKA: is : 2\n",
      "Frequency of Pembrolizumab, is : 1\n",
      "Frequency of MK-3475). is : 1\n",
      "Frequency of acts is : 2\n",
      "Frequency of checkpoint is : 3\n",
      "Frequency of specifically is : 3\n",
      "Frequency of PD1 is : 2\n",
      "Frequency of inhibitor. is : 3\n",
      "Frequency of PD-1 is : 2\n",
      "Frequency of (a is : 2\n",
      "Frequency of kind is : 2\n",
      "Frequency of cell). is : 2\n",
      "Frequency of removes is : 2\n",
      "Frequency of brakes is : 2\n",
      "Frequency of (biological is : 2\n",
      "Frequency of blockades) is : 2\n",
      "Frequency of keep is : 5\n",
      "Frequency of (also is : 2\n",
      "Frequency of lymphocytes) is : 2\n",
      "Frequency of attacking is : 2\n",
      "Frequency of FDA is : 3\n",
      "Frequency of approved is : 10\n",
      "Frequency of Lung is : 3\n",
      "Frequency of Melanoma is : 2\n",
      "Frequency of (think is : 1\n",
      "Frequency of former is : 1\n",
      "Frequency of President is : 1\n",
      "Frequency of Jimmy is : 1\n",
      "Frequency of Carter). is : 1\n",
      "Frequency of single is : 1\n",
      "Frequency of agent is : 1\n",
      "Frequency of (monotherapy), is : 1\n",
      "Frequency of shown is : 1\n",
      "Frequency of useful is : 1\n",
      "Frequency of TNBC is : 15\n",
      "Frequency of potential is : 1\n",
      "Frequency of just is : 6\n",
      "Frequency of reported is : 1\n",
      "Frequency of Dr is : 3\n",
      "Frequency of Hope is : 1\n",
      "Frequency of Rugo is : 1\n",
      "Frequency of UCSF, is : 1\n",
      "Frequency of here, is : 4\n",
      "Frequency of Pembrolizumabs is : 1\n",
      "Frequency of Potential is : 1\n",
      "Frequency of HER2- is : 4\n",
      "Frequency of patients.As is : 1\n",
      "Frequency of Feb is : 2\n",
      "Frequency of 2016, is : 3\n",
      "Frequency of least is : 2\n",
      "Frequency of 20 is : 2\n",
      "Frequency of different is : 3\n",
      "Frequency of listed is : 1\n",
      "Frequency of below is : 1\n",
      "Frequency of (This is : 2\n",
      "Frequency of list is : 2\n",
      "Frequency of serves is : 2\n",
      "Frequency of springboard is : 2\n",
      "Frequency of started. is : 2\n",
      "Frequency of Please is : 5\n",
      "Frequency of do is : 5\n",
      "Frequency of your is : 20\n",
      "Frequency of own is : 5\n",
      "Frequency of diligence). is : 1\n",
      "Frequency of 01 is : 1\n",
      "Frequency of [NCT02395627] is : 1\n",
      "Frequency of deals is : 2\n",
      "Frequency of Epigenetics, is : 1\n",
      "Frequency of includes is : 6\n",
      "Frequency of HDAC is : 1\n",
      "Frequency of inhibitor is : 2\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Frequency of too!02 is : 1\n",
      "Frequency of ER+, is : 3\n",
      "Frequency of [NCT02054806] is : 1\n",
      "Frequency of KEYNOTE-28 is : 1\n",
      "Frequency of trial. is : 9\n",
      "Frequency of basket is : 1\n",
      "Frequency of evaluating is : 1\n",
      "Frequency of PD-L1 is : 1\n",
      "Frequency of expression. is : 1\n",
      "Frequency of Results is : 1\n",
      "Frequency of 03) is : 1\n",
      "Frequency of IBC is : 1\n",
      "Frequency of [NCT02411656] is : 1\n",
      "Frequency of 04) is : 1\n",
      "Frequency of [NCT02648477] is : 1\n",
      "Frequency of 05) is : 1\n",
      "Frequency of [NCT02513472] is : 1\n",
      "Frequency of KEYNOTE-150 is : 1\n",
      "Frequency of trial06. is : 1\n",
      "Frequency of [NCT02447003] is : 1\n",
      "Frequency of KEYNOTE-086 is : 2\n",
      "Frequency of trial07. is : 1\n",
      "Frequency of [NCT02555657] is : 1\n",
      "Frequency of KEYNOTE-119 is : 1\n",
      "Frequency of trial08. is : 1\n",
      "Frequency of [NCT02129556] is : 1\n",
      "Frequency of PANACEA is : 2\n",
      "Frequency of trial09. is : 1\n",
      "Frequency of [NCT02318901] is : 1\n",
      "Frequency of PembroMab is : 1\n",
      "Frequency of trial10. is : 1\n",
      "Frequency of solid is : 8\n",
      "Frequency of [NCT02646748] is : 1\n",
      "Frequency of Microenvironment, is : 1\n",
      "Frequency of JAK is : 1\n",
      "Frequency of PI3K is : 1\n",
      "Frequency of 11) is : 2\n",
      "Frequency of [NCT02452424] is : 1\n",
      "Frequency of KEYNOTE-103 is : 1\n",
      "Frequency of 12) is : 2\n",
      "Frequency of [NCT02644369] is : 1\n",
      "Frequency of INSPIRE is : 1\n",
      "Frequency of 13) is : 2\n",
      "Frequency of [NCT02432963]. is : 1\n",
      "Frequency of 14) is : 2\n",
      "Frequency of [NCT02622074] is : 1\n",
      "Frequency of KEYNOTE is : 1\n",
      "Frequency of 173 is : 1\n",
      "Frequency of 15) is : 2\n",
      "Frequency of and/or is : 1\n",
      "Frequency of [NCT02178722] is : 1\n",
      "Frequency of KEYNOTE-037 is : 1\n",
      "Frequency of Inhibitor. is : 1\n",
      "Frequency of 16) is : 1\n",
      "Frequency of [NCT02331251] is : 1\n",
      "Frequency of PembroPlus is : 1\n",
      "Frequency of 17) is : 1\n",
      "Frequency of oligometastatic is : 1\n",
      "Frequency of [NCT02303366] is : 1\n",
      "Frequency of BOSTON is : 1\n",
      "Frequency of 18) is : 1\n",
      "Frequency of Any is : 1\n",
      "Frequency of invasive is : 1\n",
      "Frequency of [NCT01042379] is : 1\n",
      "Frequency of I-SPY is : 1\n",
      "Frequency of Evaluating is : 2\n",
      "Frequency of numerous is : 1\n",
      "Frequency of agents is : 2\n",
      "Frequency of among is : 1\n",
      "Frequency of 1,200 is : 1\n",
      "Frequency of patients19. is : 1\n",
      "Frequency of Unknown is : 1\n",
      "Frequency of [NCT02009449] is : 2\n",
      "Frequency of AM0010, is : 1\n",
      "Frequency of humanized is : 1\n",
      "Frequency of version is : 1\n",
      "Frequency of interleukin-10 is : 1\n",
      "Frequency of (IL-10) is : 1\n",
      "Frequency of No is : 3\n",
      "Frequency of longer is : 2\n",
      "Frequency of accepting is : 1\n",
      "Frequency of patients. is : 2\n",
      "Frequency of 20) is : 1\n",
      "Frequency of [NCT01174121] is : 1\n",
      "Frequency of involves is : 1\n",
      "Frequency of growing is : 2\n",
      "Frequency of patient-extracted is : 1\n",
      "Frequency of Infiltrate. is : 1\n",
      "Frequency of largest is : 2\n",
      "Frequency of analysis is : 1\n",
      "Frequency of function is : 2\n",
      "Frequency of suggests is : 1\n",
      "Frequency of dozens is : 1\n",
      "Frequency of new is : 5\n",
      "Frequency of uses is : 2\n",
      "Frequency of existing. is : 1\n",
      "Frequency of Nivolumab) is : 1\n",
      "Frequency of Like is : 2\n",
      "Frequency of (see is : 1\n",
      "Frequency of above), is : 1\n",
      "Frequency of Nov is : 1\n",
      "Frequency of 5 is : 2\n",
      "Frequency of cancers:1) is : 1\n",
      "Frequency of Squamous is : 1\n",
      "Frequency of non-small is : 1\n",
      "Frequency of (NCSLC) is : 1\n",
      "Frequency of Kidney is : 2\n",
      "Frequency of (renal is : 1\n",
      "Frequency of renal is : 1\n",
      "Frequency of carcinoma is : 1\n",
      "Frequency of RCC) is : 1\n",
      "Frequency of 4) is : 2\n",
      "Frequency of Hodgkin is : 1\n",
      "Frequency of Lymphoma is : 3\n",
      "Frequency of (for is : 2\n",
      "Frequency of those is : 3\n",
      "Frequency of relapsed is : 1\n",
      "Frequency of progressed is : 1\n",
      "Frequency of autologous is : 1\n",
      "Frequency of hematopoietic is : 1\n",
      "Frequency of stem is : 1\n",
      "Frequency of transplantation is : 1\n",
      "Frequency of [HSCT]) is : 1\n",
      "Frequency of Head is : 2\n",
      "Frequency of Neck is : 2\n",
      "Frequency of (SCCHN) is : 1\n",
      "Frequency of recurrent is : 1\n",
      "Frequency of squamous is : 1\n",
      "Frequency of carcinoma) is : 1\n",
      "Frequency of [Head is : 1\n",
      "Frequency of neck is : 1\n",
      "Frequency of group is : 1\n",
      "Frequency of cancers is : 6\n",
      "Frequency of oral is : 1\n",
      "Frequency of cavity, is : 1\n",
      "Frequency of larynx, is : 1\n",
      "Frequency of pharynx, is : 1\n",
      "Frequency of salivary is : 1\n",
      "Frequency of glands, is : 1\n",
      "Frequency of nose/nasal is : 1\n",
      "Frequency of passages]. is : 1\n",
      "Frequency of approval is : 1\n",
      "Frequency of III is : 3\n",
      "Frequency of CheckMate is : 1\n",
      "Frequency of -141, is : 1\n",
      "Frequency of described is : 1\n",
      "Frequency of diligence is : 1\n",
      "Frequency of [NCT01928394]A is : 1\n",
      "Frequency of 1/2, is : 1\n",
      "Frequency of Open-label is : 1\n",
      "Frequency of Study is : 22\n",
      "Frequency of Nivolumab is : 11\n",
      "Frequency of Monotherapy is : 1\n",
      "Frequency of Combined is : 1\n",
      "Frequency of With is : 19\n",
      "Frequency of Ipilimumab is : 2\n",
      "Frequency of Subjects is : 2\n",
      "Frequency of Advanced is : 10\n",
      "Frequency of Metastatic is : 3\n",
      "Frequency of Solid is : 9\n",
      "Frequency of Tumors is : 7\n",
      "Frequency of Estimated is : 27\n",
      "Frequency of Enrollment: is : 15\n",
      "Frequency of 1100 is : 1\n",
      "Frequency of Start is : 15\n",
      "Frequency of Date: is : 30\n",
      "Frequency of October is : 5\n",
      "Frequency of 2013 is : 3\n",
      "Frequency of Primary is : 15\n",
      "Frequency of Completion is : 15\n",
      "Frequency of August is : 5\n",
      "Frequency of 2017 is : 10\n",
      "Frequency of More is : 1\n",
      "Frequency of info is : 2\n",
      "Frequency of Sloan is : 1\n",
      "Frequency of Kettering, is : 1\n",
      "Frequency of locations is : 15\n",
      "Frequency of Colorado, is : 2\n",
      "Frequency of Connecticut, is : 3\n",
      "Frequency of Florida, is : 5\n",
      "Frequency of Georgia, is : 2\n",
      "Frequency of Maryland, is : 5\n",
      "Frequency of Massachusetts, is : 9\n",
      "Frequency of New is : 7\n",
      "Frequency of York, is : 6\n",
      "Frequency of North is : 3\n",
      "Frequency of Carolina, is : 3\n",
      "Frequency of Oregon, is : 4\n",
      "Frequency of Tennessee, is : 3\n",
      "Frequency of Texas, is : 5\n",
      "Frequency of Washington; is : 1\n",
      "Frequency of Canada, is : 3\n",
      "Frequency of Denmark, is : 1\n",
      "Frequency of Finland, is : 1\n",
      "Frequency of Germany, is : 2\n",
      "Frequency of Italy, is : 2\n",
      "Frequency of Spain, is : 4\n",
      "Frequency of United is : 1\n",
      "Frequency of Kingdom, is : 1\n",
      "Frequency of more2. is : 1\n",
      "Frequency of patients, is : 3\n",
      "Frequency of exception is : 2\n",
      "Frequency of [NCT02309177] is : 1\n",
      "Frequency of 1, is : 3\n",
      "Frequency of Open-Label, is : 2\n",
      "Frequency of Multicenter, is : 1\n",
      "Frequency of Safety is : 1\n",
      "Frequency of (BMS-936558) is : 1\n",
      "Frequency of Nab-Paclitaxel is : 3\n",
      "Frequency of Plus is : 2\n",
      "Frequency of Minus is : 1\n",
      "Frequency of Gemcitabine is : 1\n",
      "Frequency of Pancreatic is : 1\n",
      "Frequency of Carboplatin is : 1\n",
      "Frequency of Stage is : 5\n",
      "Frequency of IIIB/IV is : 1\n",
      "Frequency of Non-Small is : 1\n",
      "Frequency of Cell is : 2\n",
      "Frequency of 138 is : 1\n",
      "Frequency of December is : 5\n",
      "Frequency of 2014 is : 2\n",
      "Frequency of July is : 3\n",
      "Frequency of Arizona, is : 2\n",
      "Frequency of California, is : 6\n",
      "Frequency of Illinois, is : 6\n",
      "Frequency of Jersey, is : 1\n",
      "Frequency of Ohio, is : 1\n",
      "Frequency of Pennsylvania, is : 6\n",
      "Frequency of Washington, is : 2\n",
      "Frequency of Wisconsin, is : 1\n",
      "Frequency of more3. is : 1\n",
      "Frequency of IV is : 3\n",
      "Frequency of [NCT02453620] is : 1\n",
      "Frequency of 1 is : 2\n",
      "Frequency of Safety, is : 2\n",
      "Frequency of Tolerability, is : 2\n",
      "Frequency of Preliminary is : 2\n",
      "Frequency of Antitumor is : 1\n",
      "Frequency of Activity is : 2\n",
      "Frequency of Entinostat is : 1\n",
      "Frequency of Without is : 2\n",
      "Frequency of 45 is : 1\n",
      "Frequency of November is : 2\n",
      "Frequency of 2015 is : 9\n",
      "Frequency of January is : 1\n",
      "Frequency of more. is : 12\n",
      "Frequency of [NCT02499367] is : 1\n",
      "Frequency of Adaptive is : 1\n",
      "Frequency of Randomized is : 1\n",
      "Frequency of Non-comparative is : 1\n",
      "Frequency of After is : 2\n",
      "Frequency of Induction is : 1\n",
      "Frequency of Treatment is : 2\n",
      "Frequency of Triple-negative is : 1\n",
      "Frequency of (TNBC) is : 1\n",
      "Frequency of Patients: is : 1\n",
      "Frequency of TONIC-trial is : 1\n",
      "Frequency of 84 is : 1\n",
      "Frequency of 2019 is : 1\n",
      "Frequency of Netherlands, is : 1\n",
      "Frequency of more** is : 1\n",
      "Frequency of involve is : 1\n",
      "Frequency of experimental is : 1\n",
      "Frequency of various is : 1\n",
      "Frequency of (in is : 1\n",
      "Frequency of theory, is : 1\n",
      "Frequency of requires is : 1\n",
      "Frequency of verification is : 1\n",
      "Frequency of investigators): is : 1\n",
      "Frequency of Open-Label is : 1\n",
      "Frequency of Dose is : 2\n",
      "Frequency of Escalation is : 1\n",
      "Frequency of First-in-Human is : 1\n",
      "Frequency of Evaluate is : 1\n",
      "Frequency of Maximum is : 1\n",
      "Frequency of Tolerated is : 1\n",
      "Frequency of Dose, is : 1\n",
      "Frequency of Clinical is : 7\n",
      "Frequency of Pharmacokinetics is : 1\n",
      "Frequency of AM0010 is : 1\n",
      "Frequency of Patients is : 6\n",
      "Frequency of TumorsEstimated is : 2\n",
      "Frequency of 300 is : 1\n",
      "Frequency of Oklahoma, is : 1\n",
      "Frequency of [NCT02467361] is : 1\n",
      "Frequency of BBI608 is : 1\n",
      "Frequency of Administered is : 2\n",
      "Frequency of Inhibitors is : 2\n",
      "Frequency of Adult is : 2\n",
      "Frequency of Cancers is : 1\n",
      "Frequency of 120 is : 1\n",
      "Frequency of South is : 1\n",
      "Frequency of Carlina, is : 1\n",
      "Frequency of 7) is : 1\n",
      "Frequency of [NCT02423954] is : 1\n",
      "Frequency of Chemotherapy is : 1\n",
      "Frequency of (NivoPlus) is : 2\n",
      "Frequency of 49 is : 1\n",
      "Frequency of April is : 4\n",
      "Frequency of 8) is : 1\n",
      "Frequency of [NCT02483247]A is : 1\n",
      "Frequency of BBI503 is : 1\n",
      "Frequency of Selected is : 1\n",
      "Frequency of Anti-Cancer is : 1\n",
      "Frequency of Therapeutics is : 2\n",
      "Frequency of 200 is : 2\n",
      "Frequency of September is : 5\n",
      "Frequency of Indiana, is : 1\n",
      "Frequency of Louisiana, is : 1\n",
      "Frequency of Ontario is : 2\n",
      "Frequency of 9) is : 1\n",
      "Frequency of [NCT02253992]Safety is : 1\n",
      "Frequency of Tolerability is : 1\n",
      "Frequency of Urelumab is : 1\n",
      "Frequency of B-cell is : 1\n",
      "Frequency of Non-Hodgkins is : 1\n",
      "Frequency of France, is : 1\n",
      "Frequency of 10) is : 1\n",
      "Frequency of [NCT02598960]Study is : 1\n",
      "Frequency of BMS-986156 is : 1\n",
      "Frequency of Given is : 1\n",
      "Frequency of Alone is : 1\n",
      "Frequency of 260 is : 1\n",
      "Frequency of May is : 1\n",
      "Frequency of 2018 is : 4\n",
      "Frequency of Australia, is : 2\n",
      "Frequency of [NCT02423343]Study is : 1\n",
      "Frequency of Galunisertib is : 1\n",
      "Frequency of (LY2157299) is : 1\n",
      "Frequency of Refractory is : 2\n",
      "Frequency of Recurrent is : 1\n",
      "Frequency of NSCLC, is : 1\n",
      "Frequency of Hepatocellular is : 1\n",
      "Frequency of Carcinoma, is : 1\n",
      "Frequency of 100 is : 1\n",
      "Frequency of Alabama, is : 2\n",
      "Frequency of [NCT02614456]Combination is : 1\n",
      "Frequency of Interferon-gamma is : 1\n",
      "Frequency of 15 is : 1\n",
      "Frequency of (Final is : 1\n",
      "Frequency of data is : 2\n",
      "Frequency of collection is : 1\n",
      "Frequency of primary is : 1\n",
      "Frequency of outcome is : 1\n",
      "Frequency of measure)Trial is : 1\n",
      "Frequency of [NCT01714739]Phase is : 1\n",
      "Frequency of Anti-KIR is : 1\n",
      "Frequency of Antibody is : 2\n",
      "Frequency of Anti-PD1 is : 1\n",
      "Frequency of 162 is : 1\n",
      "Frequency of 2012 is : 1\n",
      "Frequency of [NCT01968109]Study is : 1\n",
      "Frequency of Anti-LAG-3 is : 1\n",
      "Frequency of Anti-PD-1 is : 1\n",
      "Frequency of 540Study is : 1\n",
      "Frequency of Michigan, is : 1\n",
      "Frequency of Japan, is : 1\n",
      "Frequency of [NCT02518958]Phase is : 1\n",
      "Frequency of I, is : 1\n",
      "Frequency of Ascending is : 1\n",
      "Frequency of RRx-001 is : 1\n",
      "Frequency of (PRIMETIME)Estimated is : 1\n",
      "Frequency of 45Study is : 1\n",
      "Frequency of Maryland. is : 1\n",
      "Frequency of media is : 1\n",
      "Frequency of recently is : 2\n",
      "Frequency of highlighting is : 1\n",
      "Frequency of remarkable is : 1\n",
      "Frequency of stories is : 1\n",
      "Frequency of achieving is : 1\n",
      "Frequency of Evidence is : 1\n",
      "Frequency of Disease is : 1\n",
      "Frequency of [NED], is : 1\n",
      "Frequency of would is : 2\n",
      "Frequency of wise is : 1\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Frequency of remind is : 1\n",
      "Frequency of everyone is : 1\n",
      "Frequency of exist. is : 1\n",
      "Frequency of 241 is : 2\n",
      "Frequency of open is : 1\n",
      "Frequency of Immunotherapy. is : 1\n",
      "Frequency of 11 is : 1\n",
      "Frequency of rest is : 1\n",
      "Frequency of trials:1) is : 1\n",
      "Frequency of Institutes: is : 1\n",
      "Frequency of FinderCall is : 1\n",
      "Frequency of 1-855-216-0127 is : 1\n",
      "Frequency of (toll-free) is : 1\n",
      "Frequency of reach is : 1\n",
      "Frequency of Navigator is : 1\n",
      "Frequency of who is : 10\n",
      "Frequency of identify is : 1\n",
      "Frequency of NIH is : 1\n",
      "Frequency of Trials: is : 2\n",
      "Frequency of ClinicalTrials_gov is : 1\n",
      "Frequency of worlds is : 1\n",
      "Frequency of database. is : 1\n",
      "Frequency of BreastCancerTrials_org is : 1\n",
      "Frequency of Focused is : 1\n",
      "Frequency of Wow, is : 1\n",
      "Frequency of Mr is : 1\n",
      "Frequency of Smith, is : 1\n",
      "Frequency of sure is : 2\n",
      "Frequency of job. is : 1\n",
      "Frequency of Your is : 3\n",
      "Frequency of lists is : 1\n",
      "Frequency of posted is : 1\n",
      "Frequency of somewhere is : 1\n",
      "Frequency of reference. is : 1\n",
      "Frequency of Looks is : 1\n",
      "Frequency of year is : 1\n",
      "Frequency of all. is : 3\n",
      "Frequency of Thanks, is : 1\n",
      "Frequency of John. is : 2\n",
      "Frequency of Herceptin/NeuVax is : 1\n",
      "Frequency of DC is : 1\n",
      "Frequency of intermediate is : 1\n",
      "Frequency of expressors. is : 1\n",
      "Frequency of Theyre is : 1\n",
      "Frequency of still is : 3\n",
      "Frequency of recruiting, is : 1\n",
      "Frequency of finished is : 1\n",
      "Frequency of again, is : 1\n",
      "Frequency of Here is : 2\n",
      "Frequency of thread is : 3\n",
      "Frequency of Inspire is : 2\n",
      "Frequency of website is : 2\n",
      "Frequency of started is : 1\n",
      "Frequency of member is : 2\n",
      "Frequency of Tumor-Infiltrating is : 1\n",
      "Frequency of Lymphocyte is : 1\n",
      "Frequency of really is : 2\n",
      "Frequency of exciting. is : 1\n",
      "Frequency of Pembrolizumab is : 1\n",
      "Frequency of (Keytruda) is : 1\n",
      "Frequency of https://clinicaltrial_gov/ct2/show/NCT02318901?te. is : 1\n",
      "Frequency of Is is : 4\n",
      "Frequency of research is : 4\n",
      "Frequency of led is : 1\n",
      "Frequency of http://m_cancerdiscovery_aacrjournals_org/content/. is : 1\n",
      "Frequency of looks is : 4\n",
      "Frequency of they is : 5\n",
      "Frequency of almost is : 3\n",
      "Frequency of all is : 8\n",
      "Frequency of breastSo, is : 1\n",
      "Frequency of now, is : 1\n",
      "Frequency of except is : 1\n",
      "Frequency of IBC?Best is : 1\n",
      "Frequency of wishes is : 1\n",
      "Frequency of Hi, is : 1\n",
      "Frequency of John!I is : 1\n",
      "Frequency of hoping is : 3\n",
      "Frequency of Emory. is : 1\n",
      "Frequency of Thank is : 6\n",
      "Frequency of posting is : 2\n",
      "Frequency of trying is : 1\n",
      "Frequency of out is : 3\n",
      "Frequency of more, is : 1\n",
      "Frequency of luck. is : 1\n",
      "Frequency of going is : 5\n",
      "Frequency of scans, is : 1\n",
      "Frequency of labs, is : 1\n",
      "Frequency of etc is : 1\n",
      "Frequency of next is : 3\n",
      "Frequency of week, is : 1\n",
      "Frequency of if is : 6\n",
      "Frequency of goes is : 2\n",
      "Frequency of week. is : 1\n",
      "Frequency of My is : 4\n",
      "Frequency of family is : 2\n",
      "Frequency of encouraged is : 1\n",
      "Frequency of what is : 6\n",
      "Frequency of told. is : 1\n",
      "Frequency of any is : 2\n",
      "Frequency of find.I is : 1\n",
      "Frequency of love is : 1\n",
      "Frequency of Hi is : 3\n",
      "Frequency of All,Have is : 1\n",
      "Frequency of heard is : 1\n",
      "Frequency of about is : 9\n",
      "Frequency of know is : 10\n",
      "Frequency of ? is : 1\n",
      "Frequency of woman is : 1\n",
      "Frequency of seen is : 2\n",
      "Frequency of 60% is : 1\n",
      "Frequency of reduction is : 2\n",
      "Frequency of her is : 3\n",
      "Frequency of since is : 1\n",
      "Frequency of receiving is : 2\n",
      "Frequency of primed is : 1\n",
      "Frequency of T-cells. is : 1\n",
      "Frequency of You is : 2\n",
      "Frequency of read is : 3\n",
      "Frequency of Sue. is : 1\n",
      "Frequency of reply is : 1\n",
      "Frequency of PM is : 1\n",
      "Frequency of tomorrow.@letmywifeliveThat is : 1\n",
      "Frequency of Infiltrating is : 1\n",
      "Frequency of Lymphocytes is : 1\n",
      "Frequency of [NCT01174121], is : 1\n",
      "Frequency of run is : 1\n",
      "Frequency of Dr. is : 3\n",
      "Frequency of Steven is : 1\n",
      "Frequency of Rosenberg is : 1\n",
      "Frequency of NCI, is : 1\n",
      "Frequency of bit is : 2\n",
      "Frequency of rockstar.The is : 1\n",
      "Frequency of trouble is : 1\n",
      "Frequency of accepts is : 1\n",
      "Frequency of failed is : 3\n",
      "Frequency of therapies. is : 2\n",
      "Frequency of Note is : 1\n",
      "Frequency of inclusion is : 1\n",
      "Frequency of criteria:All is : 1\n",
      "Frequency of must is : 6\n",
      "Frequency of refractory is : 2\n",
      "Frequency of systemic is : 1\n",
      "Frequency of therapy. is : 2\n",
      "Frequency of Specifically, is : 1\n",
      "Frequency of Ovarian is : 1\n",
      "Frequency of both is : 1\n",
      "Frequency of 1st is : 1\n",
      "Frequency of line is : 4\n",
      "Frequency of 2nd is : 1\n",
      "Frequency of treatments is : 2\n",
      "Frequency of received is : 1\n",
      "Frequency of second is : 3\n",
      "Frequency of chemotherapy is : 2\n",
      "Frequency of regimen. is : 1\n",
      "Frequency of assume is : 1\n",
      "Frequency of wife is : 1\n",
      "Frequency of wants is : 1\n",
      "Frequency of avoid is : 1\n",
      "Frequency of chemo. is : 1\n",
      "Frequency of circumvent is : 1\n",
      "Frequency of requirement. is : 1\n",
      "Frequency of think is : 6\n",
      "Frequency of good is : 4\n",
      "Frequency of idea is : 1\n",
      "Frequency of call is : 1\n",
      "Frequency of Tr is : 1\n",
      "Frequency of medicines is : 5\n",
      "Frequency of use is : 1\n",
      "Frequency of bodys is : 1\n",
      "Frequency of attack is : 3\n",
      "Frequency of network is : 1\n",
      "Frequency of organs, is : 1\n",
      "Frequency of tissues, is : 1\n",
      "Frequency of work is : 4\n",
      "Frequency of together is : 1\n",
      "Frequency of protect is : 1\n",
      "Frequency of body is : 4\n",
      "Frequency of attacks is : 1\n",
      "Frequency of foreign is : 1\n",
      "Frequency of invaders is : 2\n",
      "Frequency of such is : 2\n",
      "Frequency of bacteria, is : 1\n",
      "Frequency of parasites, is : 1\n",
      "Frequency of viruses, is : 1\n",
      "Frequency of fungi is : 1\n",
      "Frequency of cause is : 1\n",
      "Frequency of infection is : 1\n",
      "Frequency of disease. is : 1\n",
      "Frequency of When is : 1\n",
      "Frequency of their is : 1\n",
      "Frequency of way is : 3\n",
      "Frequency of -- is : 3\n",
      "Frequency of whether is : 1\n",
      "Frequency of break is : 1\n",
      "Frequency of skin, is : 1\n",
      "Frequency of example, is : 1\n",
      "Frequency of mouth is : 1\n",
      "Frequency of nose is : 1\n",
      "Frequency of systems is : 1\n",
      "Frequency of response is : 1\n",
      "Frequency of self-defense is : 1\n",
      "Frequency of works is : 2\n",
      "Frequency of getting is : 2\n",
      "Frequency of sick. is : 2\n",
      "Frequency of helping is : 1\n",
      "Frequency of harder is : 1\n",
      "Frequency of smarter is : 1\n",
      "Frequency of treatment, is : 5\n",
      "Frequency of substances is : 1\n",
      "Frequency of lab is : 1\n",
      "Frequency of improve is : 1\n",
      "Frequency of allowing is : 1\n",
      "Frequency of to: is : 1\n",
      "Frequency of stop is : 2\n",
      "Frequency of slow is : 1\n",
      "Frequency of spreading is : 1\n",
      "Frequency of parts is : 1\n",
      "Frequency of better is : 2\n",
      "Frequency of destroying is : 1\n",
      "Frequency of main is : 1\n",
      "Frequency of Breastcancer_org is : 1\n",
      "Frequency of sites is : 1\n",
      "Frequency of section is : 1\n",
      "Frequency of learn is : 3\n",
      "Frequency of more is : 5\n",
      "Frequency of about: is : 1\n",
      "Frequency of Immunotherapy? is : 1\n",
      "Frequency of Right is : 2\n",
      "Frequency of You? is : 1\n",
      "Frequency of Vaccines is : 1\n",
      "Frequency of Adoptive is : 1\n",
      "Frequency of Therapy is : 1\n",
      "Frequency of Targeted is : 1\n",
      "Frequency of Therapies is : 1\n",
      "Frequency of Cytokines. is : 1\n",
      "Frequency of come is : 1\n",
      "Frequency of forum is : 4\n",
      "Frequency of threads is : 1\n",
      "Frequency of experiences is : 1\n",
      "Frequency of immunotherapy. is : 2\n",
      "Frequency of Part is : 2\n",
      "Frequency of 28, is : 1\n",
      "Frequency of Sherene is : 2\n",
      "Frequency of Loi, is : 1\n",
      "Frequency of MD, is : 1\n",
      "Frequency of PhD is : 1\n",
      "Frequency of Loi is : 2\n",
      "Frequency of medical is : 3\n",
      "Frequency of oncologist is : 6\n",
      "Frequency of specializes is : 1\n",
      "Frequency of treating is : 2\n",
      "Frequency of addition is : 1\n",
      "Frequency of particularly is : 1\n",
      "Frequency of diagnosed is : 1\n",
      "Frequency of HER2-positive is : 1\n",
      "Frequency of she is : 3\n",
      "Frequency of leads is : 1\n",
      "Frequency of Translation is : 1\n",
      "Frequency of Genomics is : 1\n",
      "Frequency of Laboratory is : 1\n",
      "Frequency of Peter is : 1\n",
      "Frequency of MacCallum is : 1\n",
      "Frequency of Centre is : 1\n",
      "Frequency of Melbourne, is : 1\n",
      "Frequency of professor. is : 1\n",
      "Frequency of Much is : 1\n",
      "Frequency of focuses is : 1\n",
      "Frequency of investigating is : 1\n",
      "Frequency of treatments, is : 1\n",
      "Frequency of immunotherapy, is : 3\n",
      "Frequency of especially is : 1\n",
      "Frequency of treatments. is : 1\n",
      "Frequency of podcast is : 2\n",
      "Frequency of hear is : 2\n",
      "Frequency of explain:results is : 1\n",
      "Frequency of looked is : 1\n",
      "Frequency of medicine is : 2\n",
      "Frequency of (chemical is : 1\n",
      "Frequency of name: is : 1\n",
      "Frequency of pembrolizumab) is : 1\n",
      "Frequency of along is : 2\n",
      "Frequency of Herceptin-resistant, is : 1\n",
      "Frequency of HER2-positive, is : 1\n",
      "Frequency of advanced-stage is : 1\n",
      "Frequency of high is : 4\n",
      "Frequency of levels is : 1\n",
      "Frequency of PDL-1, is : 1\n",
      "Frequency of biomarker is : 1\n",
      "Frequency of indicates is : 1\n",
      "Frequency of effective is : 2\n",
      "Frequency of tumor-infiltrating is : 1\n",
      "Frequency of numbers is : 1\n",
      "Frequency of TILs is : 1\n",
      "Frequency of seem is : 1\n",
      "Frequency of respond is : 1\n",
      "Frequency of immunotherapyside is : 1\n",
      "Frequency of effects is : 2\n",
      "Frequency of Running is : 2\n",
      "Frequency of time: is : 2\n",
      "Frequency of 17:52 is : 1\n",
      "Frequency of podcast! is : 1\n",
      "Frequency of thank is : 2\n",
      "Frequency of Mods is : 1\n",
      "Frequency of letting is : 1\n",
      "Frequency of it. is : 1\n",
      "Frequency of creating is : 1\n",
      "Frequency of forum. is : 1\n",
      "Frequency of believe is : 2\n",
      "Frequency of advanced is : 2\n",
      "Frequency of form is : 2\n",
      "Frequency of support is : 1\n",
      "Frequency of encourage is : 1\n",
      "Frequency of women is : 2\n",
      "Frequency of men is : 1\n",
      "Frequency of seek. is : 1\n",
      "Frequency of go is : 2\n",
      "Frequency of many is : 2\n",
      "Frequency of near is : 1\n",
      "Frequency of future. is : 1\n",
      "Frequency of me is : 3\n",
      "Frequency of i is : 1\n",
      "Frequency of interested is : 1\n",
      "Frequency of third is : 1\n",
      "Frequency of time is : 4\n",
      "Frequency of thats is : 1\n",
      "Frequency of bad. is : 1\n",
      "Frequency of say is : 1\n",
      "Frequency of ahead, is : 1\n",
      "Frequency of hope is : 5\n",
      "Frequency of qualify is : 1\n",
      "Frequency of interest is : 1\n",
      "Frequency of generation is : 1\n",
      "Frequency of Lets is : 1\n",
      "Frequency of its. is : 1\n",
      "Frequency of Oh is : 1\n",
      "Frequency of manymoo, is : 1\n",
      "Frequency of well. is : 1\n",
      "Frequency of presently is : 2\n",
      "Frequency of treated is : 1\n",
      "Frequency of opdivo is : 1\n",
      "Frequency of my is : 20\n",
      "Frequency of stage is : 4\n",
      "Frequency of 4, is : 2\n",
      "Frequency of triple is : 2\n",
      "Frequency of negative, is : 1\n",
      "Frequency of pleomorphic is : 1\n",
      "Frequency of lobular is : 1\n",
      "Frequency of At is : 3\n",
      "Frequency of began is : 4\n",
      "Frequency of 6 is : 1\n",
      "Frequency of lines is : 1\n",
      "Frequency of therapy is : 3\n",
      "Frequency of 4 is : 4\n",
      "Frequency of referred is : 1\n",
      "Frequency of hospice is : 1\n",
      "Frequency of care. is : 1\n",
      "Frequency of Little is : 1\n",
      "Frequency of cusp is : 1\n",
      "Frequency of experiencing is : 1\n",
      "Frequency of level is : 2\n",
      "Frequency of healing is : 1\n",
      "Frequency of feels is : 2\n",
      "Frequency of nothing is : 3\n",
      "Frequency of short is : 1\n",
      "Frequency of miraculous.Following is : 1\n",
      "Frequency of emergency is : 1\n",
      "Frequency of surgery is : 2\n",
      "Frequency of UCSD, is : 1\n",
      "Frequency of San is : 1\n",
      "Frequency of Diego, is : 1\n",
      "Frequency of CA, is : 1\n",
      "Frequency of learned is : 1\n",
      "Frequency of I-Predict is : 1\n",
      "Frequency of (https://clinicaltrials.gov/ct2/show/NCT02534675). is : 1\n",
      "Frequency of purpose is : 1\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Frequency of study is : 1\n",
      "Frequency of personalized is : 1\n",
      "Frequency of Genomic is : 1\n",
      "Frequency of testing is : 2\n",
      "Frequency of develop is : 2\n",
      "Frequency of plan is : 2\n",
      "Frequency of targeted is : 2\n",
      "Frequency of Due is : 1\n",
      "Frequency of mutation is : 1\n",
      "Frequency of burden is : 1\n",
      "Frequency of PD-1, is : 1\n",
      "Frequency of candidate is : 1\n",
      "Frequency of opdivo.Here is : 1\n",
      "Frequency of BENEFIT:After is : 1\n",
      "Frequency of infusions is : 1\n",
      "Frequency of markers is : 2\n",
      "Frequency of dropped is : 1\n",
      "Frequency of significantly is : 1\n",
      "Frequency of (82% is : 1\n",
      "Frequency of 94%). is : 1\n",
      "Frequency of mid is : 1\n",
      "Frequency of February is : 1\n",
      "Frequency of July, is : 1\n",
      "Frequency of within is : 3\n",
      "Frequency of normal is : 2\n",
      "Frequency of range. is : 1\n",
      "Frequency of 8 is : 1\n",
      "Frequency of weeks is : 2\n",
      "Frequency of CT is : 1\n",
      "Frequency of scans is : 1\n",
      "Frequency of suggested is : 1\n",
      "Frequency of response. is : 1\n",
      "Frequency of lesions is : 1\n",
      "Frequency of visible! is : 1\n",
      "Frequency of feeling is : 1\n",
      "Frequency of great! is : 1\n",
      "Frequency of fact, is : 1\n",
      "Frequency of January, is : 1\n",
      "Frequency of confirmed is : 1\n",
      "Frequency of previously is : 2\n",
      "Frequency of GI is : 2\n",
      "Frequency of tract is : 2\n",
      "Frequency of GONE. is : 1\n",
      "Frequency of able is : 2\n",
      "Frequency of recognize is : 1\n",
      "Frequency of RISKS:Immunotherapy is : 1\n",
      "Frequency of super-charges is : 1\n",
      "Frequency of system. is : 1\n",
      "Frequency of risk is : 1\n",
      "Frequency of autoimmune is : 1\n",
      "Frequency of disorders. is : 1\n",
      "Frequency of disorders is : 2\n",
      "Frequency of range is : 2\n",
      "Frequency of scary is : 2\n",
      "Frequency of things is : 3\n",
      "Frequency of like: is : 1\n",
      "Frequency of lupus, is : 1\n",
      "Frequency of inflammation, is : 1\n",
      "Frequency of rheumatoid is : 1\n",
      "Frequency of arthritis is : 1\n",
      "Frequency of (RA), is : 1\n",
      "Frequency of scleroderma, is : 1\n",
      "Frequency of liver is : 1\n",
      "Frequency of disorders, is : 2\n",
      "Frequency of thyroid is : 1\n",
      "Frequency of pituitary is : 1\n",
      "Frequency of gland is : 1\n",
      "Frequency of small is : 1\n",
      "Frequency of manageable is : 1\n",
      "Frequency of occasional is : 1\n",
      "Frequency of UTI, is : 1\n",
      "Frequency of conjunctivitis, is : 1\n",
      "Frequency of skin is : 2\n",
      "Frequency of rash is : 1\n",
      "Frequency of treatable is : 1\n",
      "Frequency of -itis. is : 1\n",
      "Frequency of uncommon.Here is : 1\n",
      "Frequency of side is : 2\n",
      "Frequency of effects:My is : 1\n",
      "Frequency of joints is : 2\n",
      "Frequency of enlarge is : 1\n",
      "Frequency of though is : 1\n",
      "Frequency of pain, is : 1\n",
      "Frequency of appeared is : 1\n",
      "Frequency of developing is : 1\n",
      "Frequency of RA. is : 1\n",
      "Frequency of Symptoms is : 1\n",
      "Frequency of feel is : 2\n",
      "Frequency of fine is : 1\n",
      "Frequency of (several is : 1\n",
      "Frequency of fingers is : 1\n",
      "Frequency of remain is : 2\n",
      "Frequency of enlarged). is : 1\n",
      "Frequency of eczema is : 1\n",
      "Frequency of flare is : 1\n",
      "Frequency of ups is : 1\n",
      "Frequency of went is : 3\n",
      "Frequency of away. is : 1\n",
      "Frequency of occasions is : 1\n",
      "Frequency of conjunctivitis is : 1\n",
      "Frequency of apparent is : 1\n",
      "Frequency of reason. is : 1\n",
      "Frequency of away is : 1\n",
      "Frequency of eye is : 1\n",
      "Frequency of drops. is : 1\n",
      "Frequency of hands is : 1\n",
      "Frequency of showed is : 2\n",
      "Frequency of symptoms is : 1\n",
      "Frequency of scleroderma. is : 1\n",
      "Frequency of away.MORE is : 1\n",
      "Frequency of BENEFITS:I is : 1\n",
      "Frequency of ALIVE. is : 1\n",
      "Frequency of NO is : 1\n",
      "Frequency of EVIDENCE is : 1\n",
      "Frequency of OF is : 1\n",
      "Frequency of DISEASE is : 1\n",
      "Frequency of ANYWHERE!! is : 1\n",
      "Frequency of Before is : 1\n",
      "Frequency of markers, is : 1\n",
      "Frequency of CA27.29, is : 1\n",
      "Frequency of 1300. is : 1\n",
      "Frequency of For is : 1\n",
      "Frequency of 12 is : 1\n",
      "Frequency of months, is : 1\n",
      "Frequency of remained is : 1\n",
      "Frequency of less is : 1\n",
      "Frequency of than is : 2\n",
      "Frequency of 38.6. is : 1\n",
      "Frequency of perhaps is : 2\n",
      "Frequency of 1-2 is : 1\n",
      "Frequency of months is : 1\n",
      "Frequency of live. is : 1\n",
      "Frequency of grateful is : 4\n",
      "Frequency of alive! is : 1\n",
      "Frequency of Sometimes is : 1\n",
      "Frequency of wake is : 1\n",
      "Frequency of long is : 1\n",
      "Frequency of before is : 1\n",
      "Frequency of daylight is : 1\n",
      "Frequency of same is : 1\n",
      "Frequency of joy is : 1\n",
      "Frequency of excitement is : 1\n",
      "Frequency of child is : 1\n",
      "Frequency of Christmas is : 1\n",
      "Frequency of morning. is : 1\n",
      "Frequency of young is : 1\n",
      "Frequency of child, is : 1\n",
      "Frequency of force is : 1\n",
      "Frequency of myself is : 2\n",
      "Frequency of bed is : 2\n",
      "Frequency of until is : 1\n",
      "Frequency of first is : 1\n",
      "Frequency of light is : 1\n",
      "Frequency of day. is : 1\n",
      "Frequency of Then is : 1\n",
      "Frequency of bounce is : 1\n",
      "Frequency of confident is : 1\n",
      "Frequency of day is : 2\n",
      "Frequency of overflow is : 1\n",
      "Frequency of gifts. is : 1\n",
      "Frequency of And is : 1\n",
      "Frequency of does!I is : 1\n",
      "Frequency of God is : 3\n",
      "Frequency of gift is : 1\n",
      "Frequency of friends. is : 1\n",
      "Frequency of unraveling is : 1\n",
      "Frequency of mysteries is : 1\n",
      "Frequency of associated is : 1\n",
      "Frequency of sharing is : 1\n",
      "Frequency of cup is : 1\n",
      "Frequency of someone is : 2\n",
      "Frequency of need. is : 1\n",
      "Frequency of While is : 1\n",
      "Frequency of cannot is : 1\n",
      "Frequency of recurrence, is : 1\n",
      "Frequency of today. is : 1\n",
      "Frequency of gift!!Friend, is : 1\n",
      "Frequency of leave is : 1\n",
      "Frequency of stone is : 1\n",
      "Frequency of unturned. is : 1\n",
      "Frequency of Explore is : 1\n",
      "Frequency of Pursue is : 1\n",
      "Frequency of genomic is : 1\n",
      "Frequency of see is : 8\n",
      "Frequency of another is : 2\n",
      "Frequency of benefit is : 1\n",
      "Frequency of you. is : 3\n",
      "Frequency of From is : 2\n",
      "Frequency of rear is : 1\n",
      "Frequency of mirror, is : 1\n",
      "Frequency of hand is : 1\n",
      "Frequency of glove is : 1\n",
      "Frequency of circumstances is : 1\n",
      "Frequency of permitted is : 1\n",
      "Frequency of alive is : 1\n",
      "Frequency of today is : 1\n",
      "Frequency of write is : 1\n",
      "Frequency of readying. is : 1\n",
      "Frequency of pray is : 2\n",
      "Frequency of story. is : 1\n",
      "Frequency of Dear is : 2\n",
      "Frequency of HealingHopeYour is : 1\n",
      "Frequency of inspiring is : 1\n",
      "Frequency of informative! is : 1\n",
      "Frequency of you! is : 2\n",
      "Frequency of glad is : 1\n",
      "Frequency of results is : 1\n",
      "Frequency of gotten! is : 1\n",
      "Frequency of That is : 1\n",
      "Frequency of amazing. is : 1\n",
      "Frequency of Medicine is : 1\n",
      "Frequency of owes is : 1\n",
      "Frequency of intrepid is : 1\n",
      "Frequency of brave is : 1\n",
      "Frequency of willing is : 1\n",
      "Frequency of lay is : 1\n",
      "Frequency of try is : 3\n",
      "Frequency of sounds is : 1\n",
      "Frequency of promising. is : 1\n",
      "Frequency of sorry is : 2\n",
      "Frequency of unpleasant is : 1\n",
      "Frequency of suffered is : 1\n",
      "Frequency of said is : 3\n",
      "Frequency of yay! is : 1\n",
      "Frequency of alive. is : 1\n",
      "Frequency of salute is : 1\n",
      "Frequency of progress.Thank is : 1\n",
      "Frequency of situation is : 1\n",
      "Frequency of hardest is : 1\n",
      "Frequency of myself. is : 1\n",
      "Frequency of dont is : 4\n",
      "Frequency of staging is : 1\n",
      "Frequency of recent is : 1\n",
      "Frequency of guess is : 1\n",
      "Frequency of normally is : 1\n",
      "Frequency of Healing is : 1\n",
      "Frequency of hope, is : 1\n",
      "Frequency of inspirational is : 1\n",
      "Frequency of is.... is : 1\n",
      "Frequency of tomorrow is : 1\n",
      "Frequency of discuss is : 1\n",
      "Frequency of wait is : 1\n",
      "Frequency of see. is : 1\n",
      "Frequency of Fingers is : 1\n",
      "Frequency of crossed is : 1\n",
      "Frequency of Amica, is : 1\n",
      "Frequency of forgot is : 1\n",
      "Frequency of posts. is : 1\n",
      "Frequency of w is : 1\n",
      "Frequency of mandymooI is : 1\n",
      "Frequency of chemo is : 1\n",
      "Frequency of failures is : 1\n",
      "Frequency of IV. is : 1\n",
      "Frequency of frightening. is : 1\n",
      "Frequency of worth is : 2\n",
      "Frequency of shot, is : 1\n",
      "Frequency of future is : 1\n",
      "Frequency of fervently is : 1\n",
      "Frequency of achieve is : 1\n",
      "Frequency of outcome. is : 1\n",
      "Frequency of let is : 1\n",
      "Frequency of apparent;y is : 1\n",
      "Frequency of ATX is : 1\n",
      "Frequency of 101. is : 1\n",
      "Frequency of placebos. is : 1\n",
      "Frequency of waiting is : 1\n",
      "Frequency of paperwork is : 1\n",
      "Frequency of mail is : 1\n",
      "Frequency of teleconference. is : 1\n",
      "Frequency of there is : 7\n",
      "Frequency of doesnt is : 2\n",
      "Frequency of appear is : 1\n",
      "Frequency of papers is : 1\n",
      "Frequency of information is : 1\n",
      "Frequency of him is : 1\n",
      "Frequency of weeks. is : 1\n",
      "Frequency of moment is : 1\n",
      "Frequency of confused is : 1\n",
      "Frequency of thinking is : 1\n",
      "Frequency of opinion, is : 1\n",
      "Frequency of happens is : 1\n",
      "Frequency of Mandymoo,Good is : 1\n",
      "Frequency of Let is : 1\n",
      "Frequency of opinion is : 1\n",
      "Frequency of 10, is : 1\n",
      "Frequency of Jennifer is : 2\n",
      "Frequency of Litton, is : 1\n",
      "Frequency of M.D. is : 1\n",
      "Frequency of Litton is : 2\n",
      "Frequency of board is : 1\n",
      "Frequency of certified is : 1\n",
      "Frequency of associate is : 1\n",
      "Frequency of professor is : 1\n",
      "Frequency of oncology is : 1\n",
      "Frequency of University is : 1\n",
      "Frequency of Texas is : 1\n",
      "Frequency of MD is : 1\n",
      "Frequency of Anderson is : 1\n",
      "Frequency of Center is : 1\n",
      "Frequency of Houston, is : 1\n",
      "Frequency of chief is : 1\n",
      "Frequency of Section is : 1\n",
      "Frequency of Drug is : 1\n",
      "Frequency of Development is : 1\n",
      "Frequency of She is : 1\n",
      "Frequency of Task is : 1\n",
      "Frequency of Force is : 1\n",
      "Frequency of National is : 1\n",
      "Frequency of Institute.Listen is : 1\n",
      "Frequency of discuss:how is : 1\n",
      "Frequency of workwhy is : 1\n",
      "Frequency of havent is : 1\n",
      "Frequency of seemed is : 1\n",
      "Frequency of cancersthe is : 1\n",
      "Frequency of direction is : 1\n",
      "Frequency of 13:35Listen is : 1\n",
      "Frequency of o is : 1\n",
      "Frequency of Ive is : 1\n",
      "Frequency of certainly is : 1\n",
      "Frequency of promising is : 2\n",
      "Frequency of negative is : 1\n",
      "Frequency of participants is : 1\n",
      "Frequency of low-level is : 1\n",
      "Frequency of Her2, is : 1\n",
      "Frequency of was. is : 1\n",
      "Frequency of 70% is : 1\n",
      "Frequency of recurrence. is : 1\n",
      "Frequency of ahead is : 1\n",
      "Frequency of schedule is : 1\n",
      "Frequency of meeting is : 1\n",
      "Frequency of objectives. is : 1\n",
      "Frequency of approval. is : 2\n",
      "Frequency of hold-up? is : 1\n",
      "Frequency of process is : 1\n",
      "Frequency of frustrating. is : 1\n",
      "Frequency of Try is : 1\n",
      "Frequency of legislation is : 1\n",
      "Frequency of apply is : 1\n",
      "Frequency of pCR is : 1\n",
      "Frequency of neoadjuvant is : 1\n",
      "Frequency of chemo? is : 1\n",
      "Frequency of Also, is : 2\n",
      "Frequency of areas is : 1\n",
      "Frequency of country is : 1\n",
      "Frequency of trials? is : 1\n",
      "Frequency of live is : 1\n",
      "Frequency of its is : 1\n",
      "Frequency of tnfrith, is : 1\n",
      "Frequency of thanks is : 2\n",
      "Frequency of posting!All is : 1\n",
      "Frequency of great is : 2\n",
      "Frequency of questions is : 1\n",
      "Frequency of Were is : 1\n",
      "Frequency of questions, is : 1\n",
      "Frequency of bet is : 1\n",
      "Frequency of thered is : 1\n",
      "Frequency of insight is : 1\n",
      "Frequency of members is : 2\n",
      "Frequency of either is : 2\n",
      "Frequency of Trials is : 1\n",
      "Frequency of Feel is : 1\n",
      "Frequency of free is : 1\n",
      "Frequency of place is : 1\n",
      "Frequency of anyon is : 1\n",
      "Frequency of All,Im is : 1\n",
      "Frequency of confused. is : 1\n",
      "Frequency of not. is : 1\n",
      "Frequency of cant is : 2\n",
      "Frequency of anything is : 3\n",
      "Frequency of substantial is : 1\n",
      "Frequency of internet. is : 1\n",
      "Frequency of Onc is : 1\n",
      "Frequency of Doc is : 1\n",
      "Frequency of isnt is : 2\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Frequency of truly is : 1\n",
      "Frequency of valuable is : 1\n",
      "Frequency of yet.I is : 1\n",
      "Frequency of er+ is : 1\n",
      "Frequency of pr is : 1\n",
      "Frequency of ductal is : 1\n",
      "Frequency of carcinoma. is : 1\n",
      "Frequency of Mets is : 1\n",
      "Frequency of bones. is : 1\n",
      "Frequency of quickly is : 1\n",
      "Frequency of becoming is : 1\n",
      "Frequency of multi-treatment is : 1\n",
      "Frequency of resistant. is : 1\n",
      "Frequency of meds is : 1\n",
      "Frequency of crapped is : 1\n",
      "Frequency of shortly is : 1\n",
      "Frequency of worked is : 1\n",
      "Frequency of market is : 1\n",
      "Frequency of Mudpie, is : 1\n",
      "Frequency of arent is : 1\n",
      "Frequency of yet. is : 2\n",
      "Frequency of BCO is : 1\n",
      "Frequency of Look is : 1\n",
      "Frequency of topics, is : 1\n",
      "Frequency of traditional is : 1\n",
      "Frequency of tried is : 1\n",
      "Frequency of first. is : 1\n",
      "Frequency of upsetting is : 2\n",
      "Frequency of makes is : 1\n",
      "Frequency of instead is : 1\n",
      "Frequency of blanket is : 1\n",
      "Frequency of poison is : 1\n",
      "Frequency of fast is : 1\n",
      "Frequency of risky is : 1\n",
      "Frequency of business is : 1\n",
      "Frequency of healthy is : 1\n",
      "Frequency of organs. is : 1\n",
      "Frequency of Commercials is : 1\n",
      "Frequency of tv is : 1\n",
      "Frequency of making is : 1\n",
      "Frequency of sound is : 1\n",
      "Frequency of far is : 1\n",
      "Frequency of NOT. is : 1\n",
      "Frequency of absolutely is : 1\n",
      "Frequency of working. is : 1\n",
      "Frequency of disease is : 1\n",
      "Frequency of understand, is : 1\n",
      "Frequency of NED is : 1\n",
      "Frequency of Opdivo. is : 2\n",
      "Frequency of However, is : 2\n",
      "Frequency of care is : 1\n",
      "Frequency of everyone. is : 1\n",
      "Frequency of does is : 1\n",
      "Frequency of help, is : 1\n",
      "Frequency of miracle. is : 1\n",
      "Frequency of access is : 1\n",
      "Frequency of cinical is : 1\n",
      "Frequency of point. is : 1\n",
      "Frequency of Maybe is : 1\n",
      "Frequency of take is : 2\n",
      "Frequency of look is : 2\n",
      "Frequency of www.cinicaltrials.gov, is : 1\n",
      "Frequency of fit. is : 1\n",
      "Frequency of Rebek is : 1\n",
      "Frequency of You, is : 1\n",
      "Frequency of related is : 1\n",
      "Frequency of Opdivo, is : 1\n",
      "Frequency of Mudpie is : 1\n",
      "Frequency of need is : 1\n",
      "Frequency of search is : 1\n",
      "Frequency of nivolumab. is : 1\n",
      "Frequency of 31 is : 1\n",
      "Frequency of recruiting. is : 1\n",
      "Frequency of passive is : 2\n",
      "Frequency of Herceptin, is : 1\n",
      "Frequency of Perjeta, is : 1\n",
      "Frequency of (TDM-1) is : 1\n",
      "Frequency of immunotherapies, is : 1\n",
      "Frequency of Those is : 1\n",
      "Frequency of aware is : 1\n",
      "Frequency of something is : 1\n",
      "Frequency of else is : 1\n",
      "Frequency of approved. is : 1\n",
      "Frequency of Unfortunately is : 1\n",
      "Frequency of 20% is : 1\n",
      "Frequency of advantage is : 1\n",
      "Frequency of them is : 1\n",
      "Frequency of (and is : 1\n",
      "Frequency of give is : 1\n",
      "Frequency of every is : 1\n",
      "Frequency of 20%). is : 1\n",
      "Frequency of profile is : 1\n",
      "Frequency of visible is : 1\n",
      "Frequency of (or is : 1\n",
      "Frequency of hasnt is : 1\n",
      "Frequency of added) is : 1\n",
      "Frequency of status is : 1\n",
      "Frequency of youve is : 1\n",
      "Frequency of had. is : 1\n",
      "Frequency of Keytruda, is : 1\n",
      "Frequency of check is : 2\n",
      "Frequency of yet, is : 2\n",
      "Frequency of seems is : 1\n",
      "Frequency of close is : 1\n",
      "Frequency of TNBC. is : 1\n",
      "Frequency of Theres is : 1\n",
      "Frequency of (AFAIK) is : 1\n",
      "Frequency of HER2+, is : 1\n",
      "Frequency of CART is : 1\n",
      "Frequency of inhibitors. is : 1\n",
      "Frequency of quick is : 1\n",
      "Frequency of 93 is : 1\n",
      "Frequency of (66 is : 1\n",
      "Frequency of recruiting) is : 1\n",
      "Frequency of just. is : 1\n",
      "Frequency of thru is : 1\n",
      "Frequency of offered is : 1\n",
      "Frequency of opportunity is : 1\n",
      "Frequency of sign is : 1\n",
      "Frequency of mean is : 1\n",
      "Frequency of picked. is : 1\n"
     ]
    }
   ],
   "source": [
    "def freq(str): \n",
    "  \n",
    "    # break the string into list of words  \n",
    "    str = str.split()          \n",
    "    str2 = [] \n",
    "  \n",
    "    # loop till string values present in list str \n",
    "    for i in str:              \n",
    "  \n",
    "        # checking for the duplicacy \n",
    "        if i not in str2: \n",
    "  \n",
    "            # insert value in str2 \n",
    "            str2.append(i)  \n",
    "              \n",
    "    for i in range(0, len(str2)): \n",
    "  \n",
    "        # count the frequency of each word(present  \n",
    "        # in str2) in str and print \n",
    "        print('Frequency of', str2[i], 'is :', str.count(str2[i]))     \n",
    "\n",
    "def main(): \n",
    "    str = \"Immuno-Oncology (IO) and Immunotherapy drugs are humanitys best shot at beating cancer. During the last few years, IO has revealed impressive, durable responses in a variety of tumor types for which conventional therapies historically have had limited success (melanoma, leukemia, lymphoma, lung, liver, bladder, etc). The power of this approach is highlighted in countless articles (like here and here) as well as a variety of TV broadcasts, including: 1) HBOs Vice TV special: Killing Cancer, explored a subset of IO called Virotherapy and how the following three common viruses are genetically modified to find and kill cancer:- A re-engineered Measles virus was used to treat patients with Multiple Myeloma. A re-engineered Adenovirus (like the common cold) to treat patients with Glioblastoma (GBM) brain tumors. A re-engineered HIV virus to treat patients with the blood cancer Leukemia. 2) 60 Minutes TV special: Killing Cancer focused on curing GBM by using a re-engineered Polio virus. 3) PBS TV special: Cancer: The Emperor of All Maladies tells the complete story of cancer, from its history to current breakthroughs. Its six hours long, broken into three videos, with the last part covering IO. Weve reached an inflection point to change the trajectory of breast cancer treatment. In late 2015, an unprecedented coalition was formed to accelerate progress in IO. Called the Cancer Moon Shot 2020 (#CancerMoonShot), this endeavor will bring patients closer to Immunotherapies and precision medicine, by not only exploiting genetics (DNA), but also epigenetics (gene expression), proteomics (protein expression), metabolomics (cancer metabolism). Heres a couple videos discussing the effort:4) Cancer MoonShot 2020, explained in very simple terms, here. 5) Cancer MoonShot 2020 Press Conference (Jan 2016), here. Listen to the experts. If youre smart, you asked the question: how can immunotherapy be harnessed in Breast Cancer?  To answer this, I researched the usual resources and was surprised at the paucity of info. Breastcancer_orgs page, Using the Immune Response to Treat BC is outdated and extremely incomplete. It only discusses these Monoclonal Antibodies (mAbs) used for HER2+ patients: Herceptin (trastuzumab), Tykerb (lapatinib), Perjeta (pertuzumab), Kadcyla (Trastuzumab or T-DM1). The Cancer Research Institutes webpage, Immunotherapy for Breast Cancer, is the most comprehensive resource for US based research, although it was last updated Sept 2014. [Dr Leisha Emens of John Hopkins reviewed and updated the webpage in March 2016]. Its written that breast cancer has historically been considered immunologically silent. This statement may contribute to why breast cancer lags behind when compared to other cancers. This notion that breast cancer, in particular ER+ disease, is not very immunogenic is an antiquated view that needs to end. I understand its early days, but the breast cancer industry needs a serious paradigm shift. Listen to this comment at the 2016 CancerMoonShot press conference here). Priorities should be realigned towards the basic science of IO and then translated into cures that exceed the 7% that standard therapies offer metastatic patients over 10 years (Source: Weissman, June 2015, 10:00 minute mark). As patients / caretakers, we should be discussing Immunotherapies with our doctors, encouraging breast cancer researchers to explore this approach and supporting funding efforts aimed at moving the field forward. So, in a effort to advocate for this community, I wanted to start this topic and get others to ask these questions:- What progress is being made in Breast Cancer Immunotherapy?- Who are the thought leaders and researchers in Breast Cancer Immunotherapy?- Most importantly, where are the Breast Cancer. Im no expert. I found this and maybe it will be of some help. The Her2+ recurrence prevention trial I did was for encouragement of the patients immune system to fight recurrence through vaccines. chrissie - it was the GP2 peptide vaccine given with GM-CSF. This was a two armed trial, and half were given GP2 and half AE37, and some placebo with no vaccine. The placebo was the GM-CSF, so everybody got something, the GM-CSF is similar to Neulasta/Neupogen so it waspotentially immune boosting by itself. We were sorted into the arms by histological tissue type like for organ transplant. I did phase II, which is now closed to enrollment. There is no word yet regarding the start of phase III. Thanks for the info. There is a Phase 2 trial on Neuvax but I might be too late in inquiring because the treatment is supposed to start after the 3rd adjuva. Which trial are you looking at? I had thought that neuvax was for low Her2? I saw that one but I also saw this one- Phase II Trial of Combination Immuno. SpecialK - maybe I am reading it wrong but I thought is was an active study. The following link appears to be the most up to date summary of  Immunotherapy for breast cancer. Its mostly a lot of big words that probably wont make much sense unless youre doing daily research. Someday, Ill edit this post and attempt to match these therapies to the appropriate clinical trials. Will immunotherapy help us cure breast cancer?1. Monoclonal antibodies (mAbs) currently being researched in breast cancer clinical trials include:  - Avastin (bevacizumab), which targets the tumor growth factor VEGF-A    - Cyramza (ramucirumab), which targets the tumor growth factor VEGFR-2   - MGAH22 (margetuximab), which blocks the action of HER2 on tumor growth   - OMP-18R5 (vantictumab), which targets a tumor growth pathway known as the Wnt beta-catenin signaling pathway   - LJM716, which blocks a protein called HER3 that enables tumors to become resistant to treatment   - LY2875358, an anti-MET antibody   - CDX-011 (glembatumumab vedotin) and IMMU-132, which target cellular proteins that enable tumors to metastasize2. Therapeutic cancer vaccines currently being researched in breast cancer clinical trials include:  - A HER2 peptide vaccine called NeuVax (nelipepimut-S) UPDATE - JUNE 2016: The NeuVax Phase 3 clinical trial (PRESENT) has been stopped (cancelled), due to futility. NeuVax was unable to prevent recurrence in this trial; a HER2-pulsed dendritic cell vaccine; and the peptide vaccines E39 and J65, which are being tested to prevent breast cancer recurrence  - AV901, which helps the immune system destroy tumor cells that express HER2  - INO-1400 (by Inovio Pharmaceuticals), a synthetic DNA vaccine targeting the hTERT antigen. hTERT = human telomerase reverse transcriptase [This is being explored for Triple Negative BC]. 3) Checkpoint inhibitors/immune modulators currently being researched in breast cancer clinical trials include:  - The anti-CTLA-4 antibody Yervoy (ipilimumab) - The anti-PD-1 antibodies Keytruda (pembrolizumab, MK-3475) and Opdivo (nivolumab) - The anti-PD-L1 antibodies MPDL3280A and MEDI4736 - The antibodies MEDI6469 and MEDI63834. The following types of adoptive T cell transfer are being researched for patients with breast cancer:  - Tumor infiltrating lymphocytes (TILs) that are removed from a patients tumor, boosted in the lab, then given back to the patient. This is essentially CAR-T Immunotherapy, which has cured a number of people with hematological malignancies like Leukemia & Lymphoma. - T cells genetically engineered to target several cancer-associated antigens, including:   * HER2          *  cMet protein          * CEA          * VEGFR-2          * MAGE-A35. Cytokines currently being researched in clinical trials of breast cancer include the following interleukins:- Interleukin-2, an important growth factor for white blood cells Interleukin-7, an important growth factor for T cells and B cells. 6) Adjuvant immunotherapies currently being researched in breast cancer clinical trials include:- Indoximod, an IDO inhibitor, which blocks an immunosuppressive molecule produced by tumor cells- Poly-ICLC, a Toll-like receptor (T    This is an update on the Immunotherpy drug  Keytruda (AKA: Pembrolizumab, MK-3475). Keytruda is a Monoclonal antibody and acts as a checkpoint inhibitor, specifically a PD1 inhibitor. It targets the PD-1 protein on T cells (a kind of immune cell). The drug removes the brakes (biological blockades) that keep T cells (also called T lymphocytes) from attacking cancer. Its FDA approved for Lung cancer and Melanoma (think former President Jimmy Carter). As a single agent (monotherapy), its shown to be useful in TNBC trials and has similar potential in ER+ disease, as just reported by Dr Hope Rugo of UCSF, here, Pembrolizumabs Potential in ER+ / HER2- patients.As of Feb 2016, Keytruda is in at least 20 different clinical trials for breast cancer, listed below (This may not be a complete list and serves as a springboard to get you started. Please do your own due diligence). 01 metastatic ER+ [NCT02395627] This one deals with Epigenetics, and includes a HDAC inhibitor too!02 metastatic ER+, HER2- [NCT02054806] KEYNOTE-28 trial. A basket trial evaluating 20 different types of cancer with PD-L1 expression. Results of the ER+, HER2- are here. 03) metastatic IBC [NCT02411656] 04) metastatic TNBC or metastatic ER+, HER2- [NCT02648477] 05) metastatic TNBC [NCT02513472] KEYNOTE-150 trial06. metastatic TNBC [NCT02447003] KEYNOTE-086 trial07. metastatic TNBC [NCT02555657] KEYNOTE-119 trial08. metastatic HER2+ [NCT02129556] PANACEA trial09. metastatic HER2+ [NCT02318901] PembroMab trial10. metastatic TNBC & other solid tumors [NCT02646748] This one deals with the Tumor Microenvironment, and includes a JAK inhibitor, and a PI3K inhibitor. 11) TNBC & other solid tumors [NCT02452424] KEYNOTE-103 trial. 12) TNBC & other solid tumors [NCT02644369] INSPIRE trial. 13) TNBC & other solid tumors [NCT02432963]. 14) TNBC [NCT02622074] KEYNOTE 173 trial. 15) TNBC and/or HER2+ [NCT02178722] KEYNOTE-037 trial. This one includes a IDO Inhibitor. 16) ER+ & other solid tumors [NCT02331251] PembroPlus trial. 17) oligometastatic breast cancer [NCT02303366] BOSTON II trial. 18) Any invasive breast cancer [NCT01042379] I-SPY 2 trial. Evaluating numerous agents among 1,200 patients19. Unknown types of breast cancer [NCT02009449] This one includes AM0010, a humanized version of the immune protein called interleukin-10 (IL-10) - No longer accepting breast cancer patients. 20) metastatic breast cancer & other solid tumors [NCT01174121] This one involves growing patient-extracted Tumor Infiltrate. The largest analysis of breast cancer cell function to date suggests dozens of new uses for existing. This is an update on the Immunotherapy drug Opdivo (AKA: Nivolumab) Like Keytruda (see post above), Opdivo is a Monoclonal antibody and acts as a checkpoint inhibitor, specifically a PD1 inhibitor. It targets the PD-1 protein on T cells (a kind of immune cell). The drug removes the brakes (biological blockades) that keep T cells (also called T lymphocytes) from attacking cancer. As of Nov 2016, Opdivo is approved by the FDA for 5 different cancers:1) Melanoma 2) Squamous non-small cell Lung cancer (NCSLC) 3) Kidney cancer (renal cell Kidney cancer - renal cell carcinoma or RCC) 4) Hodgkin Lymphoma (for those that relapsed or progressed after autologous hematopoietic stem cell transplantation [HSCT]) 5) Head and Neck (SCCHN) (for recurrent or metastatic squamous cell carcinoma)  [Head and neck cancer is a group of cancers that includes cancers of the oral cavity, larynx, pharynx, salivary glands, and nose/nasal passages]. This approval was based on the Phase III Head & Neck clinical trial called CheckMate -141, described here. As of Feb 2016, Opdivo is being used in the following breast cancer clinical trials (This may not be a complete list and serves as a springboard to get you started. Please do your own due diligence 1) metastatic TNBC [NCT01928394]A Phase 1/2, Open-label Study of Nivolumab Monotherapy or Nivolumab Combined With Ipilimumab in Subjects With Advanced or Metastatic Solid Tumors Estimated Enrollment: 1100 Study Start Date: October 2013 Estimated Primary Completion Date: August 2017 More info from Sloan Kettering, here. Trial locations include: Colorado, Connecticut, Florida, Georgia, Maryland, Massachusetts, New York, North Carolina, Oregon, Tennessee, Texas, Washington; Canada, Denmark, Finland, Germany, Italy, Spain, United Kingdom, maybe more2. All breast cancer patients, with exception to HER2+ [NCT02309177] A Phase 1, Open-Label, Multicenter, Safety Study of Nivolumab (BMS-936558) in Combination With Nab-Paclitaxel Plus or Minus Gemcitabine in Pancreatic Cancer, Nab-Paclitaxel / Carboplatin in Stage IIIB/IV Non-Small Cell Lung Cancer or Nab-Paclitaxel in Metastatic Breast Cancer Estimated Enrollment: 138 Study Start Date: December 2014 Estimated Primary Completion Date: July 2017 Trial locations include: Arizona, California, Connecticut, Florida, Illinois, Massachusetts, New Jersey, North Carolina, Ohio, Pennsylvania, Washington, Wisconsin, maybe more3. All Stage III & IV breast cancer patients, with exception to HER2+ [NCT02453620] A Phase 1 Study Evaluating Safety, Tolerability, and Preliminary Antitumor Activity of Entinostat and Nivolumab With or Without Ipilimumab in Advanced Solid Tumors Estimated Enrollment: 45 Study Start Date: November 2015 Estimated Primary Completion Date: January 2017 Trial locations include: California, Connecticut, Maryland, Pennsylvania, maybe more. 4) metastatic TNBC [NCT02499367] Adaptive Phase II Randomized Non-comparative Trial of Nivolumab After Induction Treatment in Triple-negative Breast Cancer (TNBC) Patients: TONIC-trial Estimated Enrollment: 84 Study Start Date: August 2015 Estimated Primary Completion Date: August 2019 Trial locations include: Netherlands, maybe more** The following involve Opdivo with other experimental agents for various solid tumors (in theory, this includes breast cancer, but requires verification from the trial investigators): 5) metastatic breast cancer [NCT02009449] A Phase 1, Open-Label Dose Escalation First-in-Human Study to Evaluate the Tolerability, Safety, Maximum Tolerated Dose, Preliminary Clinical Activity and Pharmacokinetics of AM0010 in Patients With Advanced Solid TumorsEstimated Enrollment: 300 Study Start Date: November 2013 Estimated Primary Completion Date: December 2016 Trial locations include: California, Colorado, Florida, Massachusetts, New York, Oklahoma, Tennessee, Texas, maybe more. 6) metastatic breast cancer [NCT02467361] A Study of BBI608 Administered in Combination With Immune Checkpoint Inhibitors in Adult Patients With Advanced Cancers Estimated Enrollment: 120 Study Start Date: August 2015 Estimated Primary Completion Date: August 2017 Trial locations include: Georgia, Illinois, Massachusetts, New York, South Carlina, maybe more. 7) metastatic breast cancer [NCT02423954] Study of Nivolumab Plus Chemotherapy in Patients With Advanced Cancer (NivoPlus) (NivoPlus) Estimated Enrollment: 49 Study Start Date: April 2015 Estimated Primary Completion Date: April 2017 Trial locations include: Arizona, maybe more. 8) metastatic breast cancer [NCT02483247]A Study of BBI503 in Combination With Selected Anti-Cancer Therapeutics in Adult Patients With Advanced Cancer Estimated Enrollment: 200 Study Start Date: September 2015 Estimated Primary Completion Date: September 2017 Trial locations include: California, Illinois, Indiana, Louisiana, Massachusetts, Ontario Canada, maybe more. 9) metastatic breast cancer & Lymphoma [NCT02253992]Safety and Tolerability of Urelumab Administered in Combination With Nivolumab in Solid Tumors and B-cell Non-Hodgkins Lymphoma Estimated Enrollment: 200 Study Start Date: September 2014 Estimated Primary Completion Date: December 2016 Trial locations include: California, Florida, Illinois, Maryland, Massachusetts, New York, Oregon, Pennsylvania, Texas, France, Germany, Spain, maybe more. 10) metastatic breast cancer [NCT02598960]Study of BMS-986156 Given Alone and in Combination With Nivolumab in Subjects With Advanced Solid Tumors Estimated Enrollment: 260 Study Start Date: October 2015 Estimated Primary Completion Date: May 2018 Trial locations include: Tennessee, Australia, Ontario Canada, maybe more. 11) metastatic breast cancer [NCT02423343]Study of Galunisertib (LY2157299) in Combination With Nivolumab in Advanced Refractory Solid Tumors and in Recurrent or Refractory NSCLC, Hepatocellular Carcinoma, or Glioblastoma Estimated Enrollment: 100 Study Start Date: October 2015 Estimated Primary Completion Date: April 2018 Trial locations include: Alabama, California, Florida, Massachusetts, North Carolina, Texas, Spain, maybe more. 12) metastatic breast cancer [NCT02614456]Combination of Interferon-gamma and Nivolumab for Advanced Solid TumorsEstimated Enrollment: 15 Study Start Date: December 2015 Estimated Primary Completion Date: December 2017  (Final data collection date for primary outcome measure)Trial locations include: Pennsylvania, maybe more. 13) metastatic breast cancer [NCT01714739]Phase I Study of an Anti-KIR Antibody in Combination With an Anti-PD1 Antibody in Patients With Advanced Solid Tumors Estimated Enrollment: 162 Study Start Date: October 2012 Estimated Primary Completion Date: September 2017 Trial locations include: Illinois, Maryland, Massachusetts, New York, Oregon, Pennsylvania, maybe more. 14) metastatic breast cancer [NCT01968109]Study of Anti-LAG-3 With and Without Anti-PD-1 in the Treatment of Solid Tumors Estimated Enrollment: 540Study Start Date: October 2013 Estimated Primary Completion Date: September 2016 Trial locations include: Illinois, Maryland, Massachusetts, Michigan, New York, Oregon, Pennsylvania, Texas, Washington, Italy, Japan, Spain, maybe more. 15) metastatic breast cancer [NCT02518958]Phase I, Open-Label, Multiple Ascending Dose Study of RRx-001 and Nivolumab (PRIMETIME)Estimated Enrollment: 45Study Start Date: July 2015 Estimated Primary Completion Date: July 2017  Trial locations include: Maryland. With the media recently highlighting the remarkable Immunotherapy stories (like here, here, here, and here) of cancer patients achieving No Evidence of Disease [NED], I thought it would be wise to remind everyone that Immunotherapy breast cancer clinical trials do exist. I found 241 clinical trials open for breast cancer Immunotherapy. 11 of the 241 are Phase III trials. The rest are Phase I and II trials. Heres some resources to find those clinical trials:1) Cancer Research Institutes: Immunotherapy Clinical Trial FinderCall 1-855-216-0127 (toll-free) to reach a Clinical Trial Navigator who will help identify appropriate trials. 2) NIH Clinical Trials: ClinicalTrials_gov The worlds largest clinical trials database. 3) Breast Cancer Trials: BreastCancerTrials_org Focused on breast cancer. Wow, Mr Smith, you sure did a through job. Your lists should probably be posted somewhere as a resource or reference. Looks like 2017 is the year for it all. Thanks, John. Im in a Herceptin/NeuVax trial in DC for low and intermediate HER2 expressors. Theyre still recruiting, but you have to have just finished treatment. Thanks again, John. Here is a link to a thread on the Inspire website that was started by a member who is part of a Tumor-Infiltrating Lymphocyte trial that is really exciting. There is also a trial for Her2+ breast cancers with Pembrolizumab (Keytruda)  https://clinicaltrial_gov/ct2/show/NCT02318901?te. This Is some of the research that has led to this trial - http://m_cancerdiscovery_aacrjournals_org/content/. So, it looks like they are looking at it for almost all breastSo, it looks like they are looking at it for almost all breast cancers now, except maybe for IBC?Best wishes to all   cancers now    Hi, John!I am hoping to be a part of the KEYNOTE-086 trial for TNBC at Emory. Thank you for posting this info. I have been trying to find out more, but have not had much luck. I am going for scans, labs, etc next week, and if all goes well will start treatment the next week. My family and I are very encouraged by what we have been told. Please keep posting any info you may find.I would love to    Hi All,Have you heard about this particular trial and know how it is going ?    There is a woman on the Inspire website who has seen a 60% reduction in her tumors since receiving her primed T-cells. You can read about it following this     Thanks Sue. Ill reply to your PM tomorrow.@letmywifeliveThat trial, Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Cancer [NCT01174121], is being run by Dr. Steven Rosenberg at the NCI, who is a bit of a Immunotherapy rockstar.The trouble is that  this trial only accepts Stage IV patients that have failed standard therapies. Note the following inclusion criteria:All patients must be refractory to approved standard systemic therapy. Specifically, Breast and Ovarian cancer patients must be refractory to both 1st line and 2nd line treatments and must have received at least one second line chemotherapy regimen. I assume your wife wants to avoid chemo. There must be trials that circumvent this requirement. I think it might be a good idea to call the Clinical Tr Immunotherapy medicines use the power of your bodys immune system to attack cancer cells. Your immune system is the network of organs, tissues, and cells that work together to protect your body from attacks by foreign invaders such as bacteria, parasites, viruses, and fungi that can cause infection and disease. When these invaders find their way into your body -- whether through a break in the skin, for example, or through your mouth or nose -- your immune systems response is the self-defense system that works to keep you from getting sick. Immunotherapy medicines work by helping your immune system work harder or smarter to attack cancer cells. In cancer treatment, immunotherapy uses substances made by your body or in a lab to improve the function of the immune system by allowing the immune system to: stop or slow the growth of cancer cells stop cancer from spreading to other parts of the body be better at destroying cancer cells In the main Breastcancer_org sites section on Immunotherapy, you can learn more about: What Is Immunotherapy? Is Immunotherapy Right for You? Cancer Vaccines Immune Checkpoint Inhibitors Adoptive Cell Therapy Immune Targeted Therapies Cytokines. Please come back to this forum to start your own threads about your experiences with immunotherapy. Immunotherapy for Breast Cancer: Part 1, March 28, 2018 Sherene Loi, MD, PhD Dr Sherene Loi is a medical oncologist who specializes in treating breast cancer. In addition to treating patients, particularly patients diagnosed with HER2-positive breast cancer, she also leads the Translation Breast Cancer Genomics and Therapeutics Laboratory at the Peter MacCallum Cancer Centre in Melbourne, Australia, where she is a professor. Much of her clinical research focuses on investigating new treatments, such as immunotherapy, especially for breast cancers that have become resistant to standard treatments. Listen to the podcast to hear Dr Loi explain:results from the PANACEA trial, which looked at using the immunotherapy medicine Keytruda (chemical name: pembrolizumab) along with Herceptin to treat Herceptin-resistant, HER2-positive, advanced-stage breast cancer that had high levels of PDL-1, a biomarker that indicates that Keytruda will be effective how an immunotherapy medicine like Keytruda works what tumor-infiltrating lymphocytes (TILs) are and why cancer tumors with high numbers of TILs seem to respond better to immunotherapyside effects of immunotherapy medicines Running time: 17:52    Thank you for this podcast!  and thank you Mods for letting us know about it. Thank you so much for creating this forum. I believe it is a the most advanced form of treatment, and your support will encourage our women and men to seek. Thank you for this forum as it looks like this may be the way to go for many of us in the near future. My oncologist asked me if i was interested in going in a trial for immunotherapy after chemotherapy has failed me for the third time in almost six years, so thats not bad. I say go ahead, I hope I qualify and its all in the interest of the next generation of cancer patients. Lets hope that its. Oh manymoo, hoping so much you get in a clinical trial and that it goes well.    I am presently being treated with the immunotherapy drug opdivo for my stage 4, triple negative, pleomorphic lobular breast cancer. At the time I began receiving treatment I was very sick. I had failed 6 lines of therapy for stage 4 breast cancer and was being referred for hospice care.  Little did I know I was on the cusp of experiencing a level of healing that feels nothing short of miraculous.Following an emergency surgery at UCSD, San Diego, CA, I learned about a clinical trial called I-Predict (https://clinicaltrials.gov/ct2/show/NCT02534675). The purpose of this study is to learn more about personalized cancer therapy. Genomic testing on my tumor tissue was used to develop a treatment plan specifically targeted to my cancer cells. Due to the very high tumor mutation burden of my cancer, as well as a high PD-1, I was considered a good candidate for immunotherapy treatment with opdivo.Here was my BENEFIT:After just 4 immunotherapy infusions my tumor markers dropped significantly (82% to 94%). I began treatment mid February and by July, all tumor markers were within normal range. After just 8 weeks of therapy my CT scans suggested a complete response. The cancer lesions were no longer visible! I am feeling great! In fact, last January, I had a surgery which confirmed that the cancer previously seen in my GI tract is all GONE. My own immune system is presently able to recognize and kill the cancer cells. Here are some RISKS:Immunotherapy super-charges the immune system. The risk is that one will develop autoimmune disorders. The disorders range from big scary things like: lupus, GI tract inflammation, rheumatoid arthritis (RA), scleroderma, liver disorders, thyroid disorders, pituitary gland disorders to small and manageable things like an occasional UTI, conjunctivitis, skin rash or other very treatable -itis. I think the big scary things are very uncommon.Here were my side effects:My joints began to enlarge and though I had no pain, it appeared I was developing RA. Symptoms did not progress and I feel fine (several joints in my fingers remain enlarged). I also had eczema flare ups that went away. I had two occasions of conjunctivitis for no apparent reason. It went away with eye drops. The skin on my hands showed symptoms of scleroderma. It went away.MORE BENEFITS:I am ALIVE. I have NO EVIDENCE OF DISEASE ANYWHERE!! Before treatment, one of my tumor markers, the CA27.29, had reached over 1300. For the last 12 months, it has remained  within the normal range of less than 38.6. At the time I began treatment, I had from weeks to perhaps 1-2 months to live. I am just so grateful to be alive! Sometimes I wake up long before daylight with the same joy and excitement a child feels on Christmas morning. Like the young child, I force myself to remain in bed until the first light of day. Then I bounce out of bed confident that this new day will overflow with gifts. And it does!I am grateful to God for the gift of more time with my family and friends. I am grateful to researchers for unraveling some of the mysteries associated with cancer. I am grateful to you for reading and perhaps sharing my story so that a cup of hope may be given to someone in need.  While I cannot know if or when I may have a recurrence, I do know that I have today. What a gift!!Friend, leave no stone unturned. Explore clinical trials. Pursue genomic testing to see if immunotherapy or another form of targeted therapy might benefit you. From the rear view mirror, I see the hand of God in the glove of so very many circumstances that have permitted me to be alive today to write these words you are readying. I pray my story will become your story.    Dear HealingHopeYour post is so inspiring and informative!  Thank you!   I am so glad for you the results you have gotten!  That is amazing.  Medicine owes its progress to intrepid and brave women like you who are willing to lay it on the line and try new therapies.  This one sounds so promising. I am sorry for the unpleasant side effects you have suffered but like you said -- yay! youre alive.  I salute you!  I hope you keep us updated on your progress.Thank God for clinical trials. If I find myself in a situation where a clinical trial might be appropriate I am going to try my hardest to get into one myself. I dont know my staging yet after a recent recurrence and I guess they normally try conventional the Healing hope, how inspirational your story is.... I see my oncologist tomorrow to discuss and I will wait and see. Fingers crossed that this thread will be a    Amica, I forgot to thank you for your posts. Heres hoping that more people w    Dear mandymooI am so sorry you have had chemo failures at Stage IV.  It must be so frightening.  I feel for you.  I do think immunotherapy is worth a shot, I think it is the future of cancer treatment, and fervently hope and pray that you are able to get into a clinical trial and achieve a good outcome.  Please let    apparent;y it will be phase 1 of ATX 101. No placebos. I am waiting to get the paperwork in the mail as I see my oncologist through teleconference. there doesnt appear to be any research papers that I can find and not much information at all.  I see him in another 3 weeks. At the moment I am a bit confused and I am also thinking about getting a second opinion, so I will see what happens within    Mandymoo,Good for you.  Let us know as you learn more.  A second opinion can Immunotherapy for Breast Cancer: Part II, April 10, 2018 Jennifer Litton, M.D. Dr. Jennifer Litton is a board certified medical oncologist and associate professor of breast medical oncology at the University of Texas MD Anderson Cancer Center in Houston, where she is chief of the Section of Clinical Research and Drug Development for Breast Cancer. She also is a member of the Breast Immuno-Oncology Task Force of the National Cancer Institute.Listen to the podcast to hear Dr. Litton discuss:how immunotherapy medicines workwhy immunotherapy medicines havent seemed to work as well in breast cancer as they have in other cancersthe direction of immunotherapy research for breast cancer Running time: 13:35Listen now o    Ive read the data from the Herceptin and Neuvax trial, and it was certainly promising for triple negative participants with low-level Her2, which I was. It showed a 70% reduction in recurrence. The trial was closed ahead of schedule due to meeting objectives. The plan is to now get FDA approval. What is the hold-up? The process is frustrating. Will the Right to Try legislation apply to TNBC patients who dont get a pCR with neoadjuvant chemo? Also, why are there areas of the country where there are so few clinical trials? I live in Alabama, and its     Hi tnfrith, and thanks for posting!All great questions you have about this trial and the NeuVax approval. Were not sure we can answer your questions, but we bet thered be some great insight from our other members either on the Clinical Trials forum or also the thread here in the Immunotherapy forum called Immunotherapy drugs for breast cancer. Feel free to post in either place and see if anyon All,Im confused. Is there effective immunotherapy for breast cancer or not. I cant really find anything substantial on the internet. My Onc Doc said there isnt anything truly valuable yet.I have stage IV er+ pr ductal carcinoma. Mets to bones. I am quickly becoming multi-treatment resistant. The last 4 or 5 meds have crapped out shortly after treatment or not worked at all. Im in the market for a new trial. Hi Mudpie, my oncologist said we arent there yet. I believe there maybe BCO members who have had trial immunotherapy. Look on the stage 4 topics, I think traditional treatment must be tried first. It is very upsetting I know it makes so much sense to target the cancer cells instead of blanket poison to kill fast growing cells. From what I have read using a patients own modified T cells is a risky business as they can attack healthy organs. Commercials on tv are upsetting making it sound we are so far along with cancer treatment we are NOT. There absolutely are some immunotherapies that are working.  I know someone who was Stage 4, with very advanced disease from what I understand, that is now NED due to Opdivo.  However, it is not standard of care yet. Also, it wont help everyone.  However, for those it does help, it is a miracle.  You can only get access to it through cinical trials at this point.  Maybe take a look through www.cinicaltrials.gov, to see if you find anything that looks like a good fit. Rebek Thank You, I cant find a clinical related to Opdivo, unless I am looking in     Mudpie for Opdivo trials you need to search for nivolumab. I found 31 breast cancer trials currently recruiting. There are some passive immunotherapy drugs approved for breast cancer. Herceptin, Perjeta, and Kadcyla (TDM-1) are considered passive immunotherapies, as is Opdivo. Those are the only three currently approved that I am aware of unless something else has very recently been approved. Unfortunately only about 20% of us are HER2+ and can take advantage of them (and I give thanks every day that Im in the 20%). Your profile isnt visible (or hasnt been added) so I dont know your HER2 status or what treatments youve previously had. I dont think that Keytruda, a check point inhibitor immunotherapy, has been approved for breast cancer yet, but it seems close and promising for TNBC. Theres nothing approved yet (AFAIK) for people who are not HER2+, nothing approved yet in the way of active immunotherapy, no CART cell therapies approved for solid tumors yet, no approved checkpoint inhibitors. Its all still in research. A quick check of clinical trials found 93 active trials for breast cancer immunotherapy (66 currently recruiting) so it might be worth a look at more than just. Keytruda is still going thru trials level III. I just was offered the opportunity to sign up doesnt mean I will be picked.\"\n",
    "    freq(str)                     \n",
    "\n",
    "if __name__==\"__main__\": \n",
    "    main() "
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## Select posts belonging to forum F162"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 6,
   "metadata": {},
   "outputs": [],
   "source": [
    "df_new = df.loc[df['ID'] == 'F162']"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 27,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>PostType</th>\n",
       "      <th>Sequence</th>\n",
       "      <th>RawText</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>original</td>\n",
       "      <td>0</td>\n",
       "      <td>Immuno-Oncology (IO) and Immunotherapy drugs ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>reply</td>\n",
       "      <td>1</td>\n",
       "      <td>I'm no expert.I found this and maybe it wi...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>reply</td>\n",
       "      <td>2</td>\n",
       "      <td>The Her2+ recurrence prevention trial I di...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>reply</td>\n",
       "      <td>3</td>\n",
       "      <td>SpecialK what immune drug was part of your...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>reply</td>\n",
       "      <td>4</td>\n",
       "      <td>chrissie - it was the GP2 peptide vaccine ...</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "   PostType  Sequence                                            RawText\n",
       "0  original         0   Immuno-Oncology (IO) and Immunotherapy drugs ...\n",
       "1     reply         1      I'm no expert.I found this and maybe it wi...\n",
       "2     reply         2      The Her2+ recurrence prevention trial I di...\n",
       "3     reply         3      SpecialK what immune drug was part of your...\n",
       "4     reply         4      chrissie - it was the GP2 peptide vaccine ..."
      ]
     },
     "execution_count": 27,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df_new = pd.read_csv('/Users/maitreyimokashi/Documents/Thesis/Data/brca_new.csv')\n",
    "df_new.head()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 28,
   "metadata": {},
   "outputs": [],
   "source": [
    "posts = df_new['RawText']"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 29,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "55"
      ]
     },
     "execution_count": 29,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "len(posts)"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## Create a list from column 'RawText'"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 30,
   "metadata": {},
   "outputs": [],
   "source": [
    "posts = list(posts)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 31,
   "metadata": {},
   "outputs": [],
   "source": [
    "text = [''.join(x) for x in posts]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 32,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "[' Immuno-Oncology (IO) and Immunotherapy drugs are humanity\\'s best shot at beating cancer. During the last few years, IO has revealed impressive, durable responses in a variety of tumor types for which conventional therapies historically have had limited success (melanoma, leukemia, lymphoma, lung, liver, bladder, etc).The power of this approach is highlighted in countless articles (like here and here) as well as a variety of TV broadcasts, including:1. HBO\\'s Vice TV special: \"Killing Cancer\", explored a subset of IO called \"Virotherapy\" and how the following three common viruses are genetically modified to find and kill cancer:- A re-engineered Measles virus was used to treat patients with Multiple Myeloma.- A re-engineered Adenovirus (like the common cold) to treat patients with Glioblastoma (GBM) brain tumors.- A re-engineered HIV virus to treat patients with the blood cancer Leukemia.2. 60 Minutes TV special: \"Killing Cancer\" focused on curing GBM by using a re-engineered Polio virus.3. PBS TV special: \"Cancer: The Emperor of All Maladies\" tells the complete story of cancer, from its history to current breakthroughs. It\\'s six hours long, broken into three videos, with the last part covering IO. We\\'ve reached an inflection point to change the trajectory of breast cancer treatment. In late 2015, an unprecedented coalition was formed to accelerate progress in IO. Called the \"Cancer Moon Shot 2020\" (#CancerMoonShot), this endeavor will bring patients closer to Immunotherapies and precision medicine, by not only exploiting genetics (DNA), but also epigenetics (gene expression), proteomics (protein expression), metabolomics (cancer metabolism). Here\\'s a couple video\\'s discussing the effort:4. Cancer MoonShot 2020, explained in very simple terms, here.5. Cancer MoonShot 2020 Press Conference (Jan 2016), here. Listen to the experts.If you\\'re smart, you asked the question: how can immunotherapy be harnessed in Breast Cancer?To answer this, I researched the usual resources and was surprised at the paucity of info.Breastcancer.org\\'s page, Using the Immune Response to Treat BC is outdated and extremely incomplete. It only discusses these Monoclonal Antibodies (mAbs) used for HER2+ patients: Herceptin (trastuzumab), Tykerb (lapatinib), Perjeta (pertuzumab), Kadcyla (Trastuzumab or T-DM1). The Cancer Research Institute\\'s webpage, \"Immunotherapy for Breast Cancer\", is the most comprehensive resource for US based research, although it was last updated Sept 2014. [Dr. Leisha Emens of John Hopkins reviewed and updated the webpage in March 2016].It\\'s written that \"breast cancer has historically been considered immunologically silent\". This statement may contribute to why breast cancer lags behind when compared to other cancers. This notion that breast cancer, in particular ER+ disease, is \"not very immunogenic\" is an antiquated view that needs to end. I understand it\\'s \"early days\", but the breast cancer industry needs a serious paradigm shift. Listen to this comment at the 2016 CancerMoonShot press conference here). Priorities should be realigned towards the basic science of IO and then translated into cures that exceed the ~7% that standard therapies offer metastatic patients over 10 years (Source: Weissman, June 2015, ~10:00 minute mark). As patients / caretakers, we should be discussing Immunotherapies with our doctors, encouraging breast cancer researchers to explore this approach and supporting funding efforts aimed at moving the field forward. So, in a effort to advocate for this community, I wanted to start this topic and get others to ask these questions:- What progress is being made in Breast Cancer Immunotherapy?- Who are the thought leaders and researchers in Breast Cancer Immunotherapy?- Most importantly, where are the Breast Cancer Immunotherapy clinical trials?Who else shares this sense of urgency?',\n",
       " \"    I'm no expert.I found this and maybe it will be of some help.https://www.breastcancertrials.org/bct_nation/brow...  \",\n",
       " \"    The Her2+ recurrence prevention trial I did was for encouragement of the patient's immune system to fight recurrence through vaccines.http://www.cancer.gov/clinicaltrials/search/view?c...  \",\n",
       " '    SpecialK what immune drug was part of your trial?  ',\n",
       " '    chrissie - it was the GP2 peptide vaccine given with GM-CSF.\\xa0 This was a two armed trial, and half were given GP2 and half AE37, and some placebo with no vaccine.\\xa0 The placebo was the GM-CSF, so everybody got something, the GM-CSF is similar to Neulasta/Neupogen so it was\\xa0potentially immune boosting by itself.\\xa0 We were sorted into the arms by histological tissue type like for organ transplant compatability, which was independent of any cancer info.  ',\n",
       " '    SpecialK-are there results from your study yet?\\xa0 What phase was it?\\xa0  ',\n",
       " '    I did phase II, which is now closed to enrollment. There is no word yet regarding the start of phase III. Here is the preliminary info:http://www.mdanderson.org/newsroom/news-releases/2...  ',\n",
       " '    Thanks for the info.\\xa0 There is a Phase 2 trial on Neuvax but I might be too late in inquiring because the treatment is supposed to start after the 3rd adjuvant Herceptin.  ',\n",
       " '    Which trial are you looking at? I had thought that neuvax was for low Her2 expressors.  ',\n",
       " '    I saw that one but I also saw this one- Phase II Trial of Combination Immunotherapy With NeuVax and Trastuzumab in High-risk HER2+ Breast Cancer Patients.  ',\n",
       " '    SpecialK - maybe I am reading it wrong but I thought is was an active study.  ',\n",
       " \" Hi all, finally got a date for my exchange surgery. I'm glad to see the end of this part of the journey in sight. Anyways, my PS is saying I will only need to be out of work 1 day. Is this realistic? My surgery is scheduled on Friday the 20th of July, so will I really be ready to go back to a desk job that Monday morning? Anything else I should expect or be on the lookout for? Thanks bunchesKaren\",\n",
       " \"         My answer is: it depends. IF your desk job isn't too taxing or you can slack a little then it'd be alright. Monday will be 3 days post-surgery. IF you absolutely don't have any leave and can't afford to take LWOP (and the first IF holds true)IF you don't mine being a bit sore and taking Advil instead of Vicodin.Jobs have a lot of variation. I wouldn't think it would be one of your most productive weeks, but if showing up will do for a few days then it'd be OK.           \",\n",
       " '         Thanks, my job is pretty low key.  Plus my co-workers and I pick up the slack whenever one of us is not up to par.  I may just take off that Monday and give myself one more day to get it together. Karen           ',\n",
       " '         My surgeon recommended a week off, but I probably could have gone back 2 or 3 days earlier. I was surprised at how good I felt when I woke up. The next day I was sore in my cleavage area. The skin there had adhered and the surgeon said he \"had to do some work\" on it. But it really wasn\\'t too bad, and then there is that euphoria from not having expanders!Good luck,Naomi          ',\n",
       " '         I am a week past my bilateral exchange, and just today think I could have gone back to work. It took getting off the narcotics during the day to feel like myself. If you normally bounce back quickly, and you have a desk job with understanding coworkers, then Tuesday might be doable. Just go easy on yourself.I hope it goes well.          ',\n",
       " '    Karen - I scheduled my exchange surgery during my spring break so I could have the week off work.  I was more tired than sore.  I only took acetomenaphin for pain.  Take the time you need to heal.  all the best to you.  karen in denver  ',\n",
       " \"    I had my bilateral exchange surgery on Friday.  They told me to do nothing for a week, and I took Tuesday off work (Monday was a holiday).  I probably could have gone back to work on Wednesday, but I didn't.  I was in that anesthesia fog over the weekend, then by Sunday I was only taking a pain pill at night to help me sleep. Maybe you can schedule it for the end of a week so you have a few days off anyway?  Make sure you give youself the time you need.  They told me even housework uses a lot of upper body stuff and I did swell a bit after cleaning the house the other day (and got yelled at at my follow-up appt. today).  -Nancy \",\n",
       " '    Can anyone give me their opinion on which type of surgery I should choose?  I have been given the option of TRAM flap or Latissmus muscle?  Which did most of you choose?  Thanks for any advice you can give. ',\n",
       " \"         TelenaB, your choice is going to depend on your surgeon and your body and your circulation.  It will have to be up to you.My advice is to see at least 2 if not 3 plastic surgeons for consults and see what is recommended for you and your body type.  Do some reading and see what you are most comfortable with.With the Tram or Diep you will get a tummy tuck, which I would have liked for me.  I wasn't a candidate for those.I would not go for the tram with muscle tho.  Learn as much as you can and find a doc who does MANY of the kind you think you want.           \",\n",
       " '    Hi all:  I am having my exchange surgery (bi-lateral) on the 20th of June.  I don\\'t see where any of you mentioned the dreaded DRAINS!!!  Did any of you have them?  If so, for how long?  I have a major event to attend for work (it\\'s an all day \"meet the clients\" type of thing).  I am wondering if I will be able to attend....  thanks for any input.  I am sooo excited to get rid of these plastic balls on my chest!!!! ',\n",
       " '    Blue - no drains with my exchange surgery.  Recovery was fairly easy.  ',\n",
       " \" Has anyone had radiation and then reconstruction?I had lumpectomy - recurrence near lump bed - but had radiation. Mastectomy in Jan. for second cancerNo one told me radiation might disqualify me for reconstruction. I am so upset by this. I wish I had a mast the first time around - I would have had immediate reconstruction.I have apt. with surgeon in two weeks.I am so upset by all of this. I can't believe no one told me that radiation = maybe no reconstruction. I was stage 1 first (2 1/2 yrs ago) and second time.\",\n",
       " \"         I had radiation and waited a year to have reconstruction because I wanted to have expander/implant surgery.  I was advised against this particular kind of reconstruction because of the radiation.  I had it done anyway and it failed miserably.  I ended up doing a lat. flap and so far I'm very pleased.  You should be a candidate for a flap surgery or a DIEP or SGAP.  There are many different methods that should still work.  Good luck with your appointments.God bless,Chris           \",\n",
       " \"         Radiation does not = NO reconstruction, and if anyone tells you that you should slap them.  Okay, don't slap them, but maybe stand really close when you talk to them, and try to spit on them.I digress...While radiated skin does pose challenges to plastic surgeons, there are many methods of reconstruction that are successful after radiation.  The easiest methods would be an abdominal flap surgery, however, if you were only a candidate for implants, you could combine them with a lat flap, or alloderm depending on the amount of radiated tissue that needs to be salvaged, and voila--- breasts.you need to find the right Dr., and go from there.good luck           \",\n",
       " '         Although radiated skin can present problems, it is not a foregone conclusion that an implant reconstruction is not a option.  I had a lumpectomy ten years ago followed by radiation treatments.  Two months ago I had a recurrence in the same breast. I decided on having this type of construction because of the advantages it offers:  a far simpler surgery which does not weaken any other areas of the body and a much easier recovery post-surgery.  On June 6 (five days ago), my PS used Alloderm to create a sling which supplements the muscle and there was enough skin post-mastectomy for him to immediately put in an implant, skipping the expander entirely.  The implant was the same volume (gram for gram) as the tissue which was removed.  So I am here to say, yes, there are many choices out there and you should investigate them all to decide which is right for you.  The implant method is one of your choices.  I wish you strength during this difficult journey.  I made it through and with the help of your loved ones and friends, so will you.God Bless You,ladyinbrevard          ',\n",
       " '    I am due to have my perm implants put in 6/21.  Had first occurence of bc 2001 - had lump/radiation.  Second recurrence last Aug = had bilat mast with immediate recon.  PS said only \\'wrench\\' in the deal was the radiated breast.  Had one \\'fill\\' am a nice \"B\" cup.  All going great, but just developed a small scab on radiated breast scar.  PS concerned = not infected - says he\\'s never seen this so far out into recovery.  Saw his PA Mon and going to see him today.  If i have to postone exchange a few weeks it\\'s fine.  I\\'ve been questioning my decision and will take his advice . I truly respect his knowledge.  I don\\'t want any more problems but i\\'ve come so far and enjoy having a nice bustline. I\\'m only 48!  SO....i would take a chance and go for it, but be prepared for some \\'bumps\\' in the road. Good luck.  I plan to post here my outcome asap. ',\n",
       " \"         I am sure that some people have success with expander/implants after radiation. The best scenario seems to be where you have the expander and get expanded BEFORE the radiation. Then they radiate the expanded tissue. Even then sometimes I read about discomfort, infection, or unsatisfactory cosmetic results.  But oftentimes that seems to satisfy people.It just seems like so many women have problems with expander/implants after radiation that I think I would give serious consideration to another type of reconstruction if I'd already had radiation. It's stressful to have it and then have it fail, why not just go with a method you're sure will work.I don't want to be disrespectful of Plastic Surgeons, but they get paid whether it works or not, and if it doesn't work they stand a chance of getting paid again to fix it. So if you are really against a more involved reconstruction method, like a lat flag, TRAM, DIEP - I think they will try the expander/implant. But you are the one going through multiple surgeries and spending your time and emotional energy, so I would listen to the PS when they tell you what the chances of success are.           \",\n",
       " \"         I know a woman who had very bad skin damage from radiation. She had a recurrence in same breast after lump. (had mast second time) Her surgeon told her same thing - probably no reconstruction due to radiation damage. But the plastic surgeon - who agreed her skin was damaged -was able to do reconstruction for her. She was very pleased with results.So, since she was able to do it with badly damaged skin you most likely will succeed too.Don't panic till you talk to the plastic surgeon. And I would suggest getting a second opinion.  From other posts I have read it seems almost anything is doable with reconstruction.          \",\n",
       " \"    I had mastectomy, expander placed at the same time, chemo, exchange for implant, then radiation. Implant failed and got worse over time! Refused to have a tram. Researched and found the diepflap.com website. Had surgery to remove implant, get a prophylactic mast. and bilateral diep reconstruction 3/13/07. Best thing I've ever done for myself!! \"]"
      ]
     },
     "execution_count": 32,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "text[:30]"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## Tokenize each sentence"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 48,
   "metadata": {},
   "outputs": [],
   "source": [
    "from nltk.tokenize import sent_tokenize\n",
    "from nltk.tokenize import word_tokenize"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 34,
   "metadata": {},
   "outputs": [],
   "source": [
    "sent = []\n",
    "for i in posts:\n",
    "    a = sent_tokenize(i)\n",
    "    sent.append(a)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 35,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "[[\" Immuno-Oncology (IO) and Immunotherapy drugs are humanity's best shot at beating cancer.\",\n",
       "  'During the last few years, IO has revealed impressive, durable responses in a variety of tumor types for which conventional therapies historically have had limited success (melanoma, leukemia, lymphoma, lung, liver, bladder, etc).The power of this approach is highlighted in countless articles (like here and here) as well as a variety of TV broadcasts, including:1.',\n",
       "  'HBO\\'s Vice TV special: \"Killing Cancer\", explored a subset of IO called \"Virotherapy\" and how the following three common viruses are genetically modified to find and kill cancer:- A re-engineered Measles virus was used to treat patients with Multiple Myeloma.- A re-engineered Adenovirus (like the common cold) to treat patients with Glioblastoma (GBM) brain tumors.- A re-engineered HIV virus to treat patients with the blood cancer Leukemia.2.',\n",
       "  '60 Minutes TV special: \"Killing Cancer\" focused on curing GBM by using a re-engineered Polio virus.3.',\n",
       "  'PBS TV special: \"Cancer: The Emperor of All Maladies\" tells the complete story of cancer, from its history to current breakthroughs.',\n",
       "  \"It's six hours long, broken into three videos, with the last part covering IO.\",\n",
       "  \"We've reached an inflection point to change the trajectory of breast cancer treatment.\",\n",
       "  'In late 2015, an unprecedented coalition was formed to accelerate progress in IO.',\n",
       "  'Called the \"Cancer Moon Shot 2020\" (#CancerMoonShot), this endeavor will bring patients closer to Immunotherapies and precision medicine, by not only exploiting genetics (DNA), but also epigenetics (gene expression), proteomics (protein expression), metabolomics (cancer metabolism).',\n",
       "  \"Here's a couple video's discussing the effort:4.\",\n",
       "  'Cancer MoonShot 2020, explained in very simple terms, here.5.',\n",
       "  'Cancer MoonShot 2020 Press Conference (Jan 2016), here.',\n",
       "  \"Listen to the experts.If you're smart, you asked the question: how can immunotherapy be harnessed in Breast Cancer?To answer this, I researched the usual resources and was surprised at the paucity of info.Breastcancer.org's page, Using the Immune Response to Treat BC is outdated and extremely incomplete.\",\n",
       "  'It only discusses these Monoclonal Antibodies (mAbs) used for HER2+ patients: Herceptin (trastuzumab), Tykerb (lapatinib), Perjeta (pertuzumab), Kadcyla (Trastuzumab or T-DM1).',\n",
       "  'The Cancer Research Institute\\'s webpage, \"Immunotherapy for Breast Cancer\", is the most comprehensive resource for US based research, although it was last updated Sept 2014.',\n",
       "  '[Dr. Leisha Emens of John Hopkins reviewed and updated the webpage in March 2016].It\\'s written that \"breast cancer has historically been considered immunologically silent\".',\n",
       "  'This statement may contribute to why breast cancer lags behind when compared to other cancers.',\n",
       "  'This notion that breast cancer, in particular ER+ disease, is \"not very immunogenic\" is an antiquated view that needs to end.',\n",
       "  'I understand it\\'s \"early days\", but the breast cancer industry needs a serious paradigm shift.',\n",
       "  'Listen to this comment at the 2016 CancerMoonShot press conference here).',\n",
       "  'Priorities should be realigned towards the basic science of IO and then translated into cures that exceed the ~7% that standard therapies offer metastatic patients over 10 years (Source: Weissman, June 2015, ~10:00 minute mark).',\n",
       "  'As patients / caretakers, we should be discussing Immunotherapies with our doctors, encouraging breast cancer researchers to explore this approach and supporting funding efforts aimed at moving the field forward.',\n",
       "  'So, in a effort to advocate for this community, I wanted to start this topic and get others to ask these questions:- What progress is being made in Breast Cancer Immunotherapy?- Who are the thought leaders and researchers in Breast Cancer Immunotherapy?- Most importantly, where are the Breast Cancer Immunotherapy clinical trials?Who else shares this sense of urgency?'],\n",
       " [\"    I'm no expert.I found this and maybe it will be of some help.https://www.breastcancertrials.org/bct_nation/brow...\"],\n",
       " [\"    The Her2+ recurrence prevention trial I did was for encouragement of the patient's immune system to fight recurrence through vaccines.http://www.cancer.gov/clinicaltrials/search/view?c...\"],\n",
       " ['    SpecialK what immune drug was part of your trial?'],\n",
       " ['    chrissie - it was the GP2 peptide vaccine given with GM-CSF.',\n",
       "  'This was a two armed trial, and half were given GP2 and half AE37, and some placebo with no vaccine.',\n",
       "  'The placebo was the GM-CSF, so everybody got something, the GM-CSF is similar to Neulasta/Neupogen so it was\\xa0potentially immune boosting by itself.',\n",
       "  'We were sorted into the arms by histological tissue type like for organ transplant compatability, which was independent of any cancer info.'],\n",
       " ['    SpecialK-are there results from your study yet?', 'What phase was it?'],\n",
       " ['    I did phase II, which is now closed to enrollment.',\n",
       "  'There is no word yet regarding the start of phase III.',\n",
       "  'Here is the preliminary info:http://www.mdanderson.org/newsroom/news-releases/2...'],\n",
       " ['    Thanks for the info.',\n",
       "  'There is a Phase 2 trial on Neuvax but I might be too late in inquiring because the treatment is supposed to start after the 3rd adjuvant Herceptin.'],\n",
       " ['    Which trial are you looking at?',\n",
       "  'I had thought that neuvax was for low Her2 expressors.'],\n",
       " ['    I saw that one but I also saw this one- Phase II Trial of Combination Immunotherapy With NeuVax and Trastuzumab in High-risk HER2+ Breast Cancer Patients.'],\n",
       " ['    SpecialK - maybe I am reading it wrong but I thought is was an active study.'],\n",
       " [' Hi all, finally got a date for my exchange surgery.',\n",
       "  \"I'm glad to see the end of this part of the journey in sight.\",\n",
       "  'Anyways, my PS is saying I will only need to be out of work 1 day.',\n",
       "  'Is this realistic?',\n",
       "  'My surgery is scheduled on Friday the 20th of July, so will I really be ready to go back to a desk job that Monday morning?',\n",
       "  'Anything else I should expect or be on the lookout for?',\n",
       "  'Thanks bunchesKaren'],\n",
       " ['         My answer is: it depends.',\n",
       "  \"IF your desk job isn't too taxing or you can slack a little then it'd be alright.\",\n",
       "  'Monday will be 3 days post-surgery.',\n",
       "  \"IF you absolutely don't have any leave and can't afford to take LWOP (and the first IF holds true)IF you don't mine being a bit sore and taking Advil instead of Vicodin.Jobs have a lot of variation.\",\n",
       "  \"I wouldn't think it would be one of your most productive weeks, but if showing up will do for a few days then it'd be OK.\"],\n",
       " ['         Thanks, my job is pretty low key.',\n",
       "  'Plus my co-workers and I pick up the slack whenever one of us is not up to par.',\n",
       "  'I may just take off that Monday and give myself one more day to get it together.',\n",
       "  'Karen'],\n",
       " ['         My surgeon recommended a week off, but I probably could have gone back 2 or 3 days earlier.',\n",
       "  'I was surprised at how good I felt when I woke up.',\n",
       "  'The next day I was sore in my cleavage area.',\n",
       "  'The skin there had adhered and the surgeon said he \"had to do some work\" on it.',\n",
       "  \"But it really wasn't too bad, and then there is that euphoria from not having expanders!Good luck,Naomi\"],\n",
       " ['         I am a week past my bilateral exchange, and just today think I could have gone back to work.',\n",
       "  'It took getting off the narcotics during the day to feel like myself.',\n",
       "  'If you normally bounce back quickly, and you have a desk job with understanding coworkers, then Tuesday might be doable.',\n",
       "  'Just go easy on yourself.I hope it goes well.'],\n",
       " ['    Karen - I scheduled my exchange surgery during my spring break so I could have the week off work.',\n",
       "  'I was more tired than sore.',\n",
       "  'I only took acetomenaphin for pain.',\n",
       "  'Take the time you need to heal.',\n",
       "  'all the best to you.',\n",
       "  'karen in denver'],\n",
       " ['    I had my bilateral exchange surgery on Friday.',\n",
       "  'They told me to do nothing for a week, and I took Tuesday off work (Monday was a holiday).',\n",
       "  \"I probably could have gone back to work on Wednesday, but I didn't.\",\n",
       "  'I was in that anesthesia fog over the weekend, then by Sunday I was only taking a pain pill at night to help me sleep.',\n",
       "  'Maybe you can schedule it for the end of a week so you have a few days off anyway?',\n",
       "  'Make sure you give youself the time you need.',\n",
       "  'They told me even housework uses a lot of upper body stuff and I did swell a bit after cleaning the house the other day (and got yelled at at my follow-up appt.',\n",
       "  'today).',\n",
       "  '-Nancy'],\n",
       " ['    Can anyone give me their opinion on which type of surgery I should choose?',\n",
       "  'I have been given the option of TRAM flap or Latissmus muscle?',\n",
       "  'Which did most of you choose?',\n",
       "  'Thanks for any advice you can give.'],\n",
       " ['         TelenaB, your choice is going to depend on your surgeon and your body and your circulation.',\n",
       "  'It will have to be up to you.My advice is to see at least 2 if not 3 plastic surgeons for consults and see what is recommended for you and your body type.',\n",
       "  'Do some reading and see what you are most comfortable with.With the Tram or Diep you will get a tummy tuck, which I would have liked for me.',\n",
       "  \"I wasn't a candidate for those.I would not go for the tram with muscle tho.\",\n",
       "  'Learn as much as you can and find a doc who does MANY of the kind you think you want.'],\n",
       " ['    Hi all:  I am having my exchange surgery (bi-lateral) on the 20th of June.',\n",
       "  \"I don't see where any of you mentioned the dreaded DRAINS!!!\",\n",
       "  'Did any of you have them?',\n",
       "  'If so, for how long?',\n",
       "  'I have a major event to attend for work (it\\'s an all day \"meet the clients\" type of thing).',\n",
       "  'I am wondering if I will be able to attend....  thanks for any input.',\n",
       "  'I am sooo excited to get rid of these plastic balls on my chest!!!',\n",
       "  '!'],\n",
       " ['    Blue - no drains with my exchange surgery.',\n",
       "  'Recovery was fairly easy.'],\n",
       " [' Has anyone had radiation and then reconstruction?I had lumpectomy - recurrence near lump bed - but had radiation.',\n",
       "  'Mastectomy in Jan. for second cancerNo one told me radiation might disqualify me for reconstruction.',\n",
       "  'I am so upset by this.',\n",
       "  'I wish I had a mast the first time around - I would have had immediate reconstruction.I have apt.',\n",
       "  'with surgeon in two weeks.I am so upset by all of this.',\n",
       "  \"I can't believe no one told me that radiation = maybe no reconstruction.\",\n",
       "  'I was stage 1 first (2 1/2 yrs ago) and second time.'],\n",
       " ['         I had radiation and waited a year to have reconstruction because I wanted to have expander/implant surgery.',\n",
       "  'I was advised against this particular kind of reconstruction because of the radiation.',\n",
       "  'I had it done anyway and it failed miserably.',\n",
       "  'I ended up doing a lat.',\n",
       "  \"flap and so far I'm very pleased.\",\n",
       "  'You should be a candidate for a flap surgery or a DIEP or SGAP.',\n",
       "  'There are many different methods that should still work.',\n",
       "  'Good luck with your appointments.God bless,Chris'],\n",
       " ['         Radiation does not = NO reconstruction, and if anyone tells you that you should slap them.',\n",
       "  \"Okay, don't slap them, but maybe stand really close when you talk to them, and try to spit on them.I digress...While radiated skin does pose challenges to plastic surgeons, there are many methods of reconstruction that are successful after radiation.\",\n",
       "  'The easiest methods would be an abdominal flap surgery, however, if you were only a candidate for implants, you could combine them with a lat flap, or alloderm depending on the amount of radiated tissue that needs to be salvaged, and voila--- breasts.you need to find the right Dr., and go from there.good luck'],\n",
       " ['         Although radiated skin can present problems, it is not a foregone conclusion that an implant reconstruction is not a option.',\n",
       "  'I had a lumpectomy ten years ago followed by radiation treatments.',\n",
       "  'Two months ago I had a recurrence in the same breast.',\n",
       "  'I decided on having this type of construction because of the advantages it offers:  a far simpler surgery which does not weaken any other areas of the body and a much easier recovery post-surgery.',\n",
       "  'On June 6 (five days ago), my PS used Alloderm to create a sling which supplements the muscle and there was enough skin post-mastectomy for him to immediately put in an implant, skipping the expander entirely.',\n",
       "  'The implant was the same volume (gram for gram) as the tissue which was removed.',\n",
       "  'So I am here to say, yes, there are many choices out there and you should investigate them all to decide which is right for you.',\n",
       "  'The implant method is one of your choices.',\n",
       "  'I wish you strength during this difficult journey.',\n",
       "  'I made it through and with the help of your loved ones and friends, so will you.God Bless You,ladyinbrevard'],\n",
       " ['    I am due to have my perm implants put in 6/21.',\n",
       "  'Had first occurence of bc 2001 - had lump/radiation.',\n",
       "  'Second recurrence last Aug = had bilat mast with immediate recon.',\n",
       "  \"PS said only 'wrench' in the deal was the radiated breast.\",\n",
       "  'Had one \\'fill\\' am a nice \"B\" cup.',\n",
       "  'All going great, but just developed a small scab on radiated breast scar.',\n",
       "  \"PS concerned = not infected - says he's never seen this so far out into recovery.\",\n",
       "  'Saw his PA Mon and going to see him today.',\n",
       "  \"If i have to postone exchange a few weeks it's fine.\",\n",
       "  \"I've been questioning my decision and will take his advice .\",\n",
       "  'I truly respect his knowledge.',\n",
       "  \"I don't want any more problems but i've come so far and enjoy having a nice bustline.\",\n",
       "  \"I'm only 48!\",\n",
       "  \"SO....i would take a chance and go for it, but be prepared for some 'bumps' in the road.\",\n",
       "  'Good luck.',\n",
       "  'I plan to post here my outcome asap.'],\n",
       " ['         I am sure that some people have success with expander/implants after radiation.',\n",
       "  'The best scenario seems to be where you have the expander and get expanded BEFORE the radiation.',\n",
       "  'Then they radiate the expanded tissue.',\n",
       "  'Even then sometimes I read about discomfort, infection, or unsatisfactory cosmetic results.',\n",
       "  \"But oftentimes that seems to satisfy people.It just seems like so many women have problems with expander/implants after radiation that I think I would give serious consideration to another type of reconstruction if I'd already had radiation.\",\n",
       "  \"It's stressful to have it and then have it fail, why not just go with a method you're sure will work.I don't want to be disrespectful of Plastic Surgeons, but they get paid whether it works or not, and if it doesn't work they stand a chance of getting paid again to fix it.\",\n",
       "  'So if you are really against a more involved reconstruction method, like a lat flag, TRAM, DIEP - I think they will try the expander/implant.',\n",
       "  'But you are the one going through multiple surgeries and spending your time and emotional energy, so I would listen to the PS when they tell you what the chances of success are.'],\n",
       " ['         I know a woman who had very bad skin damage from radiation.',\n",
       "  'She had a recurrence in same breast after lump.',\n",
       "  '(had mast second time) Her surgeon told her same thing - probably no reconstruction due to radiation damage.',\n",
       "  'But the plastic surgeon - who agreed her skin was damaged -was able to do reconstruction for her.',\n",
       "  \"She was very pleased with results.So, since she was able to do it with badly damaged skin you most likely will succeed too.Don't panic till you talk to the plastic surgeon.\",\n",
       "  'And I would suggest getting a second opinion.',\n",
       "  'From other posts I have read it seems almost anything is doable with reconstruction.'],\n",
       " ['    I had mastectomy, expander placed at the same time, chemo, exchange for implant, then radiation.',\n",
       "  'Implant failed and got worse over time!',\n",
       "  'Refused to have a tram.',\n",
       "  'Researched and found the diepflap.com website.',\n",
       "  'Had surgery to remove implant, get a prophylactic mast.',\n",
       "  'and bilateral diep reconstruction 3/13/07.',\n",
       "  \"Best thing I've ever done for myself!\",\n",
       "  '!'],\n",
       " ['         Thanks to all who responded.',\n",
       "  'I have now made a second apt with another reconstruction surgeon.',\n",
       "  'Have been reading all posts on reconstruction.Seems many go to New Orleans or South Carolina!',\n",
       "  \"i guess I need to find out if my insurance will pay for reconstruction if its outside my state.I'm beginning to think this is where the reconstruction  experts are!\"],\n",
       " ['    There are reconstruction experts everywhere depending on the procedure.',\n",
       "  'In addition to their expertise, it is important that you feel really comfortable with the doctors and hospital that you choose.',\n",
       "  'You are going to working with them and seeing them on a very regular basis.',\n",
       "  'Traveling for your reconstruction is not for everyone.',\n",
       "  'Since you are doing the research anyway I recommend you research what is available near you in addition to the \"national experts\".'],\n",
       " ['    PS was concerned about scab so had exchange last thurs 6/14.',\n",
       "  \"So far he's pleased - all went well but he warned me that he wants to watch radiated breast very closely.\",\n",
       "  'Am nervous but hopeful.',\n",
       "  \"It's tighter but both look and feel great.\"],\n",
       " [' Lump, mammogram, ultrasound, biopsy, diagnosis, carefully studied options, a plan.',\n",
       "  \"That's what one does, right?\",\n",
       "  'I opted to have a double mastectomy so that if nodes were clear I would be all done.',\n",
       "  'Put the surgery on my calendar then went for pre-op chest x-ray, EKG, and MRI.',\n",
       "  'So much for my plan.',\n",
       "  'There is an enlarged internal mammary gland and I get to have another biopsy before surgery.',\n",
       "  'So much for the hope of avoiding chemo.',\n",
       "  \"It's all so darned scary.\",\n",
       "  \"I don't wanna do this.\"],\n",
       " ['         Towhee, it is scary ... take one step at a time, one day at a time and you will get through it.',\n",
       "  'I remember how scary it was when I got my diagnosis ... and how scary it was until I knew and understood the full picture ... and how hard it was to make the decisions about my treatment plan.',\n",
       "  \"Hard to believe but once you have a treatment plan in place it does get easier -  because from that point on you're just going what you've decided you need to do.\",\n",
       "  \"I'm so sorry you had to join our club - but also glad that you've found the discussion groups here.\",\n",
       "  \"There's a wealth of information and a ton of support and inspiration here.\",\n",
       "  \"You're sure to find others who have been where you are - and facing the same decisions and treatment you decide on -  there will be others in front of you on the journey - and unfortunately - others will follow ...    there are many here to help you get through - who totally understand and relate to the feelings you're experiencing.\",\n",
       "  \"I hope you'll get good news on the additional biopsy and be able to move forward with your treatment plan quickly.\",\n",
       "  'gentle hugs to you ...Doreen'],\n",
       " ['    If you are having a bilateral mast - why another biop?'],\n",
       " ['         Hi, sorry you have to rework your plan.',\n",
       "  \"I guess you've heard the old saying: If you want to make God laugh, make a plan.We are glad you have found us tho.\",\n",
       "  \"I hope you'll come here often and let us be with you when you need us.\",\n",
       "  'Or just to hang about if you want and help out other newbies.'],\n",
       " ['         \"Towhee songs commonly consist of two parts, (1) one or more introductorynotes, and (2) a trill.',\n",
       "  'A few songs lack the first part, a few lack the secondpart, and a few are double (introductory notes, a trill, then more introductorynotes, then another trill).A towhee generally sings at the rate of five to ten songs a minute.',\n",
       "  'Its songsare usually all alike, but it may occasionally sing songs of one type for a while, and then change to a different type; rarely a bird may sing two types of songs that alternatel\"  ( Donald J. Borror)You seem to be following your plan, sounding a lot like all we other Towhees by singing one common song for a while.',\n",
       "  'Yet on occasion we Towhees stop singing our common song, and for a time, change to a different song.',\n",
       "  'Only the strongest of us, it seems, can sing two songs in alternation.',\n",
       "  'You are strong, Towhee, and we will sing with you throughout.Tender'],\n",
       " [\"    Awwww--you're all so sweet.\",\n",
       "  \"I, too, wondered why another biopsy if I'm having surgery.\",\n",
       "  'I made them call my surgeon.',\n",
       "  'Yes, she wants it.',\n",
       "  \"I don't think they usually remove internal mammarys even if they are positive.\",\n",
       "  \"I guess I'll find out.\",\n",
       "  'Just hate this waiting.',\n",
       "  'Tender, the song of the Towhee during mating season is one I look forward to each year.',\n",
       "  'It has been described as sounding like \"cup of tea\" with cup a middle sound, of a bit lower, tea higher and trilled.',\n",
       "  'It seems like this time in my life could use a cup of tea!'],\n",
       " ['         I love the quote by Eleanor Rosevelt \"Women are like tea bags, you don\\'t know how strong you are until you get thrown into a cup of hot water.\"',\n",
       "  'Here you are in the same cup of hot water we all have been thrown into and together we make a strong cup of tea.I had bi-lat June 1, I pray the best for you.Sheila'],\n",
       " ['    Towhee, I am so sorry that it seems like things are no going according to your plan.',\n",
       "  'I am not a big fan of pre-op tests.',\n",
       "  'Seems like everytime I go in for pre-op they find something wrong.',\n",
       "  'In fall 2005 when I had pre-op for my bi-lateral they found something on my chest x-ray the day before surgery and called me to schedule a CT scan.',\n",
       "  'I was absolutely scared sh**tless.',\n",
       "  \"I was convinced the cancer had spread to my lungs and I was stage IV and wouldn't be able to have surgery.\",\n",
       "  \"I went in, had the CT scan and wouldn't leave until I got the results.\",\n",
       "  'My scan came back clear and I proceeded to surgery the next day.',\n",
       "  'Sending a hug your way and hopes this turns out to be nothing so you can proceed with your plan.',\n",
       "  'Hang in there.',\n",
       "  'Liz'],\n",
       " ['         You got it Liz!',\n",
       "  'I went from feeling somewhat in control with a strong sense that the surgery would be the end of it, to the MRI and an enlarged node in a bad place and loss of that feeling of control.',\n",
       "  \"Now I am certain that i have lung involvement (I'm sure I'm not getting as much oxygen as I used to), brain (Geez I've been a klutz lately and I'm dizzy all the time), bones (I thought that pain in my wrist was arthritis, but I've never had it there before), liver (what it that nagging ache in my back over the liver area), to even colon (was that recent bout of diverticulitis really an indication of cancer instead), ovary/uterus (what is that heavy, aching sensation anyway).Yup, I've turned in to a raging hypochondriac over a single suspicious node under my breastbone.\",\n",
       "  \"Even knowing it is all in my mind, there is a constant nagging sense that the news is going to be bad and I'm not ready for that.\",\n",
       "  \"As my doctor's brother so wonderfully put it....ASOG (Another Sucky Opportunity for Growth)...has entered my life and I need to make the most of it!\",\n",
       "  'Or, chant the motto of a tiny town I once lived in where resources were hard to come by, \"Buck up and deal.\"'],\n",
       " [\"         Silly Goose, we can't ALL have all those things!\",\n",
       "  'Believe it or not I had to go in for a crown and the dang dentist found a lump inside my tongue.',\n",
       "  'I was shocked.',\n",
       "  'He took it out and after a weekend of terror, it was benign.But I have had mets to the brain (no more simple headaches), aches all over all my bones (always bone mets), and plus, we are all hypersensitive to all the little noises your body makes all the time, that we USED to ignore!Damn disease, the gift that keeps on giving.Hugs, Shirlann'],\n",
       " [\"         So sorry things aren't going as planned.\",\n",
       "  \"Isn't that always the case?\",\n",
       "  'Know that how you are feeling is normal.',\n",
       "  'It is scary, but you should know more soon.',\n",
       "  'I will keep you in my thoughts.',\n",
       "  'Hang in there.Patti'],\n",
       " [\" Hello, I'm 42, Dx 8/10/2007, IDC, Stage I, Grade 3, 0/2 nodes, ER+/PR+, HER2+.\",\n",
       "  'I sailed through the biopsy, my diagnosis and my surgery.',\n",
       "  'But now, having met my onc for the first time and hearing my recommended treatment plan, I am terrified!!',\n",
       "  '(Really, it was the Her2+ diagnosis that put me over the edge.',\n",
       "  'I still am not sure what Her2 really means!',\n",
       "  ')I believe the BC diagnosis was perhaps easy for me to deal with because my mother is a 25+ year BC survivor!',\n",
       "  \"(She's *awesome*) Therefore, I knew what to expect in terms of the diagnostic procedures and the mastectomy.\",\n",
       "  \"But, since Mom didn't go through chemo treatments I do not have anything to guide me.\",\n",
       "  \"I suppose it's the fear of the unknown that worries me.\",\n",
       "  '???',\n",
       "  \"?I read the posts here and it seems that my dx is so much less significant than others - and I'm just really feeling down on myself for not being stronger.\",\n",
       "  'Isn\\'t it the \"C\" word that is supposed to put us into terrified fits???',\n",
       "  'Yet for me, with a beautiful prognosis, the mere idea of chemo is TERRIFYING.',\n",
       "  'I feel like a wimp.Any suggestions on how, or what I can do to \"buck up\" and take this one day at a time?',\n",
       "  \"I don't know what the Her2 really means, nor can I seem to find a concise answer elsewhere - plus I don't know what 6 months chemo & 12 months herceptin will be like!\",\n",
       "  'And if I admit it, a BIG part of me wonders, \"do I really need to subject my body to this?',\n",
       "  '\"For the first time since this rollercoaster ride began in August, I feel weak and indecisive.',\n",
       "  'My hope is that I am not alone - that some of you strong major surviors can set me straight???',\n",
       "  'Thank you in advance'],\n",
       " [\"     Sunflower, you don't need to buck up at all.\",\n",
       "  \"You are feeling just what your body is telling you to feel, and you've come to the right place for support.\",\n",
       "  'I am so sorry about your diagnosis.',\n",
       "  'Each woman is vital: your diagnosis is still the \"C\" word, and it\\'s scary.',\n",
       "  \"So, I wish to say I'm sorry you had to join us in this unfortunate way.\",\n",
       "  \"We're a lively bunch here, and I hope you derive the satisfaction that I have by coming here.\",\n",
       "  'I just wanted to say this right now.',\n",
       "  'Soon others will post wonderful commentary to you.',\n",
       "  'I will follow along your journey.',\n",
       "  \"No, you won't be alone at all.\",\n",
       "  'Tender'],\n",
       " [\"    Sunflower, I think it's pretty normal to have fears about chemo and wondering if you really need it.\",\n",
       "  \"It's basically up to each of us what route we decide to travel in our treatment options.\",\n",
       "  'However, I have read that herceptin is\\xa0of great benefit for Her2neu positive tumors.',\n",
       "  'Also, the oncotype test for ER positive tumors is another tool for women to use to help in their decisions.',\n",
       "  'Maybe ask your onc if this test would be of benefit for you?',\n",
       "  'Taking everything into consideration, most doctors will recommend chemo based on age, tumor size (anything over 1 CM in the US), and grade of aggressiveness and other factors.',\n",
       "  'I believe the Her2neu is a gene that helps control cell growth.',\n",
       "  \"Someone a lot more educated about this will reply soon, I'm sure.\",\n",
       "  \"I'm sorry you had to join us but the ladies here are well informed and caring.\",\n",
       "  'Good luck in your decision.'],\n",
       " ['    Sunflower - You are NOT a wimp.',\n",
       "  'This stuff is really scarry regardless of your prognosis.Her2 + means that the bc cells in your body are overexpressing a certain receptor.',\n",
       "  'It also means that the drug Herceptin will work to help you.',\n",
       "  'Take a look at this info: www.breastcancer.org/symptoms/...',\n",
       "  'I know several women who have taken Herceptin - most of them have had few or no side effects from it.',\n",
       "  \"You can post a question about Her2 in the chemotherapy section of this board - I bet you'll get lots and lots of first hand responses.There are a lot of scary things about chemo.\",\n",
       "  \"I didn't know how sick I would feel, would I be able to take care of my kids, would I be able to keep working, how would I deal with being bald, etc., etc.\",\n",
       "  'Chemo for me was much worse than surgery because I could hide the surgery - but once my hair fell out I looked sick.',\n",
       "  \"I couldn't pretend that I was OK.\",\n",
       "  'But, with that said - chemo was no where near as horrible as I thought it would be.',\n",
       "  'I got through it, lots of women have, and you can too.',\n",
       "  'It sucks, but you can handle it.',\n",
       "  'The anti-nausea drugs they have now are incredible.',\n",
       "  'I felt crappy during chemo, but I never threw up.Every step of the way so far my anticipation of treatment has always been worse than actually going through it.',\n",
       "  'Hang in there.',\n",
       "  'It will get better.',\n",
       "  \"It's OK to be afraid.\"],\n",
       " ['    In addition to the HER2 section of this board, there is a terrific website called www.her2support.org.',\n",
       "  \"My mom is HER2 + (I'm not), and I've read that board every day for 5 years.\",\n",
       "  \"I've learned more off of it than anything the oncs have ever told us.\",\n",
       "  \"BTW, you're not a wimp.\",\n",
       "  'Things are just overwhelming in the beginning.',\n",
       "  'And yes, with a grade 3, HER2+ tumor, it would be very prudent to do chemo and Herceptin.',\n",
       "  \"even if it's stage 1.\",\n",
       "  \"My mom has been on chemo for 5 years, and I'm halfway through my 6 cycle course.\",\n",
       "  \"It sucks, but it's doable.\"],\n",
       " ['    hi,my aunt took herceptin.she had no side effects.',\n",
       "  'having fears is normal.',\n",
       "  'you are not a wimp.my aunt is halfway through her 6 months of treatment she does good.',\n",
       "  'i hope you do great with your treatment.',\n",
       "  'remember one day at a time.dear never say you are a wimp.',\n",
       "  'it seems to me you are a fighter.'],\n",
       " ['    Sunflower, you are not a wimp.',\n",
       "  'Chemo is scary.',\n",
       "  'I remember the first time the onc nurse reached for my port to start my chemo.',\n",
       "  'I bolted out of the chair and ran to the bathroom!!!!',\n",
       "  \"I just wasn't ready yet.\",\n",
       "  'She laughed at me.',\n",
       "  'So did my husband.',\n",
       "  \"So did I after a few minutes.There's a lot of information available on this web site about Her2++.\",\n",
       "  'There are many women here who have had the same treatment.',\n",
       "  \"It's a good news bad news situation.\",\n",
       "  'Her2++ tumors are more aggressive but Herceptin does a great job at defeating them!!!!!',\n",
       "  \"It's a more targeted chemotherapy than what the rest of us get.\",\n",
       "  'After you finish you first chemo your hair will even start growing back while you are on herceptin.',\n",
       "  'By the time you finish chemo you will have a full head of hair.',\n",
       "  'You are a fighter.',\n",
       "  'We all are.',\n",
       "  'Have Faith and let us help you.hugsSusan'],\n",
       " ['    Never worry about being a wimp, we have all been there done that.',\n",
       "  'As you pass through this journey you will have many peaks and valleys.And all the sisters will be here for each and ever one of them.What kept me going was my November 2005 chemo girls.',\n",
       "  \"We're still\\xa0 on the boards today.\",\n",
       "  'They have been my rock.So find the month you start chemo, and stick with those girls.Remember strength in numbers.'],\n",
       " ['    Sunflower!First of all I want to give you a hug!',\n",
       "  '(((()))) Now as a daughter and double neice of\\xa0bc survivors I fully understand.',\n",
       "  'Being near cancer and having cancer are two different animals.',\n",
       "  'You are not being a wimp or weak.',\n",
       "  'You are\\xa0at a rough spot in the road, this is a rollercoaster ride at best.',\n",
       "  'I had delayed depression, after my surgery.',\n",
       "  'It happens, I was so busy being pro-active I was not accepting my cancer.',\n",
       "  \"Everyone's road is different, everyone's struggles are different.\",\n",
       "  'But what makes us sisters is the shared common enemy of cancer.',\n",
       "  'Yes you are blessed to have\\xa0\"just IDC stage 1\".',\n",
       "  'but Sunflower you had\\xa0breast Cancer!!!!',\n",
       "  'It is scarey, it is hard but as many\\xa0survivors will tell you \"doable\".',\n",
       "  'You are doing fine, just a rough\\xa0patch.',\n",
       "  'You will cowboy up when you have to, but right now you need a hug and maybe some chocolate!Praying for you!',\n",
       "  'PM anytime!!!',\n",
       "  '!'],\n",
       " ['    Oh my goodness, thank you all for the wonderful, warm and positive responses.',\n",
       "  \"Today I'm feeling so much better; and am realizing (from reading other posts) that this is just the start of an ongoing battle with good day/bad day scenarios.\",\n",
       "  'I KNOW I will have more good days than bad days!',\n",
       "  \"Thanks for the reminder of the Her2 information that is contained on this site - I have read so much information in the past month it's easy to overlook or forget where to go!\",\n",
       "  \"In retrospect, I *am* very fortunate to have the Her2 & ER/PR positive results as that does allow me to have a more targeted treatment approach.Terry, thank you for the oncotype suggestion - I hadn't considered that and will definitely discuss it with my doctor next week.Thank you all so much for allowing me to whine and for helping me to feel better!!\",\n",
       "  \"This little rollercoaster ride looks so much less daunting now - I'm off to find the chocolate - YUMM.\",\n",
       "  'Bless all of you!'],\n",
       " [\"    Hi Sunflower, you are always welcome here to whine, rant, cry, all the things you can't do at home because it upsets the family!\",\n",
       "  'Here, anything goes.',\n",
       "  'We all understand and you do not upset us.',\n",
       "  'We have all been there.',\n",
       "  'You are correct, this is a looong journey, and that fact alone is scary.',\n",
       "  'None of us are used to that facet of cancer.',\n",
       "  'But this does not mean you will not have a full recovery.',\n",
       "  'I am 9 years post treatment and doing just fine.',\n",
       "  'You will too.',\n",
       "  'Gentle hugs, SHirlann']]"
      ]
     },
     "execution_count": 35,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "sent"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 36,
   "metadata": {},
   "outputs": [],
   "source": [
    "lowerList = [[string.lower() for string in innerList] for innerList in sent]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 38,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "[[\" immuno-oncology (io) and immunotherapy drugs are humanity's best shot at beating cancer.\",\n",
       "  'during the last few years, io has revealed impressive, durable responses in a variety of tumor types for which conventional therapies historically have had limited success (melanoma, leukemia, lymphoma, lung, liver, bladder, etc).the power of this approach is highlighted in countless articles (like here and here) as well as a variety of tv broadcasts, including:1.',\n",
       "  'hbo\\'s vice tv special: \"killing cancer\", explored a subset of io called \"virotherapy\" and how the following three common viruses are genetically modified to find and kill cancer:- a re-engineered measles virus was used to treat patients with multiple myeloma.- a re-engineered adenovirus (like the common cold) to treat patients with glioblastoma (gbm) brain tumors.- a re-engineered hiv virus to treat patients with the blood cancer leukemia.2.',\n",
       "  '60 minutes tv special: \"killing cancer\" focused on curing gbm by using a re-engineered polio virus.3.',\n",
       "  'pbs tv special: \"cancer: the emperor of all maladies\" tells the complete story of cancer, from its history to current breakthroughs.',\n",
       "  \"it's six hours long, broken into three videos, with the last part covering io.\",\n",
       "  \"we've reached an inflection point to change the trajectory of breast cancer treatment.\",\n",
       "  'in late 2015, an unprecedented coalition was formed to accelerate progress in io.',\n",
       "  'called the \"cancer moon shot 2020\" (#cancermoonshot), this endeavor will bring patients closer to immunotherapies and precision medicine, by not only exploiting genetics (dna), but also epigenetics (gene expression), proteomics (protein expression), metabolomics (cancer metabolism).',\n",
       "  \"here's a couple video's discussing the effort:4.\",\n",
       "  'cancer moonshot 2020, explained in very simple terms, here.5.',\n",
       "  'cancer moonshot 2020 press conference (jan 2016), here.',\n",
       "  \"listen to the experts.if you're smart, you asked the question: how can immunotherapy be harnessed in breast cancer?to answer this, i researched the usual resources and was surprised at the paucity of info.breastcancer.org's page, using the immune response to treat bc is outdated and extremely incomplete.\",\n",
       "  'it only discusses these monoclonal antibodies (mabs) used for her2+ patients: herceptin (trastuzumab), tykerb (lapatinib), perjeta (pertuzumab), kadcyla (trastuzumab or t-dm1).',\n",
       "  'the cancer research institute\\'s webpage, \"immunotherapy for breast cancer\", is the most comprehensive resource for us based research, although it was last updated sept 2014.',\n",
       "  '[dr. leisha emens of john hopkins reviewed and updated the webpage in march 2016].it\\'s written that \"breast cancer has historically been considered immunologically silent\".',\n",
       "  'this statement may contribute to why breast cancer lags behind when compared to other cancers.',\n",
       "  'this notion that breast cancer, in particular er+ disease, is \"not very immunogenic\" is an antiquated view that needs to end.',\n",
       "  'i understand it\\'s \"early days\", but the breast cancer industry needs a serious paradigm shift.',\n",
       "  'listen to this comment at the 2016 cancermoonshot press conference here).',\n",
       "  'priorities should be realigned towards the basic science of io and then translated into cures that exceed the ~7% that standard therapies offer metastatic patients over 10 years (source: weissman, june 2015, ~10:00 minute mark).',\n",
       "  'as patients / caretakers, we should be discussing immunotherapies with our doctors, encouraging breast cancer researchers to explore this approach and supporting funding efforts aimed at moving the field forward.',\n",
       "  'so, in a effort to advocate for this community, i wanted to start this topic and get others to ask these questions:- what progress is being made in breast cancer immunotherapy?- who are the thought leaders and researchers in breast cancer immunotherapy?- most importantly, where are the breast cancer immunotherapy clinical trials?who else shares this sense of urgency?'],\n",
       " [\"    i'm no expert.i found this and maybe it will be of some help.https://www.breastcancertrials.org/bct_nation/brow...\"],\n",
       " [\"    the her2+ recurrence prevention trial i did was for encouragement of the patient's immune system to fight recurrence through vaccines.http://www.cancer.gov/clinicaltrials/search/view?c...\"]]"
      ]
     },
     "execution_count": 38,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "lowerList[:3]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 43,
   "metadata": {},
   "outputs": [],
   "source": [
    "result = sum(lowerList, [])"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 75,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "[\" immuno-oncology (io) and immunotherapy drugs are humanity's best shot at beating cancer.\",\n",
       " 'during the last few years, io has revealed impressive, durable responses in a variety of tumor types for which conventional therapies historically have had limited success (melanoma, leukemia, lymphoma, lung, liver, bladder, etc).the power of this approach is highlighted in countless articles (like here and here) as well as a variety of tv broadcasts, including:1.',\n",
       " 'hbo\\'s vice tv special: \"killing cancer\", explored a subset of io called \"virotherapy\" and how the following three common viruses are genetically modified to find and kill cancer:- a re-engineered measles virus was used to treat patients with multiple myeloma.- a re-engineered adenovirus (like the common cold) to treat patients with glioblastoma (gbm) brain tumors.- a re-engineered hiv virus to treat patients with the blood cancer leukemia.2.',\n",
       " '60 minutes tv special: \"killing cancer\" focused on curing gbm by using a re-engineered polio virus.3.',\n",
       " 'pbs tv special: \"cancer: the emperor of all maladies\" tells the complete story of cancer, from its history to current breakthroughs.',\n",
       " \"it's six hours long, broken into three videos, with the last part covering io.\",\n",
       " \"we've reached an inflection point to change the trajectory of breast cancer treatment.\",\n",
       " 'in late 2015, an unprecedented coalition was formed to accelerate progress in io.',\n",
       " 'called the \"cancer moon shot 2020\" (#cancermoonshot), this endeavor will bring patients closer to immunotherapies and precision medicine, by not only exploiting genetics (dna), but also epigenetics (gene expression), proteomics (protein expression), metabolomics (cancer metabolism).',\n",
       " \"here's a couple video's discussing the effort:4.\",\n",
       " 'cancer moonshot 2020, explained in very simple terms, here.5.',\n",
       " 'cancer moonshot 2020 press conference (jan 2016), here.',\n",
       " \"listen to the experts.if you're smart, you asked the question: how can immunotherapy be harnessed in breast cancer?to answer this, i researched the usual resources and was surprised at the paucity of info.breastcancer.org's page, using the immune response to treat bc is outdated and extremely incomplete.\",\n",
       " 'it only discusses these monoclonal antibodies (mabs) used for her2+ patients: herceptin (trastuzumab), tykerb (lapatinib), perjeta (pertuzumab), kadcyla (trastuzumab or t-dm1).',\n",
       " 'the cancer research institute\\'s webpage, \"immunotherapy for breast cancer\", is the most comprehensive resource for us based research, although it was last updated sept 2014.',\n",
       " '[dr. leisha emens of john hopkins reviewed and updated the webpage in march 2016].it\\'s written that \"breast cancer has historically been considered immunologically silent\".',\n",
       " 'this statement may contribute to why breast cancer lags behind when compared to other cancers.',\n",
       " 'this notion that breast cancer, in particular er+ disease, is \"not very immunogenic\" is an antiquated view that needs to end.',\n",
       " 'i understand it\\'s \"early days\", but the breast cancer industry needs a serious paradigm shift.',\n",
       " 'listen to this comment at the 2016 cancermoonshot press conference here).',\n",
       " 'priorities should be realigned towards the basic science of io and then translated into cures that exceed the ~7% that standard therapies offer metastatic patients over 10 years (source: weissman, june 2015, ~10:00 minute mark).',\n",
       " 'as patients / caretakers, we should be discussing immunotherapies with our doctors, encouraging breast cancer researchers to explore this approach and supporting funding efforts aimed at moving the field forward.',\n",
       " 'so, in a effort to advocate for this community, i wanted to start this topic and get others to ask these questions:- what progress is being made in breast cancer immunotherapy?- who are the thought leaders and researchers in breast cancer immunotherapy?- most importantly, where are the breast cancer immunotherapy clinical trials?who else shares this sense of urgency?',\n",
       " \"    i'm no expert.i found this and maybe it will be of some help.https://www.breastcancertrials.org/bct_nation/brow...\",\n",
       " \"    the her2+ recurrence prevention trial i did was for encouragement of the patient's immune system to fight recurrence through vaccines.http://www.cancer.gov/clinicaltrials/search/view?c...\",\n",
       " '    specialk what immune drug was part of your trial?',\n",
       " '    chrissie - it was the gp2 peptide vaccine given with gm-csf.',\n",
       " 'this was a two armed trial, and half were given gp2 and half ae37, and some placebo with no vaccine.',\n",
       " 'the placebo was the gm-csf, so everybody got something, the gm-csf is similar to neulasta/neupogen so it was\\xa0potentially immune boosting by itself.',\n",
       " 'we were sorted into the arms by histological tissue type like for organ transplant compatability, which was independent of any cancer info.']"
      ]
     },
     "execution_count": 75,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "result[:30]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 52,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "373"
      ]
     },
     "execution_count": 52,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "len(result)"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## Examples of sentences containing drug names"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 49,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "['it only discusses these monoclonal antibodies (mabs) used for her2+ patients: herceptin (trastuzumab), tykerb (lapatinib), perjeta (pertuzumab), kadcyla (trastuzumab or t-dm1).']"
      ]
     },
     "execution_count": 49,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "[i for i in result if u\"kadcyla\" in word_tokenize(i)]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 50,
   "metadata": {},
   "outputs": [],
   "source": [
    "a = [i for i in result if u\"herceptin\" in word_tokenize(i)]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 51,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "['it only discusses these monoclonal antibodies (mabs) used for her2+ patients: herceptin (trastuzumab), tykerb (lapatinib), perjeta (pertuzumab), kadcyla (trastuzumab or t-dm1).', 'there is a phase 2 trial on neuvax but i might be too late in inquiring because the treatment is supposed to start after the 3rd adjuvant herceptin.', \"i don't know what the her2 really means, nor can i seem to find a concise answer elsewhere - plus i don't know what 6 months chemo & 12 months herceptin will be like!\", 'however, i have read that herceptin is\\xa0of great benefit for her2neu positive tumors.', 'it also means that the drug herceptin will work to help you.', 'i know several women who have taken herceptin - most of them have had few or no side effects from it.', 'and yes, with a grade 3, her2+ tumor, it would be very prudent to do chemo and herceptin.', 'her2++ tumors are more aggressive but herceptin does a great job at defeating them!!!!!', 'after you finish you first chemo your hair will even start growing back while you are on herceptin.']\n"
     ]
    }
   ],
   "source": [
    "her = list(a)\n",
    "print(her)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 54,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "[\" immuno-oncology (io) and immunotherapy drugs are humanity's best shot at beating cancer.\",\n",
       " \"listen to the experts.if you're smart, you asked the question: how can immunotherapy be harnessed in breast cancer?to answer this, i researched the usual resources and was surprised at the paucity of info.breastcancer.org's page, using the immune response to treat bc is outdated and extremely incomplete.\",\n",
       " 'the cancer research institute\\'s webpage, \"immunotherapy for breast cancer\", is the most comprehensive resource for us based research, although it was last updated sept 2014.',\n",
       " 'so, in a effort to advocate for this community, i wanted to start this topic and get others to ask these questions:- what progress is being made in breast cancer immunotherapy?- who are the thought leaders and researchers in breast cancer immunotherapy?- most importantly, where are the breast cancer immunotherapy clinical trials?who else shares this sense of urgency?',\n",
       " '    i saw that one but i also saw this one- phase ii trial of combination immunotherapy with neuvax and trastuzumab in high-risk her2+ breast cancer patients.']"
      ]
     },
     "execution_count": 54,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "[i for i in result if u\"immunotherapy\" in word_tokenize(i)]"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## Extracting sentences with drug names"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 93,
   "metadata": {},
   "outputs": [],
   "source": [
    "## List of drugs used in immunotherapy\n",
    "drug_names = ['kadcyla','lapatinib',\"perjeta\",\"pertuzumab\",\"kadcyla\",\"trastuzumab\",\"t-dm1\", \"gp2\",\"peptide\",\"gm-csf\",\"ae37\",\"neulasta\",\"neupogen\",\"neuvax\",\"mabs\" ,\"avastin\",\"bevacizumab\",\"vegf-a\",\"cyramza\",\"ramucirumab\",\"vegfr-2\",\"mgah22\",\"margetuximab\",\"omp-18R5\",\"vantictuma\",\"glembatumumab vedotin\",\"nelipepimut-s\",\"ipilimumab\",\"yervoy\",\"pembrolizumab\",\"keytruda\" ,\"opdivo\",\"nivolumab\",\"urelumab\",\"galunisertib\",]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 98,
   "metadata": {},
   "outputs": [],
   "source": [
    "new_list = []\n",
    "for line in result:\n",
    "    for word in drug_names:\n",
    "        if word in line:\n",
    "            new_list.append(line)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 104,
   "metadata": {},
   "outputs": [],
   "source": [
    "drug_ner = pd.DataFrame(new_list)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 105,
   "metadata": {},
   "outputs": [],
   "source": [
    "drug_ner.columns = ['Text']"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 259,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Text</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>It only discusses these Monoclonal Antibodies ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>Listen to the podcast to hear Dr Loi explain:r...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>She also is a member of the Breast Immuno-Onco...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>Herceptin, Perjeta, and Kadcyla (TDM-1) are co...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>It only discusses these Monoclonal Antibodies ...</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                                                Text\n",
       "0  It only discusses these Monoclonal Antibodies ...\n",
       "1  Listen to the podcast to hear Dr Loi explain:r...\n",
       "2  She also is a member of the Breast Immuno-Onco...\n",
       "3  Herceptin, Perjeta, and Kadcyla (TDM-1) are co...\n",
       "4  It only discusses these Monoclonal Antibodies ..."
      ]
     },
     "execution_count": 259,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "drug_ner.head()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 261,
   "metadata": {},
   "outputs": [],
   "source": [
    "drug_ner.to_csv('drug_ner_new.csv')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 262,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Unnamed: 0</th>\n",
       "      <th>Text</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>0</td>\n",
       "      <td>It only discusses these Monoclonal Antibodies ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>1</td>\n",
       "      <td>Listen to the podcast to hear Dr Loi explain:r...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>2</td>\n",
       "      <td>She also is a member of the Breast Immuno-Onco...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>3</td>\n",
       "      <td>Herceptin, Perjeta, and Kadcyla (TDM-1) are co...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>4</td>\n",
       "      <td>It only discusses these Monoclonal Antibodies ...</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "   Unnamed: 0                                               Text\n",
       "0           0  It only discusses these Monoclonal Antibodies ...\n",
       "1           1  Listen to the podcast to hear Dr Loi explain:r...\n",
       "2           2  She also is a member of the Breast Immuno-Onco...\n",
       "3           3  Herceptin, Perjeta, and Kadcyla (TDM-1) are co...\n",
       "4           4  It only discusses these Monoclonal Antibodies ..."
      ]
     },
     "execution_count": 262,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df_drug = pd.read_csv('drug_ner_new.csv')\n",
    "df_drug.head()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 263,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Unnamed: 0</th>\n",
       "      <th>Text</th>\n",
       "      <th>length</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>0</td>\n",
       "      <td>It only discusses these Monoclonal Antibodies ...</td>\n",
       "      <td>176</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>1</td>\n",
       "      <td>Listen to the podcast to hear Dr Loi explain:r...</td>\n",
       "      <td>625</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>2</td>\n",
       "      <td>She also is a member of the Breast Immuno-Onco...</td>\n",
       "      <td>526</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>3</td>\n",
       "      <td>Herceptin, Perjeta, and Kadcyla (TDM-1) are co...</td>\n",
       "      <td>93</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>4</td>\n",
       "      <td>It only discusses these Monoclonal Antibodies ...</td>\n",
       "      <td>176</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "   Unnamed: 0                                               Text  length\n",
       "0           0  It only discusses these Monoclonal Antibodies ...     176\n",
       "1           1  Listen to the podcast to hear Dr Loi explain:r...     625\n",
       "2           2  She also is a member of the Breast Immuno-Onco...     526\n",
       "3           3  Herceptin, Perjeta, and Kadcyla (TDM-1) are co...      93\n",
       "4           4  It only discusses these Monoclonal Antibodies ...     176"
      ]
     },
     "execution_count": 263,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "## Length of words in each sent\n",
    "df_drug['length'] = df_drug['Text'].apply(len)\n",
    "df_drug.head()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 264,
   "metadata": {},
   "outputs": [],
   "source": [
    "import matplotlib.pyplot as plt\n",
    "import seaborn as sns\n",
    "\n",
    "%matplotlib inline"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 123,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "<matplotlib.axes._subplots.AxesSubplot at 0x13c4342b0>"
      ]
     },
     "execution_count": 123,
     "metadata": {},
     "output_type": "execute_result"
    },
    {
     "data": {
      "image/png": "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\n",
      "text/plain": [
       "<Figure size 432x288 with 1 Axes>"
      ]
     },
     "metadata": {
      "needs_background": "light"
     },
     "output_type": "display_data"
    }
   ],
   "source": [
    "df_drug['length'].plot(bins=50, kind='hist')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 124,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "count      48.000000\n",
       "mean      284.937500\n",
       "std       207.848493\n",
       "min        43.000000\n",
       "25%       136.750000\n",
       "50%       197.000000\n",
       "75%       368.500000\n",
       "max      1010.000000\n",
       "Name: length, dtype: float64"
      ]
     },
     "execution_count": 124,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df_drug.length.describe()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 200,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "'This is an update on the Immunotherapy drug Opdivo (AKA: Nivolumab) Like Keytruda (see post above), Opdivo is a Monoclonal antibody and acts as a checkpoint inhibitor, specifically a PD1 inhibitor.'"
      ]
     },
     "execution_count": 200,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df_drug[df_drug['length'] == 197]['Text'].iloc[0]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 126,
   "metadata": {},
   "outputs": [],
   "source": [
    "import re\n",
    "import nltk\n",
    "from nltk.corpus import stopwords\n",
    "from nltk.stem.porter import PorterStemmer\n",
    "corpus=[]\n",
    "for i in range(0,48):\n",
    "    review = re.sub('[^a-zA-Z]', ' ', df_drug['Text'][i] )\n",
    "    review=review.lower()\n",
    "    review=review.split()\n",
    "    ps=PorterStemmer()\n",
    "    review=[ps.stem(word) for word in review if not word in set(stopwords.words('english'))]\n",
    "    review=' '.join(review)\n",
    "    corpus.append(review)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 127,
   "metadata": {},
   "outputs": [],
   "source": [
    "from sklearn.feature_extraction.text import CountVectorizer\n",
    "cv=CountVectorizer(max_features=100)\n",
    "X=cv.fit_transform(corpus).toarray()\n",
    "y=df_drug.iloc[:,0].values"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 128,
   "metadata": {},
   "outputs": [],
   "source": [
    "from sklearn.model_selection import train_test_split\n",
    "X_train, X_test, y_train, y_test = train_test_split(X, y, test_size = 0.20, random_state = 0)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 129,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "array([[0, 0, 0, ..., 0, 0, 0],\n",
       "       [1, 0, 1, ..., 0, 0, 0],\n",
       "       [0, 0, 0, ..., 1, 0, 0],\n",
       "       ...,\n",
       "       [0, 0, 0, ..., 0, 0, 0],\n",
       "       [0, 0, 0, ..., 1, 0, 0],\n",
       "       [0, 1, 0, ..., 0, 0, 0]])"
      ]
     },
     "execution_count": 129,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "X_train"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 130,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "array([-1,  0,  1, -1,  1,  1,  1,  0,  0,  0])"
      ]
     },
     "execution_count": 130,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "y_test"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 191,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "RandomForestClassifier(bootstrap=True, class_weight=None, criterion='entropy',\n",
       "                       max_depth=None, max_features='auto', max_leaf_nodes=None,\n",
       "                       min_impurity_decrease=0.0, min_impurity_split=None,\n",
       "                       min_samples_leaf=1, min_samples_split=2,\n",
       "                       min_weight_fraction_leaf=0.0, n_estimators=5,\n",
       "                       n_jobs=None, oob_score=False, random_state=0, verbose=0,\n",
       "                       warm_start=False)"
      ]
     },
     "execution_count": 191,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "from sklearn.ensemble import RandomForestClassifier\n",
    "classifier = RandomForestClassifier(n_estimators = 5, criterion = 'entropy', random_state = 0)\n",
    "classifier.fit(X_train, y_train)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 192,
   "metadata": {},
   "outputs": [],
   "source": [
    "y_pred = classifier.predict(X_test)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 193,
   "metadata": {},
   "outputs": [],
   "source": [
    "from sklearn.metrics import confusion_matrix\n",
    "cm = confusion_matrix(y_test, y_pred)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 194,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "array([[1, 0, 1],\n",
       "       [2, 2, 0],\n",
       "       [1, 0, 3]])"
      ]
     },
     "execution_count": 194,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "cm"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 195,
   "metadata": {},
   "outputs": [],
   "source": [
    "predictions = classifier.predict(X_test)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 196,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "[[1 0 1]\n",
      " [2 2 0]\n",
      " [1 0 3]]\n",
      "              precision    recall  f1-score   support\n",
      "\n",
      "          -1       0.25      0.50      0.33         2\n",
      "           0       1.00      0.50      0.67         4\n",
      "           1       0.75      0.75      0.75         4\n",
      "\n",
      "    accuracy                           0.60        10\n",
      "   macro avg       0.67      0.58      0.58        10\n",
      "weighted avg       0.75      0.60      0.63        10\n",
      "\n",
      "0.6\n"
     ]
    }
   ],
   "source": [
    "from sklearn.metrics import classification_report, confusion_matrix, accuracy_score\n",
    "\n",
    "print(confusion_matrix(y_test,predictions))\n",
    "print(classification_report(y_test,predictions))\n",
    "print(accuracy_score(y_test, predictions))"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## Vader Sentiment Analyzer"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 202,
   "metadata": {},
   "outputs": [],
   "source": [
    "from vaderSentiment.vaderSentiment import SentimentIntensityAnalyzer"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 209,
   "metadata": {},
   "outputs": [],
   "source": [
    "trial = df_drug['Text']"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 210,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "0    It only discusses these Monoclonal Antibodies ...\n",
       "1    Listen to the podcast to hear Dr Loi explain:r...\n",
       "2    She also is a member of the Breast Immuno-Onco...\n",
       "3    I have read the data from the Herceptin and Ne...\n",
       "4    It only discusses these Monoclonal Antibodies ...\n",
       "5    Herceptin, Perjeta, and Kadcyla (TDM-1) are co...\n",
       "6    This was a two armed trial, and half were give...\n",
       "7    chrissie - it was the GP2 peptide vaccine give...\n",
       "8    Therapeutic cancer vaccines currently being re...\n",
       "9    NeuVax was unable to prevent recurrence in thi...\n",
       "Name: Text, dtype: object"
      ]
     },
     "execution_count": 210,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "trial[:10]"
   ]
  },
  {
   "cell_type": "raw",
   "metadata": {},
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": 211,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "[{'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0, 'headline': 'It only discusses these Monoclonal Antibodies (mAbs) used for HER2+ patients: Herceptin (trastuzumab), Tykerb (lapatinib), Perjeta (pertuzumab), Kadcyla (Trastuzumab or T-DM1).'}, {'neg': 0.086, 'neu': 0.778, 'pos': 0.136, 'compound': 0.4926, 'headline': 'Listen to the podcast to hear Dr Loi explain:results from the PANACEA trial, which looked at using the immunotherapy medicine Keytruda (chemical name: pembrolizumab) along with Herceptin to treat Herceptin-resistant, HER2-positive, advanced-stage breast cancer that had high levels of PDL-1, a biomarker that indicates that Keytruda will be effective how an immunotherapy medicine like Keytruda works what tumor-infiltrating lymphocytes (TILs) are and why cancer tumors with high numbers of TILs seem to respond better to immunotherapyside effects of immunotherapy medicines Running time: 17:52    Thank you for this podcast!'}, {'neg': 0.196, 'neu': 0.773, 'pos': 0.031, 'compound': -0.9201, 'headline': 'She also is a member of the Breast Immuno-Oncology Task Force of the National Cancer Institute. Listen to the podcast to hear Dr. Litton discuss:how immunotherapy medicines work why immunotherapy medicines havent seemed to work as well in breast cancer as they have in other cancers the direction of immunotherapy research for breast cancer Running time: 13:35'}, {'neg': 0.124, 'neu': 0.705, 'pos': 0.171, 'compound': 0.1027, 'headline': 'I have read the data from the Herceptin and Neuvax trial, and it was certainly promising for triple negative participants with low-level Her2, which I was.'}, {'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0, 'headline': 'It only discusses these Monoclonal Antibodies (mAbs) used for HER2+ patients: Herceptin (trastuzumab), Tykerb (lapatinib), Perjeta (pertuzumab), Kadcyla (Trastuzumab or T-DM1).'}, {'neg': 0.0, 'neu': 0.859, 'pos': 0.141, 'compound': 0.2023, 'headline': 'Herceptin, Perjeta, and Kadcyla (TDM-1) are considered passive immunotherapies, as is Opdivo.'}, {'neg': 0.109, 'neu': 0.891, 'pos': 0.0, 'compound': -0.296, 'headline': 'This was a two armed trial, and half were given GP2 and half AE37, and some placebo with no vaccine.'}, {'neg': 0.0, 'neu': 1.0, 'pos': 0.0, 'compound': 0.0, 'headline': 'chrissie - it was the GP2 peptide vaccine given with GM-CSF.'}, {'neg': 0.257, 'neu': 0.743, 'pos': 0.0, 'compound': -0.8934, 'headline': 'Therapeutic cancer vaccines currently being researched in breast cancer clinical trials include:  - A HER2 peptide vaccine called NeuVax (nelipepimut-S) UPDATE - JUNE 2016: The NeuVax Phase 3 clinical trial (PRESENT) has been stopped (cancelled), due to futility.'}, {'neg': 0.168, 'neu': 0.72, 'pos': 0.112, 'compound': -0.7579, 'headline': 'NeuVax was unable to prevent recurrence in this trial; a HER2-pulsed dendritic cell vaccine; and the peptide vaccines E39 and J65, which are being tested to prevent breast cancer recurrence  - AV901, which helps the immune system destroy tumor cells that express HER2  - INO-1400 (by Inovio Pharmaceuticals), a synthetic DNA vaccine targeting the hTERT antigen.'}]\n"
     ]
    }
   ],
   "source": [
    "from nltk.sentiment.vader import SentimentIntensityAnalyzer as SIA\n",
    "\n",
    "sia = SIA()\n",
    "results = []\n",
    "\n",
    "for line in trial:\n",
    "    pol_score = sia.polarity_scores(line)\n",
    "    pol_score['headline'] = line\n",
    "    results.append(pol_score)\n",
    "\n",
    "print(results[:10])"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 212,
   "metadata": {},
   "outputs": [],
   "source": [
    "immun = pd.DataFrame(results)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 213,
   "metadata": {},
   "outputs": [],
   "source": [
    "immun.to_csv('immun.csv')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 215,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>compound</th>\n",
       "      <th>headline</th>\n",
       "      <th>neg</th>\n",
       "      <th>neu</th>\n",
       "      <th>pos</th>\n",
       "      <th>rating 1</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>0.0000</td>\n",
       "      <td>It only discusses these Monoclonal Antibodies ...</td>\n",
       "      <td>0.000</td>\n",
       "      <td>1.000</td>\n",
       "      <td>0.000</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>0.4926</td>\n",
       "      <td>Listen to the podcast to hear Dr Loi explain:r...</td>\n",
       "      <td>0.086</td>\n",
       "      <td>0.778</td>\n",
       "      <td>0.136</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>-0.9201</td>\n",
       "      <td>She also is a member of the Breast Immuno-Onco...</td>\n",
       "      <td>0.196</td>\n",
       "      <td>0.773</td>\n",
       "      <td>0.031</td>\n",
       "      <td>-1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>0.1027</td>\n",
       "      <td>I have read the data from the Herceptin and Ne...</td>\n",
       "      <td>0.124</td>\n",
       "      <td>0.705</td>\n",
       "      <td>0.171</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>0.0000</td>\n",
       "      <td>It only discusses these Monoclonal Antibodies ...</td>\n",
       "      <td>0.000</td>\n",
       "      <td>1.000</td>\n",
       "      <td>0.000</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "   compound                                           headline    neg    neu  \\\n",
       "0    0.0000  It only discusses these Monoclonal Antibodies ...  0.000  1.000   \n",
       "1    0.4926  Listen to the podcast to hear Dr Loi explain:r...  0.086  0.778   \n",
       "2   -0.9201  She also is a member of the Breast Immuno-Onco...  0.196  0.773   \n",
       "3    0.1027  I have read the data from the Herceptin and Ne...  0.124  0.705   \n",
       "4    0.0000  It only discusses these Monoclonal Antibodies ...  0.000  1.000   \n",
       "\n",
       "     pos  rating 1  \n",
       "0  0.000         0  \n",
       "1  0.136         1  \n",
       "2  0.031        -1  \n",
       "3  0.171         1  \n",
       "4  0.000         0  "
      ]
     },
     "execution_count": 215,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df_sent = pd.read_csv('immun.csv')\n",
    "df_sent.head()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 223,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "(48, 7)"
      ]
     },
     "execution_count": 223,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df_sent.shape"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 224,
   "metadata": {},
   "outputs": [],
   "source": [
    "df_sent.loc[df_sent['compound'] <= -0.05, 'rating 2'] = -1\n",
    "df_sent.loc[df_sent['compound'] >= 0.05, 'rating 2'] = 1\n",
    "df_x = df_sent.fillna(0)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 217,
   "metadata": {},
   "outputs": [],
   "source": [
    "from sklearn import metrics"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 225,
   "metadata": {},
   "outputs": [],
   "source": [
    "y_test = df_x['rating 1']\n",
    "y_pred = df_x['rating 2']"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 226,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "0     0.0\n",
       "1     1.0\n",
       "2    -1.0\n",
       "3     1.0\n",
       "4     0.0\n",
       "5     1.0\n",
       "6    -1.0\n",
       "7     0.0\n",
       "8    -1.0\n",
       "9    -1.0\n",
       "10    0.0\n",
       "11    1.0\n",
       "12   -1.0\n",
       "13   -1.0\n",
       "14    1.0\n",
       "15    0.0\n",
       "16   -1.0\n",
       "17   -1.0\n",
       "18    0.0\n",
       "19   -1.0\n",
       "20    0.0\n",
       "21   -1.0\n",
       "22    1.0\n",
       "23   -1.0\n",
       "24   -1.0\n",
       "25    1.0\n",
       "26    1.0\n",
       "27    0.0\n",
       "28    1.0\n",
       "29    1.0\n",
       "30    0.0\n",
       "31    1.0\n",
       "32   -1.0\n",
       "33   -1.0\n",
       "34    1.0\n",
       "35    1.0\n",
       "36    1.0\n",
       "37    1.0\n",
       "38    1.0\n",
       "39   -1.0\n",
       "40   -1.0\n",
       "41   -1.0\n",
       "42   -1.0\n",
       "43   -1.0\n",
       "44   -1.0\n",
       "45   -1.0\n",
       "46   -1.0\n",
       "47   -1.0\n",
       "Name: rating 2, dtype: float64"
      ]
     },
     "execution_count": 226,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "y_pred"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 227,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Mean Absolute Error: 0.6041666666666666\n",
      "Mean Squared Error: 0.8958333333333334\n",
      "Root Mean Squared Error: 0.9464847243000456\n"
     ]
    }
   ],
   "source": [
    "print('Mean Absolute Error:', metrics.mean_absolute_error(y_test, y_pred))  \n",
    "print('Mean Squared Error:', metrics.mean_squared_error(y_test, y_pred))  \n",
    "print('Root Mean Squared Error:', np.sqrt(metrics.mean_squared_error(y_test, y_pred)))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 265,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.5416666666666666\n"
     ]
    }
   ],
   "source": [
    "print(accuracy_score(y_test, y_pred))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python 3",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.6.8"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 2
}
